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Aim and Scope of This Dissertation 
The guiding principle of practitioners of Traditional Chinese Medicine is the 
maintenance of the natural balance of the human body and its restoration to balance 
during periods of pathogenic invasions and poor health. Substances, for such curative 
purpose, are derived from nature. The substances can be animal bodies, organs or 
tissues, higher plant structures, algae, fungi etc.. Fungi such as Ganoderma 
applanatum and Ganoderma lucidum have long been valuable substances in Traditional 
Chinese Medicine. It has been found that polysaccharides extracted from these fungi 
were active biological response modifier (BRM) and antitumor agent. Other fungi, 
including many edible mushrooms such as Lentinus edodes were also found to have 
polysaccharides which possesses B R M and antitumor properties. 
In this project, three edible mushrooms which are popular foodstuffs in oriental 
countries will be screened as a source for the extraction of potential antitumor 
polysaccharide(s). Flammulina velutipes, one of the mushrooms chosen for screening, 
was selected for the extraction. The bioactive components will be isolated and partially 
purified from the cell wall of Flammulina velutipes. Furthermore, the chemical, 




A b s t r a c t 
M a n y a n t i - t u m o r po lysacchar ides, iso lated f r o m fung i , w e r e iden t i f ied as ( 3 - ( l - ^ 3 ) -
D -g lucans . In this p ro jec t , three types o f edible fungus ； Volvariella volvacea, Lyophyllum 
aggregaliim ( shinieji ) and h'lamniulina ve/iilipes, w e r e screened fo r the presence o f P - ( l 
- > 3 ) - D - g l u c a n by ani l ine b lue stain ing. B y the s ta in ing m e t h o d , Flammulina veliitipes 
was found to be the r ichest source o f P - ( l - > 3 ) - D - g l u c a n a m o n g the three Ring i and w a s 
chosen as the target fungus in the pro jec t . F u r t h e r m o r e , the 3 ) - D - g l u c a n w a s 
main ly loca ted at the cell wa l l rather than in the cy top lasm o f the f l ingus . 
A f t e r s c r e e n i n g， t h e i so la t ion o f | 3 - ( 1 ^ 3 ) - D - g l u c a n f r o m the cel l w a l l o f the 
m u s h r o o m was t r ied. Cel l wa l l mater ia ls o f the m u s h r o o m was ob ta ined af ter ex tens ive 
wash ing o f the lyophy l i sed and p o w d e r e d fungus w i t h several types o f so lvent ( ddH:。， 
c h l o r o f o r m - m e t h a n o l m ix tu re , acetone and d d H ^ O ). p - ( l - > 3 ) - D - g l u c a n w a s first 
ex t rac ted f r o m the cell wa l l by hot wa te r ex t r ac t i on ( 1210C, 30 min . ). T h e ho t w a t e r 
ext rac ted residues was then t reated w i t h a lka l ine-urea m i x t u r e ( 65 o c , 30 min . ) t o 
release the rema in ing | 3 - ( l - > 3 ) - D - g l u c a n in the hot w a t e r ex t rac ted cel l w a l l . T h e 
ex t rac ted P - ( l — 3 ) - D - g l u c a n s we re neut ra l ised f i rs t w i t h acet ic ac id and then d ia lysed w i t h 
d H 2 0 t o reta in mac romo lecu les o f mo lecu la r w e i g h t > 3.5 k D . T h e ho t w a t e r ex t rac ted p -
( 1 — 3 ) - D - g l u c a n was named F H and the a lka l ine ex t rac ted p - ( l - > 3 ) - D - g l u c a n w a s named 
F A l . T h e F A l f rac t i on was f u n her separated in to the so lub le f r a c t i o n ( S F A l ) and the 
inso lub le f r ac t i on ( I F A l ) . T h e iso la ted F H , F A l and S F A l f r ac t i ons w e r e f o u n d t o be able 
t o t r i gge r a un ique t ype o f i n f l a m m a t i o n , V D H ( Vascu la r D i l a t i o n and H a e m o r r a g h e ) 
response. T h e response was repo r ted to have a h igh c o r r e l a t i o n w i t h the a n t i t u m o r ac t i v i t y 
f 
o f the po lysacchar ides. O n this basis, F H and S F A l w e r e selected f o r f u r t he r studies. B o t h 
F H and S F A l f rac t ions w e r e f o u n d to be s imi lar in the i r phys ica l p roper t ies . F o r examp le , 
they are b o t h h igh ly v iscous and have mo lecu la r w e i g h t es t ima ted > 300 k D b y gel. 
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permeat ion ch roma tog raphy . Chemica l analysis showed that bo th F H and S F A l con ta in 
main ly g lucose. T h e ident i ty o f bo th F H and S F A l was con f i rmed to be P - ( 1 ^ 3 ) - D -
g lucan by enzyme ( a f3-( 1 —>3)-D-glucanase isolated f r o m a b r o w n algae; Laminaria s p . ) 
d igest ion analysis. H o w e v e r , F H and S F A l we re found to possess d i f fe rent secondary 
st ructure. B y the C o n g o Red dye method, F H was f o u n d to possess a t r ip le hel ical 
s t ruc ture and S F A l possess a single helical s t ructure. 
B o t h F H and S F A l we re found to have no s igni f icant c y t o t o x i c ef fect w h e n us ing 
B r i ne Sh r imp as ind ica tor . F H and S F A l also have no d i rect c y t o t o x i c ef fect on mur i ne 
t u m o r cell l ines such as Sc -180 and P U 5 - 1 . 8 . W h e n the med ia t i on o f the regression o f 
t ransplantab le t u m o r s ( Sc -180 and PU5-1 .8 ) on mice was tested b o t h F H and S F A l 
caused m o r e than 90 % o f t u m o r regression. T h e regression was suspected to be caused 
by the augmen ta t i on o f mur ine i m m u n e system by F H and S F A l . I n the in vitro system, the 
ac t i va t ion o f B - l y m p h o c y t e , T - l y m p h o c y t e and macrophage w e r e tested. I t was f o u n d 
that on ly the p ro l i f e ra t i on o f B - l y m p h o c y t e was s l ight ly enhanced by F H . I n the in vivo 
system, b o t h F H and S F A l we re shown to act ivate bo th T - c e l l and macrophage, and an 
increase in serum interferon-、/ level. O ther than these act iv i t ies, F H and S F A l w h e n 
admin is tered in to mice can media te an increase in serum comp lemen t level and F H can 
mediate the secre t ion o f t u m o r necrosis fac to r ( T N F ) . F r o m the resul ts, i t w a s conc luded 
that F H and S F A l can enhance the regression o f some t ransp lantab le t u m o r s in mice. T h e 
enhancement o f the regression was not due to a d i rect c y t o t o x i c e f fect . Instead, the k i l l i n g 
was med ia ted t h r o u g h the augmen ta t i on o f the mur ine i m m u n e system. 
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Introduction 
Introduction 
C H A P T E R ONE 
I N T R O D U C T I O N 
1.1 I N T R O D U C T I O N 
N e o p l a s t i c g r o w t h is a resul t o f the t r a n s f o r m a t i o n o f n o r m a l cel l i n t o a state o f 
u n c o n t r o l l e d cel l d iv i s ion . T h e t r a n s f o r m a t i o n may be i nduced by va r i ous chemica ls , 
phys ica l and v i ra l agents. B e n i g n neop lasm w h e n lef t u n n o t i c e d may conve r t i n t o fa ta l 
ma l i gnan t t u m o r . T h e p reven t i on o f neop las t ic g r o w t h i n o u r b o d y is ach ieved b y o u r 
i m m u n e defence mechanisms. I t was p r o p o s e d that t u m o r do possess pa r t i cu la r an t igens， 
such as t u m o r - s p e c i f i c t ransp lan ta t i on ant igens ( T S T A s ) and t u m o r - s p e c i f i c ant igens 
( T S A s ) (Schre iber e l a / , 1988), w h i c h can be recogn ized and des t royed b y o u r i m m u n e 
system. 
T h e t rea tmen t o f cancer has l o n g been re l ied o n surgery , rad io the rapy and d r u g 
therapy . A l t h o u g h these therapeu t i c s t rategies are c o m m o n in c l in ica l pract ices, t hey su f fe r 
f r o m a lo t o f l im i t a t i ons and d isadvantages. Recen t l y , t w o n e w branches o f cancer t he rapy 
e v o l v e d ~ g e n e the rapy and i m m u n o t h e r a p y . These therap ies seem t o be the m o s t 
a t t rac t i ve cancer therapy . I t is because these therapies cause less side e f fec ts t h a n o t h e r 
types o f therapy . 
I m m u n o t h e r a p y inc ludes a n t i b o d y therapy , a d o p t i v e ce l lu lar i m m u n o t h e r a p y , 
c y t o k i n e t he rapy and s t imu la t i on o f i m m u n e ef fec tors . T h e s t i m u l a t i o n o f i m m u n e 
e f fec to rs can be d o n e by a lo t o f na tura l substances. I n m y M . Ph i l p ro j ec t , I a imed t o 
ex t rac t po ten t i a l a n t i - t u m o r po lysacchar ides , P - ( l - > 3 ) - D - g l u c a n ( s ) , f r o m the cel l w a l l o f 
Flammulina veluHpes, w h i c h k i l l t u m o r v ia s t imu la t i ng the host i m m u n e e f fec to rs . 
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1.2 T U M O R BTOLOGY 
T h e r e exist D N A sequences, the oncogenes ( H u n t e r , 1984)，in the n o r m a l cel l 
nuc le i w h e n a l tered can cause neoplast ic change. Oncogenes is may be i n d u c e d by 
chemica ls such as ca rc inogen ic h y d r o c a r b o n me thycho lan th rene etc. , phys ica l agents such 
as U V , X - , Y - i r rad ia t ion etc. , and v i ra l agents ( B i s h o p , 1985) such as A I D S v i r u s etc. . 
Oncogenes is may occu r as a resul t o f ove r express ion o f the una l te red genes (quan t i t a t i ve 
a l te rna t ion) o r as a resul t o f a m u t a t i o n w h i c h causes the gene t o p r o d u c e a n e w p r o t e i n 
(qua l i t a t i ve a l te rna t ion) . These agents a lways cause a l t e rna t i on at c h r o m o s o m a l leve l 
( C r o c e and K l e i u , 1985). Somet imes , the a l te rna t ion is spec i f ic i n na ture , e.g. the 9 : 2 2 
t rans loca t i on in ch ron i c g r a n u l o c y t i c l eukemia ( Ph i l ade lph ia c h r o m o s o m e ) and the 8 :2 , 
14 o r 22 t r ans loca t i on in B u r k i t t ' s l y m p h o m a , a t u m o r o f B - l y m p h o c y t e s . I n the B u r k i t t ' s 
t rans loca t ion , the c-myc oncogene is t rans fe r red t o a c h r o m o s o m a l r e g i o n w h i c h n o r m a l l y 
codes f o r i m m u n o g l o b u l i n s . S o m e o f the p ro te ins p r o d u c e d b y oncogenes i n the i n i t i a t i o n 
o r ma in tenance o f ma l i gnancy have been d i scove red t o have b i o l o g i c a l e f fec ts w h i c h may , 
at least pa r t l y , exp la in the neoplast ic process. Some are e x t r e m e l y s im i la r t o n o r m a l 
g r o w t h fac to rs (e.g. p la te le t -de r i ved g r o w t h f ac to r , ep ide rma l g r o w t h f a c t o r ) , o r the i r ce l l 
sur face recep to rs act ivates enzymes, such as kinases, and can the reby i n d u c e ce l l d i v i s ion . 
M a l i g n a n t t u m o r s usua l ly s h o w an increased m i t o t i c ac t i v i t y . H o w e v e r , 
ma l ignan t cel ls do no t a lways m u l t i p l y faster than the i r n o r m a l c o u n t e r p a r t s and a t u m o r 
resul ts because o f an imba lance b e t w e e n ce l lu la r p r o l i f e r a t i o n and ce l l loss. I n a t u m o r , 
there is a va r iab le p r o p o r t i o n o f ma l ignan t cel ls and a substant ia l p r o p o r t i o n o f n o n -
ma l ignan t s t r oma l o r reac t i ve cel ls. O n l y a p r o p o r t i o n o f the m a l i g n a n t cel ls c o m p o n e n t 
w i t h i n cancer have the capac i t y f o r i nde f in i te se l f - rep l i ca t ion . T h e y are ca l led t he s tem 
cells and are the ta rge ts f o r t r ea tmen t w i t h r ad io the rapy o r d r u g the rapy . T h e ra te o f 
t u m o r g r o w t h depends on the size o f the g r o w t h f rac t i on , the p r o p o r t i o n o f ma l i gnan t cel ls 
3 
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proceed ing t h r o u g h the cell cyc le to mi tos is at any one t ime, and also o n the cel l cyc le 
t ime. 
D u e to the occur rence o f m u t a t i o n in act ive p ro l i f e ra t i ng cells, he terogene i ty 
increases as the t u m o r s g r o w s . T h e heterogene i ty inc ludes var ia t ions in ce l lu lar 
appearance, h o r m o n e receptor concent ra t ions , and var ia t ions in response to t rea tment in 
d i f fe ren t metastases. Th i s he terogene i ty is thus a substant ia l b l o c k to successful t rea tment . 
Rad io the rapy , h o r m o n e therapy, c y t o t o x i c chemothe rapy and m o n o c l o n a l an t i body 
therapy o f ten fai l because o f the presence o f a smal l number o f cells w h i c h are resistant t o 
at tack. 
O the r than he terogene i ty , there is a p rope r t y o f ma l ignant t u m o r cal led metastat ic 
spread ( N i c o l s o n , 1979) that makes cancer d i f f i cu l t t o be cured. Me tas ta t i c spread is a 
comp l i ca ted process w h i c h occurs m o r e f requen t l y w i t h und i f fe ren t ia ted , rap id ly g r o w i n g 
tumors . O n l y a ve ry smal l p r o p o r t i o n o f shed cells are capable o f eventua l deve lopmen t 
in to d istant t umors . F o r successful spread, cells have t o b reach the vascu lar basement 
membrane in a target o rgan and then p ro l i f e ra te i n a f o r e i g n m i c r o - e n v i r o n m e n t . T h e 
breach ing o f basement membrane may invo lve , col lagenase and o ther d igest ive enzymes. 
1.3 T H E D E F E N C E M E C H A N I S M S 
A l l animals have defence mechanisms that p r o v i d e p r o t e c t i o n against pa thogens 
such as chemicals , v i rus , bacter ia , fung i , p r o t o z o a , he lmin thes and f o r e i g n t issues. T h e 
most comp l i ca ted and w e l l deve loped defence mechanisms are the h u m a n defence 
mechanisms. T h e defence mechan isms o f o u r b o d y can be non-spec i f i c o r h i gh l y speci f ic . 
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1.3.1 NON-SPECIFIC DEFENCE M E C H A N I S M S 
Non-spec i f i c defence mechanisms, innate i m m u n i t y ( R o i t t , 1988) , are d i rec ted 
against a m u l t i t u d e o f fo re ign agents by barr iers, p reven t ing the i r ent rance in to o u r body , 
o r by des t roy ing t hem qu i ck l y i f they do penetrate the body 's barr iers. T h e m a j o r bar r ie r is 
the sk in w h i c h is impermeab le to mos t in fec t ious agents. F u r t h e r m o r e , the ac id ic 
secret ions o f the sk in suppress the g r o w t h o f bacter ia. T h e inner surface o f o u r b o d y is 
l ined w i t h membranous layer covered w i t h mucus. T h e mucus toge the r w i t h t r apped 
bacter ia is r e m o v e d by c i l ia ry movemen t , cough ing and sneezing. Secret ions f r o m g lands 
o r the barr iers re in fo rce the barr ier f unc t i on such as ac id in gast r ic j u i ce , spermine and z inc 
in semen, lac toperox idase in m i l k and l ysozyme in tears, nasal secret ions and saliva. G u t 
m ic rob ia l f l o ra w h i c h can suppress the g r o w t h o f o ther m i c r o o r g a n i s m s also re in fo rce the 
bar r ie r func t ion . 
T h e des t ruc t i on o f i nvad ing pathogens is ach ieved by agents such as phagocy t i c 
cells, comp lemen t , acute phase pro te ins , in ter ferons, na tura l k i l l e r cel ls and eos inophi ls . 
A n y invaded c i r cu la t i ng m ic roo rgan i sms are ingested by phagocy tes , p o l y m o r p h o n u c l e a r 
neu t roph i l s and macrophages, and w e r e k i l l ed inside the phagocy tes . A l t e r n a t e l y , the 
c i r cu la t i ng m ic roo rgan i sms may act ivate the b l o o d c o m p l e m e n t p ro te ins , t h r o u g h the 
alternate pathway, which drill holes on the microorganism and cause lysis. Acute phase 
prote ins , C - reac t i ve pro te in , f i b r i nogen , C9 , F a c t o r B etc. , increase d u r i n g i n f ec t i on m a y 
i m p r o v e o u r genera l defences. T h e level o f the an t i - v i ra l agents; i n te r fe rons ( a - i n t e r f e r o n s , 
p - i n t e r f e rons and 丫 - i n t e r f e r o n s ) increases d u r i n g v i ra l i n fec t ion . T h e in te r fe rons can 
suppress v i ra l rep l i ca t i on and its spreading. N a t u r a l k i l l e r ce l l ( N K ce l l ) is a t y p e o f la rge 
g ranu la r l y m p h o c y t e s w h i c h help defence v i ra l i n fec t i on by k i l l i n g v i r a l l y i n fec ted cel ls and 
o ther pathogenesis. Eos inoph i l s are leucocy tes w h i c h p lay m a j o r defence ro l e i n he lm in the 
in fec t ion . A l l the agents descr ibed k i l l invaders in a non-spec i f i c manner . 
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1.3.2. SPECIFIC DEFENCE M E C H A N I S M S 
T h e spec i f ic defence mechan isms o r the i m m u n e response, u n l i k e non -spec i f c 
de fence mechan isms, w h e n ac t i va ted are t a i l o r - m a d e t o pa r t i cu la r t ype o f pa thogenes is 
and is h igh ly e f f ec t i ve in r e m o v i n g the pa thogen . I n general , there are t w o m a i n t ypes o f 
i m m u n e responses; the an t i body med ia ted i m m u n e response and the ce l l -med ia ted i m m u n e 
response. 
F o r the i m m u n e responses t o be ac t i va ted , any invaders shou ld be p rocessed 
b e f o r e they can be recogn i zed by e i ther the a n t i b o d y - o r ce l l -med ia ted i m m u n e response 
ca l led an t igen p resen ta t i on ( Janeway , 1993) . T h e an t igen p resen ta t i on requ i res an t igen-
p resen t i ng cel ls ( A P C s ) such as mac rophages , dendr i t i c cel ls, B - c e l l s etc. . D u r i n g t he 
process, invaders o r ant igens are f i rs t r equ i r ed to b i n d t o A P C s . T h e m e m b r a n e b o u n d 
ant igens are then in te rna l i sed t h r o u g h phagocy tos i s , r e c e p t o r - m e d i a t e d endocy tos i s o r 
p i n o c y t o s i s t o f o r m c y t o p l a s m i c vesic les ca l led endosomes. I n endosomes , t he an t igens are 
d iges ted in to f r a g m e n t s by enzymes, and d iges ted f r agmen ts are made t o assoc iate w i t h 
m a j o r h i s t o c o m p a t a b i l i t y c o m p l e x m o l e c u l e ( M H C ) . T h i s d iges ted an t igen f r a g m e n t and 
M H C c o m p l e x is f ina l l y m i g r a t e d t o sur face m e m b r a n e o f A P C s and ready t o be p resen ted 
t o o the r cel l t ypes o f the i m m u n e sys tem such as helper T - c e l l . 
Antibody-mediated immune response is highly effective in removing circulating 
pa thogens . I n a n t i b o d y - m e d i a t e d i m m u n e response, the e f f e c t o r agent is a n t i b o d y w h i c h is 
p r o d u c e d by B - l y m p h o c y t e s . B e f o r e a res t i ng B - c e l l can p r o d u c e a n t i b o d y e f f ec t i ve l y , i t 
s h o u l d be ac t i va ted . T h e a c t i v a t i o n o f a res t i ng B - c e l l and T - c e l l i n v o l v e t he b i n d i n g， 
p rocess ing and p resen t i ng o f c o r r e s p o n d i n g an t igen t o he lper T - c e l l ~ t h e mas te r ce l l f o r 
b o t h a n t i b o d y - and ce l l -med ia ted i m m u n e response. A f t e r p resen ta t ion , th is he lpe r T - c e l l 
is ac t i va ted t o increase i ts i n t e r l e u k i n - 2 ( I L - 2 ) r ecep to r exp ress ion and i ts I L - 2 , I L - 6 and 
in te r fe ron -Y ( I F N - y ) secre t ion . T h e secre ted I L - 2 s t imu la tes t he r es t i ng B - c e l l t o 
p r o l i f e r a t e and d i f f e ren t i a te i n to a c l one o f p lasma cel l . T h i s c l one o f p l asma ce l l p r o d u c e s 
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a n t i b o d y e f f ec t i ve l y , and the a n t i b o d y secreted o n l y recogn izes an t igen tha t has been 
presented ( the a n t i b o d y secreted is m o n o c l o n a l w i t h respect t o its an t igen b i n d i n g si te). 
T h e cons tan t r e g i o n o f the secreted a n t i b o d y can be de f ined i n to f i ve classes name ly I g G , 
I g A , I g M , I g D and I g E . I t is the d i f fe rences a m o n g the classes o f an t i body tha t a l l o w the 
an t i body cal l f o r d i f fe ren t k i l l i n g mechan isms i n v o l v i n g c o m p l e m e n t , N K cel ls, 
mac rophage , mast cel l , n e u t r o p h i l etc. , t o des t roy the an t igen e f fec t i ve ly . 
C e l l - m e d i a t e d i m m u n e response un l i ke a n t i b o d y - m e d i a t e d response is e f f ec t i ve i n 
r e m o v i n g in t race l l u la r i nvader ( v i r us ) , ma l i gnan t cel ls and f o r e i g n t issues. I n the ce l l -
med ia ted i m m u n e response , the e f f ec to r agent is c y t o t o x i c T - l y m p h o c y t e s ( C T L s ) . T h e 
ac t i va t i on o f p r e - C T L s requ i re t w o signals. O n e o f the s ignal r equ i red is class I M H C -
ant igen c o m p l e x o n a ta rget cel l , and the o t h e r is p r o v i d e d by cy tok i nes ( I L - 2 , I L - 6 and 
I F N - y ) secre ted by ac t i va ted he lper T - c e l l . T h e ac t i va ted p r e - C T L s d i f f e ren t i a te i n t o 
m a t u r e C T L s , w h e n recogn i zed i ts ta rge t cel l , w i t h class I M H C and c o r r e s p o n d i n g 
an t igen, secretes p e r f o r i n and t o x i n . P e r f o r i n d r i l l s ho les o n ta rge t ce l l and cause ce l l lys is, 
and t o x i n such as l y m p h o t o x i n causes apop tos i s o f ta rge t cel l . T h e l y m p h o k i n e s re leased 
by he lper T - c e l l no t o n l y regu la te T - and B - c e l l bu t also mob i l i se o the r cel ls o f the de fence 
mechan i sm such as m a c r o p h a g e , k i l l e r c e l l，N K cel l , g ranu locy tes etc.. 
1.4 E F F E C T O R M E C H A N I S M S IN A N T I - T U M O R I M M U N I T Y 
O u r b o d y defence sys tem does p rocess e f fec to rs tha t can d e s t r o y t u m o r cel ls 
named the i m m u n o s u r v e i l a n c e hypothes is . T h i s idea w a s f i rs t a r t i cu la ted b y M a c f a r l a n e 
B u r n e t ( 1 9 7 0 ) . T h e e f f ec to rs m a y be p r o t e c t i v e even a f te r ma l i gnan t cel ls have g r o w n i n t o 
t u m o r s . T h e e f f ec to r s i nc lude ; B - c e l l s , k i l l e r cel ls, he lper T cel ls, c y t o t o x i c T cel ls , n a t u r a l 
k i l l e r cel ls and mac rophages . H o w e v e r , the hypo thes i s is cha l l enged b y t he fac t t ha t i t is 
n o t genera l l y v a l i d f o r m o s t f o r m s o f cancer . F o r examp le , i f t he i m m u n e sys tem is 
r e q u i r e d t o p r e v e n t the f r equen t o c c u r r e n c e o f cancers, one w o u l d expec t t ha t m a n y m o r e 
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mal ignant t u m o r s w o u l d deve lop in ind iv idua ls w i t h congen i ta l o r acqu i red i m m u n o -
def ic iencies than in immunocompe ten t ind iv iduals. I n fact, th is is no t the case f o r most 
c o m m o n f o rms o f cancers, such as carc inomas o f the co lon , lung, o r breast. H o w e v e r , 
there is a remarkab ly increased inc idence o f cer ta in f o rms o f cancer in immunosuppressed 
ind iv iduals . 
1.4.1 B - C E L L 
B - c e l l , w h e n act ivated by t u m o r ant igens, p roduces an t ibody d i rec t against the 
t u m o r cells. H o w e v e r , bo th exper imenta l mode ls studies in h u m a n demons t ra te that 
an t i body is not very e f fec t ive in causing t u m o r re jec t ion, pa r t i cu la r l y so l id t umors . 
A n t i b o d y may play some roles in the con t ro l o f leukemia. I n the re jec t i on o f t u m o r , 
an t ibody calls fo r k i l le r cells and comp lemen t to comp le te the k i l l i n g (Abbas , 1991) . K i l l e r 
( K ) cells ( n o n - T , n o n - B , nul l cel ls) have Fc recep to r o n the i r membrane. I f t hey encoun te r 
a t u m o r cel l that has I g G molecules on its surface they w i l l in teract w i t h that "sensi t ised" 
cel l and des t roy it. T h e process is cal led the an t ibody -dependen t ce l lu lar c y t o t o x i c i t y 
( A D C C ) . T h e K cel l k i l l i ng process also invo lves an t ibody bu t requi res m u c h less an t i body 
than does A D C C . W h e n comp lemen t k i l l i ng is i n vo l ved I g M an t i body is requ i red . A s 
an t ibody b inds to the surface o f the t u m o r cel l , the classical c o m p l e m e n t p a t h w a y is 
t r i ggered , lead ing to the eventual des t ruc t i on o f the t u m o r cell . 
1.4.2 N A T U R A L KILLER (NK) CELLS (NON-T, N O N - B ) 
N K cells are m o r p h o l o g i c a l l y associated w i t h large g ranu la r l ymphocy tes . I t is 
be l ieved that N K cells are responsib le f o r immunosurve i l ance . T h e cel ls recogn ise and k i l l 
t u m o r cel ls v ia a d i rec t in te rac t ion be tween the N K cells and the t u m o r cel ls (by the same 
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mechanism as C T L cells). N K cells also have Fc receptors ; h o w e v e r , these cells can k i l l 
t u m o r cells w i t h o u t any at tached an t ibody (Abbas, 1991). 
1.4.3 M A C R O P H A G E S 
A c t i v a t e d macrophages are c y t o t o x i c to t u m o r cells (F i lder , 1974 ； L i o t t a , 1977) . 
T h e ac t i va t ion can be achieved by several routes. T u m o r cells coated w i t h ant ibod ies can 
act ivate mac rophage v ia the Fc recep to r o f macrophage. L y m p h o k i n e cal led mac rophage -
ac t i va t ing fac to r ( M A F ) released f r o m ac t iva ted T helper cells can also ac t iva te 
macrophage. M A F changes mac rophage metabo l i sm, and makes t h e m po ten t k i l le rs o f 
t u m o r cells. A c t i v a t e d macrophages do not re ly o n i n te rac t i ng w i t h any speci f ic t u m o r 
ant igen, bu t , l i ke N K cells, do seem to d is t ingu ish ma l ignan t f r o m n o r m a l cells. T h e r e are 
p robab ly several mechanisms o f macrophage k i l l i ng o f t u m o r ta rge t cel ls, some o f w h i c h 
are essential ly the same as the mechanisms o f macrophage k i l l i n g o f i n fec t ious o rgan isms 
(Abbas , 1991). These inc lude the release o f l ysozyma l enzymes and reac t ive o x y g e n 
metabol i tes. O the r react ive chemica l species, such as n i t r i c ox ide , may also p lay a ro le. 
A c t i v a t e d macrophages also secrete cy tok ines , i n te r fe ron ( I F N ) and t u m o r necros is f ac to r 
( T N F ) , that con t r i bu te to t u m o r cel l des t ruc t ion . I n te r fe rons may serve p r i m a r i l y as ant i -
p ro l i f e ra t i ve agents as we l l as the ac t i va t i on o f N K cells. I n add i t i on , i n te r fe rons augmen t 
the express ion o f class I M H C molecu les w h i c h make t u m o r s m o r e suscept ib le t o c o n t r o l 
by i m m u n e e f fec to r mechanisms. T N F k i l ls t u m o r s by at least t w o d i f f e ren t mechan isms. 
F i rs t , b i nd i ng o f T N F to h i gh -a f f i n i t y cel l sur face recep to rs is d i rec t l y t o x i c t o t u m o r cells. 
T h e t o x i c i t y may be a result o f the p r o d u c t i o n o f f ree radicals. D i r e c t t o x i c e f fec ts o f T N F 
may also i nvo l ve d i s rup t i on o f cy toske le tons . Second, in vivo ’ T N F causes t u m o r necros is 
by i m p a i r i n g the vascu lar isa t ion o f the t u m o r and in te r rup t nu t r i en t supp ly . 
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1.4.4 C Y T O T O X I C T-LYiMPFIOCYTES (CTLs) 
C T L s w e r e demonst ra ted to be e f fec t ive a n t i - t u m o r e f fec to r in vivo. T h e C T L s 
i nvo l ved are p redominan t l y class I M H C rest r ic ted. These cells may on l y p lay ro le in 
immunosurve i l l ance o f v i ra l l y induced tumors . M o n o n u c l e a r cells de r i ved f r o m the 
i n f l ammato ry in f i l t ra te in human sol id t umors , cal led t u m o r - i n f i l t r a t i n g l ymphocy tes ( T I L s ) 
w e r e found con ta in ing C T L s w i t h the capac i ty to lyse the t u m o r f r o m w h i c h they w e r e 
der ived (Rosenberg , 1986). H o w e v e r , the spec i f i c i ty o f the a n t i - t u m o r C T L s de r i ved f r o m 
per iphera l b l o o d or t u m o r s is not w e l l establ ished, since they also s h o w reac t i v i t y against 
unre la ted t u m o r cells. The k i l l i ng mechanisms o f C T L s i n v o l v e d i rec t cel l con tac t b e t w e e n 
C T L s and target tumors . A f t e r con tac t , the C T L s release p ro te ins w h i c h dr i l l s holes o n 
target cell and cause lysis. Fig. 1.1 summar ise the e f fec to r mechan isms in a n t i - t u m o r 
i m m u n i t y . 
1.5 C A N C E R T R E A T M E N T 
Cancer therapeut ic strategies i nvo l ve surgery, rad io the rapy , d r u g the rapy , gene 
therapy or immuno the rapy . T h e most c o m m o n l y used therapeu t i c strategies w e r e l im i t ed 
to surgery, rad io therapy and d r u g therapy. Gene therapy and i m m u n o t h e r a p y are st i l l i n 
the i r in fant stage f o r pract ica l purposes. 
1.5.1 S U R G E R Y 
Surgery cures m o r e pat ients o f cancer than do b o t h r ad io the rapy and c y t o t o x i c 
chemo the rapy toge ther . Surgery is also nove l by its m in ima l s ide e f fec t . H o w e v e r , su rgery 
do suf fer many disadvantages. I n case o f i r reparab le organs such as b r a i n and ne rvous 
t issues are i n v o l v e d , the use o f surgery w i l l be l im i ted . S u r g e r y also fa i ls t o cu re w h e n 
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Fig. 1.1 The effector mechanisms in anti-tumor immunity. 
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there is extensive metastasis, or when local exc is ion is incomple te . Fu r the rmore , surgery is 
not pract ical fo r patients o f advanced age or poo r general health such as pat ients w i t h 
anemia w i l l have increased anesthetic risks. 
1.5.2 R A D I O T H E R A P Y 
Radio therapy uses ion is ing radiat ions to cure cancer. The radiat ions may be X -
ray f r o m a X - r a y machine, 丫 - r a y s f r o m rad ionuc l ides such as 60Co, P-rays o r e lectrons 
f r o m rad ionuc l ides or machine and fast neut rons f r o m cyc lo t ron . T h e ion is ing radiat ions 
k i l l cancer cells by conver t ing oxygen to t ox i c radicals w h i c h cause D N A damage and 
prevent mitosis. A potent ia l advantage o f rad io therapy over surgery is that a greater 
v o l u m e o f t issue can be treated, but the t reated t u m o r cells are no t inev i tab ly eradicated. 
T h e inef fec t ive k i l l i ng may be due to the present o f hypox ia w i t h i n some tumors . O the r 
than these defects, rad io therapy causes severe t issue damage such as dermat i t is , 
leucocy topen ia etc.. 
1.5.3 D R U G T H E R A P Y 
I n rou t ine cl inical pract ices, ant i -cancer drugs fa l l i n to t w o ma in g roups , 
ho rmona l and cy to tox i c . H o r m o n a l agents are general ly m u c h bet ter to le ra ted than 
c y t o t o x i c drugs w h i c h can cause severe m o r b i d i t y and even death. O the r than t o x i c i t y , 
c y t o t o x i c drugs usual ly induce resistance (Hayes and W o l f , 1990) . T h e cura t i ve po ten t ia l 
o f these drugs are largely conf ined to re la t ive ly u n c o m m o n tumors . 
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1.5.4 G E N E T H E R A P Y 
T h e deve lopmen t o f gene therapy and i m m u n o t h e r a p y aims t o k i l l cancer 
se lect ive ly in o r d e r to m in im ise the d isadvantage o f surgery , rad io the rapy and d r u g 
therapy. O n e examp le o f gene therapy , v i m s - d i r e c t e d e n z y m e / p r o d r u g therapy ( R u b e r , 
1991 )， i nvo lves the in fec t ion o f hepa toma w i t h re t rov i rus bear ing var ice l la -zos te r v i r us 
t h y m i d i n e k inase ( V Z V T K ) gene. T h e gene is expressed m o r e e f fec t i ve ly in neop las t i c 
cel ls than no rma l l i ver cells. Expressed V Z V T K p r o d u c t can ac t iva te a n o n t o x i c p r o d r u g 
, 6 - m e t h o x y p u r i n e a rab inonuc leos ide ( a r a M ) t o c y t o t o x i c anabol i te adenine 
a rab inonuc leos ide t r i phospha te (ara A T P ) and thus achieve speci f ic k i l l i ng . 
1.5.5 I M M U N O T H E R A P Y 
I m m u n o t h e r a p y , w h i c h inc ludes an t i body therapy , a d o p t i v e ce l lu la r 
i m m u n o t h e r a p y , c y t o k i n e therapy and s t imu la t i on o f i m m u n e e f fec tors , takes advantage o f 
the natura l e f f e c t o r o f the defence mechan ism. A n t i b o d y the rapy t reats cancer by ra is ing 
an t i body against speci f ic t u m o r ant igens. T h e an t i body w i t h o r w i t h o u t con juga te ( d r u g , 
t o x i n , r a d i o i s o t o p e etc. ) is used t o k i l l cancer spec i f ica l ly (Pastan, 1991) . I n a d o p t i v e 
ce l lu lar i m m u n o t h e r a p y , cells such as natura l k i l l e r cel ls and t u m o r - i n f i l t r a t i n g l y m p h o c y t e s 
(Rosenberg , 1986) w i t h t u m o r k i l l i n g capac i ty , w e r e iso la ted f r o m pat ients and c u l t u r e d 
/>? vitro w i t h l L - 2 . A f t e r cu l tu re , ac t i va ted cel ls may be admin is te red e i ther t oge the r w i t h 
o r w i t h o u t I L - 2 i n to the pat ients f o r cu ra t i ve pu rpose (Rosenberg , 1988，1989). 
O t h e r than c o n t r i b u t i o n t o a d o p t i v e ce l lu la r i m m u n o t h e r a p y , c y t o k i n e s w h e n 
used a lone also have cu ra t i ve po ten t ia l . C y t o k i n e s such as I L - 2 , I L - 4 , T N F , I F N - a , I F N - y , 
G M - C S F and G - C S F are c u r r e n t l y unde r c l in ica l t r ia ls ( J e r n b e r g - W i k l u n d , 1991) . T h e use 
o f these c y t o k i n e s a ims to ac t i va te the in vivo i m m u n e e f fec to rs t o k i l l cancer . A l t h o u g h 
1 3 
Introduction 
these cy tok ines are present endogenous ly , w h e n h igh dosage is admin is te red (dosage 
usual ly requ i red to g ive e f fec t ive t rea tment ) , severe side ef fects may occur . 
A n o t h e r w a y to s t imula te the i m m u n e e f fec tors t o k i l l cancer cells is achieved by 
exogenous p roduc ts such as B C G , g lucan, Levam iso le ( P r o c t o r et al, 1977) etc.. T h e 
p roduc ts have great var ia t ions in nature. These p roduc ts also der ived f r o m d iversed 
sources such as t u m o r cell an t igen ( f r o m t u m o r cel ls), l ip ids, p ro te ins o r po lysacchar ides 
( f r o m h igher p lants, algae, f l i ng i and bacter ia) and L e v a m i s o l e f r o m synthet ic compounds . 
These p roduc ts s t imu la te the non-spec i f i c endogenous i m m u n e responses. 
1.6 N O N - C Y T O T O X I C A N T I T U M O R POLYSACCHARIDES OF FUNGI 
Bo tan i ca l source (h igher plants, algae, f ung i and bacter ia ) is the ma jo r source o f 
n o n - c y t o t o x i c a n t i t u m o r po lysacchar ides (Wh is t l e r , 1976). These po lysacchar ides va r ied a 
lo t in the i r componen t s and l inkages. The po lysacchar ides may con ta in phosphate g r o u p , 
am ino g r o u p , 0 - a c e t y l a t e d g r o u p , u ron i c acids, am ino acids and the m o n o sugar u n i t s ~ 
g lucose, mannose, galactose, arabinose, xy lose etc.. T h e sugar un i ts make up the 
po lysacchar ide ske le ton may be l i nked toge ther by a - , P- , (1—2)，（1—3), ( l-»4) o r (l-> 
6) - l i nkages (Wh i s t l e r , 1976). E v e n there exist many var iab les that con t r i bu te t o the great 
d ivers i ty o f the po lysacchar ides, the n o n - c y t o t o x i c a n t i t u m o r po lysacchar ides o f f ung i are 
qu i te un ique in the i r compos i t i ons and s t ruc ture . T h e a n t i t u m o r f unga l po lysacchar ides 
was r o u g h l y d i v i ded in to three ma jo r g roups ; yeast po lysacchar ides, l i chen po lysacchar ides 
and f l inga l po lysacchar ides ( i n c l u d e all f ung i except yeast and l i chen ). 
1.6.1 Y E A S T P O L Y S A C C H A R I D E S 
Z y m o s a n , composed o f essential ly in tac t yeast cel l w a l l r o u g h l y conta ins equa l 
a m o u n t o f P - ( l - > 3 ) - D - g l u c a n and a - m a n n a n ( B a c o n et al, 1969) , has been repo r ted t o be 
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act ive against so l id t umors such as Sa rcoma 37’ and Sa rcoma 180 in I C R a lb ino mice 
( B r a d n e r et " / ’ 1958), whereas ascites t u m o r we re not responsive. M a n n a n f rac t ions are 
ob ta ined f r o m the h o t - w a t e r ex t rac t o f yeast cells, and g l ucan f rac t ions are ob ta ined by 
a lka l ine ex t rac t i on o f the residue. D e p e n d i n g on the species and the m e t h o d o f 
f rac t i ona t ion , mannan or g lucomannan , or b o t h can be obta ined. I t was f o u n d tha t g lucan , 
mannan and g l ucomannan ex t rac ted w e r e all act ive. H o w e v e r , mannans are m o r e ac t ive 
than the g lucan f rac t ion . T h e ac t i v i t y o f the g l u c o m a n n a n f r a c t i o n seems t o depend o n the 
con ten t o f D - g l u c o s e and, perhaps, the l inkages. T h e i r a n t i t u m o r ac t iv i t ies and 
c o m p o s i t i o n s are g i ven in Tab le 1.1. 
1.6.2 LICHEN P O L Y S A C C H A R I D E S 
V a r i o u s g lucans, such as pustu lan, l ichenan, and iso l ichenan, i so la ted f r o m 
l ichens, have been f o u n d to be ac t ive against so l id sarcomas in mice. P u s t u l a n - l i k e g lucans 
con ta in i ng (3-( l - ^ 6 ) - D - l i n l < a g e s have been iso la ted f r o m Gyrophera esculeuta and 
Lassalia papulose (Sh ibata el al, 1968), bu t these g lucans d i f f e red f r o m pus tu lan i n 
containing 4-10 % of acetyl groups situated at 0 - 3 . Deacetylation lowered the activity, 
and rep lacement o f 0 - a c e t y l g r o u p s by 0 - m e t h y l g r o u p s , o r c o m p l e t e ace t y l a t i on o f the 
g l u c a n ’ y ie lded inac t ive p r o d u c t ( W h i s t l e r， 1 9 6 5 ) . S im i la r , pa r t i a l l y ace ty la ted g lucans 
have been iso la ted f r o m Umhilicaria sp., and l i chenan [a p - ( l - > 3 ) - , ( l - > 4 ) - D g l u c a n ] and 
iso l ichenan [an a - ( l - > 3 ) - , ( 1 — 4 ) - D - g l u c a n ] have been iso la ted f r o m Cetraria sp.. A n 
a n t i t u m o r l ichenan has also been iso la ted f r o m Alectoria sp. O t h e r l i chens tha t have 
y ie lded a n t i t u m o r g lucans are Parmelia caperata, Clandomia mitus, Usnea baylei and 
Evernia pnmastri (Wh is t l e r , 1976). These g lucans w e r e ac t i ve against S a r c o m a 180 so l id 
t u m o r s，a n d inac t i ve against ascites t u m o r s . T h e a n t i t u m o r ac t i v i t y , c o m p o s i t i o n s and 
s t ruc tu re o f va r i ous g lucans iso la ted f r o m l ichens are g i v e n in T a b l e 1.2. 
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1.6.3 FUNGAL POLYSACCHARIDES 
Crude , fungal ext racts f r o m a number o f f ung i (ascomycetes , bas id iomyce tes , 
deu te romyce tes and oomyce tes ) have been repo r ted to be ac t ive against expe r imen ta l 
t u m o r s , and, in some cases, they s h o w e d de f in i te pa l l ia t i ve ac t i on o n non-operab le , h u m a n 
t u m o r s (Wh is t l e r , 1976). A number o f a n t i t u m o r po lysacchar ides have been ex t rac ted 
f r o m the f l ing i . T h e ske le ton o f the ex t rac ted po lysacchar ides c o m p o s e d ma in l y o f — 
3 ) - l i n k e d D - g l u c o s e and smal l p r o p o r t i o n s o f D - g a l a c t o s e and D - m a n n o s e have been 
ex t rac ted f r o m f ru i t bodies, myce l ia , and f r o m cu l t u re f l u ids o f va r i ous f l i n g i such as 
Cereosparie crypto丨mriae, Chaetomhm cochlides, Cladosporiiim fuhnwi, Cochliobolus 
miyabeamis ( N a n b a and K u r o d a , 1987), Grifola frondosa ( O h n o et al, 1984 ,1986 ) , 
Lefidmis eciodes (Ch ihara et al, 1970 and T o g a m i et al, 1982) , Pholiota namenko, 
Phytophthora species ( B a i n e t e a u et al, 1988) , Plevrotus ostreatiis ( Y o s h i o k a et al, 1972)， 
戶o/./V/ cocos, Pyrensphora teres、Sclewlinia sclerotionim etc.. Such po lysacchar ides have 
s h o w n ac t i v i t y against sol id t u m o r s such as sa rcoma 37 and sa rcoma 180，whereas no 
response was seen against ascites sa rcoma and syngeneic t u m o r s . A n t i t u m o r 
po lysacchar ides w i t h ske le ton dev ia te f r o m the l inear (3- ( l - > 3 ) - l i n k e d D - g l u c o s e s t ruc tu re 
have also been ex t rac ted f r o m some f l ing i . 
Po lysacchar ides f r o m Tremella d i f f e r f r o m o the r f bnga l po lysacchar ides i n 
chemica l c o m p o s i t i o n , be ing c o m p o s e d o f D - x y l o s e , D - m a n n o s e , and D - g l u c u r o n i c ac id. 
O t h e r va r ia t ions inc ludes P - ( l — 4 ) - l i n k e d D - g l u c a n s f r o m Lentimis edodes (Sasak i et al, 
1976)，p-(l->3)- and (l->4)-linked D-glucans from Ganoderma applanatum (Sasaki et 
al, 1971) and Phe/iimis lin/eiis (Sasak i et al, 1971) , a P - ( l - > 3 ) - D - g l u c a n h a v i n g a p - D -
g l u c o p y r a n o s y l g r o u p l inked ( l - > 6 ) t o every t h i r d t o f o u r t h res idue o f the m a i n cha in f r o m 
Schizophyllwv commune ( Y a i n a m o t o et al, 1981) etc.. V a r i a t i o n s , due t o f r e q u e n c y and 
l eng th o f branch, also exist. Never the less , they al l s h o w ac t i v i t y . T h e i r a n t i t u m o r ac t i v i t y , 
c o m p o s i t i o n s and s t ruc tu re are s h o w n in Tab le 1.3. 
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1.7 FUNGI A N D THEIR POLYSACCHARIDES 
Fung i can s imply be def ined as wa l l ed eukaryo t i c organisms w h o s e n u t r i t i o n 
depends on abso rp t i on o f p re fo rmed organ ic mat ter by passive d i f fus ion . K i n g d o m o f 
fung i was r o u g h l y d i v ided in to f i ve ma jo r g roups ; Oomycetes , Z y g o m y c e t e s , 
Ascomyce tes , Bas id iomyce tes and Deu te romyce tes , accord ing to the i r s t ruc tu re , 
phys io logy and b iochemis t ry (Ba r tn i ck i -Ga rc i a , 1961). 
T h e po lysacchar ides p roduced by fung i are qu i te diverse ( L e w i s , 1991) . T h e 
d i f fe rent f o r m o f po lysacchar ides may act as ei ther reserve carbohydra tes o r s t ruc tu ra l 
carbohydrates. Fungal po lysacchar ides are s t ruc tu ra l l y qu i te d i f fe ren t f r o m 
polysacchar ides o f o ther natura l sources, and they are g r o u p e d acco rd i ng t o the i r 
componen t sugars and p redominan t con f igu ra t ions , or in the case o f he te ropo lymers , the 
s t ruc tu re o f the ma in chain. 
1.7.1 R E S E R V E C A R B O H Y D R A T E S 
Reserve carbohydra tes in Ringi can be f o u n d in t race l lu la r ly ( c y t o p l a s m i c ) o r 
ex t race l lu la r ly (e.g. cu l tu re med ium) . A l l the reserve carbohydra tes act as on l y ca rbon 
reserve and energy reserve except po lyo ls ( S m i t h and B e r r y , 1978) ; the c o m m o n e s t and 
mos t abundant so lub le carbohydra tes in myce l ia o f mos t f l i ng i ( L e w i s and Smi th , 1967) . 
Po l yo l s are sugar a lcoho l such as mann i to l and arabi to l . T reha lose is an a , a - d i g l u c o s i d e 
present in cy top lasm. O ther less c o m m o n carbohydra te reserves inc lude g l y cogen , starch, 
m y c o d e x t r a n (n igeran) , a - D - g l u c a n , p - D - g l u c a n , po lyga lac tose, and ac id ic 
po lysacchar ides. G l y c o g e n and starch present in f l i ng i in t race l lu lar ly . T h e y , b o t h have 
s imi lar s t ruc tures, consist o f mu l t i p l e branched molecu les con ta in ing n u m e r o u s chains o f 
oc-( 1 — 4 ) - l i nked D - g l u c o s e residues except starch possesses add i t i ona l l inear a - ( l - > 4 ) -
l i nked D - g l u c o s e po lymers . M y c o d e x t r a n , exists in t race l lu la r ly , w h i c h is a l inear p o l y m e r 
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o f D - g l u c o s e w i t h a l ternate a - ( l - ^ 3 ) - D - and a - ( l - > 4 ) - D - l i nked g l u c o p y r a n o s y l residues 
( G o r i n & Spencer , 1968). a - D - g l u c a n such as pu l lu lan p r o d u c e d by Pulhilaria pullttlans 
present ex t race l lu la i i y . a - D - g l u c a n d i f fe r f r o m m y c o d e x t r a n by its l inkage. U n l i k e 
m y c o d e x t r a n , a - D - g l u c a n such as pseudonigeran, de r i ved f r o m Aspergillus niger 
N R R L 3 2 6 , con ta ins p redominan t l y a - ( I - > 3 ) - D - l inkages ( 8 7 % ) and some a - ( l - > 4 ) _D_ 
l inkages ( 1 3 % ) instead o f a l ternate a - ( l - ^ 3 ) - D - and a - ( l — 4 ) - D - l i n k a g e s on ly . P - D -
G lucans serve as reserve are present in t race l lu la r ly and ch ie f l y conta ins 1 — 3 l inkages. I t 
may also con ta in b ranched P - D - g l u c a n s w i t h 1 — 4 l inkage and 1 — 6 l inkage. L i n e a r P - D -
g lucan w i t h exc lus ive ly ( 1 — 6 ) l inkage also exist ( M a n n e r s et al, 1974) . F r e e m a n and 
M a c p h e r s o n ( 1 9 4 9 ) descr ibed t w o ex t race l lu la r po lysacchar ides p r o d u c e d b y strains o f 
Penicilliinn Infenm, a neutra l po lyga lac tose and an ac id ic po l yg lucose . O t h e r ex t race l lu la r 
ac id ic po lysacchar ides such as malanoga lac tan and p e p t i d o p h o s p h o g a l a c t o - m a n n a n s w e r e 
also repo r ted ( G a n d e r , 1974), 
1.7.2 S T R U C T U R A L P O L Y S A C C H A R I D E S 
St ruc tu ra l po lysacchar ides o f f l i ng i are ma in ly res t r i c ted t o the cel l w a l l . U n l i k e 
p lant cel l w a l l ’ f i i nga l cel l w a l l has great va r ia t ions in i ts m a j o r w a l l c o m p o n e n t s ( S m i t h 
and B e r r y , 1978) . F o r example , the m a j o r c o m p o n e n t s can be ch i t in , ce l lu lose, p - D -
g lucan，glycogen, ch i tosan, mannan, ga lac tosamine and galactose. C h i t i n is t he c o m m o n e s t 
m a j o r w a l l po lysacchar ides o f fung i . I t is a l inear p o l y m e r o f N - a c e t y l g l u c o s a m i n e l i n k e d 
by 4 ) g l y c o s i d i c bond. Ce l lu lose, the m a j o r w a l l c o m p o n e n t o f p lan t , ex is ts as m a j o r 
w a l l po lysacchar ides o f cer ta in funga l g r o u p . I t is a l inear p o l y m e r o f g l ucose l i n k e d b y p -
( 1 — 4 ) g l ycos id i c bond . P - D - g l u c a n s are g lucose h o m o p o l y m e r w i t h p - ( l - > 3 ) - l i n k a g e 
(unbranched) . V a r i a t i o n s due to the presence o f P - ( l ~ > 4 ) o r 6 ) l i nkages also exist . 
G l y c o g e n , a reserve po lysacchar ide , does c o n t r i b u t e t o the w a l l s t r uc tu re o f ce r ta in f u n g i 
( A l e x o p o u l o s and M i m s , 1979). I t is a m u l t i p l y b ranched mo lecu les c o n t a i n i n g m a n y 
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chains o f a - ( 1 ^ 4 ) - l i n k e d glucose. Ch i tosan is a l inear p o l y m e r o f g lucosamine l i nked by P 
- ( l - > 4 ) - l i n k a g e . Mannan , is a h o m o p o l y m e r o f mannose, w h i c h may con ta in a - ( l - > 2 ) - D - , 
a - ( l - ^ 3 ) - D - , a - ( l - > 6 ) - D - , p - ( l - > 3 ) - D - and p - ( l - > 4 ) - D - l i n k a g e s . Polysacchar ides, such 
as a - D - g l u c a n s w i t h a - ( l — 3 ) - and a - ( l - > 4 ) - l i n k a g e , heteropo lysacchar ides and ac id ic 
polysacchar ides also con t r ibu te to the wa l l s t ruc tu re bu t res t r ic ted to ma t r i x c o m p o n e n t s 
but not skeletal elements. A l l fung i can be d i v ided in to three g roups acco rd ing t o the i r 
ma jo r skeletal e lements; the ch i t inous g roup , the ce l lu los ic g r o u p and the misce l laneous 
g r o u p (O 'B r i en and Ralph, 1966). Tab le 1.4 shows representat ive f l i nga l m e m b e r o f 
d i f fe ren t cell wa l l ca tegory . 
1.8 T H E A R C H I T E C T U R E OF T H E F U N G A L C E L L W A L L 
In this paragraph, on ly the a rch i tec tu re o f ch i t i nous g r o u p w i l l be descr ibed as the 
target fungus-Hamn川""a ve/iiiipes-of my p r o j e c t , be longs to this g roup . 
The wa l l o f ch i t inous fung i adapt a m i c ro f i b r i l l a r s t ruc tu re (Wessels et al, 1989) : 
a ske le ton o f i n t e r w o v e n m ic ro f ib r i l s , con fe r r i ng tensi le s t rength, embedded in an 
amorphous mat r i x . The m ic ro f i b r i l is a g r o u p o f paral le l unsubs t i tu ted a l ka l i - i nso lub le 
g l ycosaminog l ycan (ch i t i n ) chains associated by h y d r o g e n - b o n d i n g to f o r m f i b r i l s t ruc tu re . 
T h e mic ro f ib r i l s f o r m a s t i f f n e t w o r k o f i n te rconnec ted m ic ro f i b r i l s by h y d r o g e n - b o n d o f 
subst i tu ted g l ycosaminog lycan chains be tween ch i t i n m ic ro f i b r i l s . Th ree chains o f P - ( l — 
3)-D-glucans twisted to form a triple helices. The hydroxyl group of the terminal glucose 
residues o f the helices w i l l condense (by Schi fF reac t ion ) w i t h the am ino g r o u p o f the 
g lucosaminog l ycan to f o r m a cova len t a t tachment (S tagg and Feather , 1973) . T h i s f u r t he r 
s t rengthen the m ic ro f i b r i l n e t w o r k s t ruc ture . Some p - D - g l u c o s e s may rema in una t tached 
in mature cel l wa l l and are embedded in the a m o r p h o u s m a t r i x w h i c h f i l l u p the spaces 
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between the n e t w o r k . Fig. 1,2 i l lustrates the arrangement o f the w a l l componen ts . O the r 
than polysacchar ides, the amorphous mat r i x do conta in a f e w pro te ins and l ip ids. 
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Cell Wall Composition in the Fungi. (Modified slightly from Barnicki-Garcia, 
1970) 
Fungal Group Cell Wall Category Representative Genera 
Chitinous Chitin-Chitosan Mucor, Phycomyces, 
Zygorhynchus 
Chitin-p-Glucan Allomyces, Neurospora, 
Aspergillus 
Chitin-Maiman Sporobolomyces, Rhodotorula 
Cellulosic Cellulose-Glycogen Polysphondylium, 
Dictyostelium 
Cellulose-P-Glucan Phytophthora, Pythium, 
Saprolegnia 
Cellulose-Chitin Rhizidiomyces 
Miscellaneous Mannan-P-Glucan Saccharomyces, Candida 
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C H A P T E R T W O 
M A T E R I A L S AND M E T H O D S 
2.1 M A T E R I A L S 
2.1.1 A N I M A L S 
Inbred female B A L B / c , female C 5 7 B L / 6 J and ou tb red male I C R a lb ino m ice 
w e r e bred at the A n i m a l H o u s e o f the Chinese Un i ve r s i t y o f H o n g K o n g . T h e y w e r e fed 
by animal diet ( C h o w 5001, Roden t Lab . ) . Excep t as ind icated, female B A L B / c and 
female C 5 7 B L / 6 J m ice at the age o f 6 -8 w e e k o l d and male I C R a lb ino m ice w e i g h t e d at 
38 g w e r e used in each exper iment . 
2.1.2 M U S H R O O M S 
Fresh f r u i t i n g bod ies o f Flammulina velutipes, LyophyUitm aggregatiim {shimeji) 
and Volvarie/la vohacea w e r e b r o u g h t f r o m Yaohan ’ a loca l depar tmen t s tore. T h e 
m u s h r o o m s w e r e i m p o r t e d f r o m Japan. 
2.1.3 BUFFERS, C U L T U R E M E D I A A N D C H E M I C A L S 
Phosphate-bufFered-sa l ine 
P B S w a s p repared by d i sso l v ing 8.0 g N a C l , 0 .2 g K C l , 1.44 g l ^ a ^ W O ^ . l U f i , 
0 .2 g K H , P O , in 1 l i t re doub le d is t i l led w a t e r ( d d H ^ O ) . T h e p H o f the s o l u t i o n w a s 
ad justed to 7.4 w i t h 1 M N a O H o r 1 M H C l . T h e so lu t i on w a s ster i l ised b y a u t o c l a v i n g at 
121 OC f o r 20 min . 
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Hank ' s Ba lanced Salt S o l u t i o n ( H B S S ) 
Hank ' s Ba lanced Salt p o w d e r ( S i g m a Chem. Co . , U . S . A . ) f o r 1 l i t re p r e p a r a t i o n 
w a s d isso lved in 1 l i t re o f d d H ^ O con ta i n i ng 0 .35 g s o d i u m b icarbonate . T h e s o l u t i o n w a s 
ad jus ted t o p H 7.4 and ster i l ised by m e m b r a n e f i l t ra t i on . 
R P M I - 1 6 4 0 M e d i u m 
R P M I - 1 6 4 0 p o w d e r ( G i b c o Co . , U . S . A . ) f o r 1 l i t re p r e p a r a t i o n w a s d i sso l ved i n 
1 l i t re o f d d H a O c o n t a i n i n g 0 .85 g N a H C O ] . T h e s o l u t i o n w a s ad jus ted t o p H 7 .4 and 
s ter i l ised by m e m b r a n e f i l t r a t i on . R P M I m e d i u m w i t h o u t supp lemen t o the r t h a n 1 % 
an t ib io t i cs was usua l l y used in w a s h i n g cel ls and was des igna ted as "p l a i n R P M I m e d i u m " . 
S e r u m Supp lemen ts 
Feta l c a l f se rum ( F C S ) w a s ob ta ined f r o m F l o w L a b . , A u s t r a l i a and G i b c o , 
U . S . A . F C S was p repared as 50 ml a l i quo ts and s to red at - 2 0 ^ C u n t i l use. H e a t -
i nac t i va ted F C S ( H I F C S ) was p repa red by i n c u b a t i n g the a l i quo ts at 56 ^ C f o r 30 m in . 
F C S w a s usua l l y used as a supp lemen t t o g r o w t h m e d i u m f o r ce l l cu l t u re in vitro and the 
f ina l c o n c e n t r a t i o n w a s n o r m a l l y 10 % . H I F C S , o n the o the r h a n d，w a s used as a s e r u m 
supp lemen t f o r c y t o t o x i c i t y and cy tos ta t i c assays. 
P e n i c i l l i n - S t r e p t o m y c i n - F i i n g i z o n e S o l u t i o n ( P S F ) 
P S F was b r o u g h t f r o m G i b c o , U . S . A . S t o c k s o l u t i o n ( l O O x ) c o n t a i n i n g 10 ,000 
u n i t s / m l pen ic i l l i n G , 10,000 | . ig/ml o f s t r e t o m y c i n su l fa te and 3 0 0 | . ig/ml o f a m p h o t e r i c i n 
B was s to red at - 2 0 ^ C as 5 m l a l iquo ts . Usua l l y , 5 m l P S F s t o c k w a s added t o 5 0 0 m l 
R P M I m e d i u m c o n t a i n i n g 10% F C S as the " c o m p l e t e m e d i u m " f o r in vitro ce l l c u l t u r e . 
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An t i bod ies 
M o n o c l o n a l rat an t i -mouse T h y 1.2 an t ibody (c lone F 7 D 5 ) was purchased f r o m 
Serotec Co. , U . K . and used at a d i l u t i o n o f 1 :1 ,000 in R P M I med ium. 
Rabbi t ant i -sheep red b l o o d cell an t i body ( S R B C ) was purchased f r o m ( A c c u r a t e 
Chemica ls and Scient i f ic C o , U . S . A . ) and was s tored at - 2 0 ^ C as 250 |_d a l iquots . 
B a r l e y - P - D - g l u c a n 
Th is is a so lub le 3 ) - D - g l u c a n der i ved f r o m bar ley and was purchased f r o m 
S igma Chem. Co. , U . S . A . . T h e g lucan was d isso lved in ddH〗。 (3 m g / m l ) and s to red at -
20 OC as 1 ml a l iquots . 
P - ( l - > 3 ) - D - g I u c a n 
Th is is an inso lub le p - ( l - ^ 3 ) - D - g l u c a n der ived f r o m Pleiirotus ostreatiis and was 
purchased f r o m S igma Chem. Co. , U . S . A . . T h e g lucan w a s suspended in d d H s O (3 
m g / m l ) and s tored at - 20 ^ C as 1 m l a l iquots . 
C o m p l e m e n t ( C ) 
H e m o - L o gu inea p ig c o m p l e m e n t was purchased f r o m Cedar lane Lab . , Canada. 
T h e l yophy l i sed p o w d e r was recons t i tu ted w i t h ice co ld d is t i l led w a t e r , d i s t r i bu ted in 1 m l 
a l iquo ts and immed ia te l y f rozen at - 7 0 〇。unt i l use. 
L a m i n a r i n 
Th is is a so lub le P - ( l - > 3 ) - D - g l u c a n de r i ved f r o m a sea b r o w n algae, Laminaria 
digitata, and was purchased f r o m S igma Chem. Co . , U . S . A . . T h e g lucan was suspended in 
細 2 0 (3 m g / m l ) and s tored at - 2 0 ^ C as 1 m l a l iquots . 
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Laminar inase 
Th is is a 1 - > 3 - ( 1 - > 3 ; 1 - » 4 ) - P - D - G l u c a n 3 (4 ) -g lucanohydro lase , w h o s e natura l 
substrate is Lamina r i n . Th is was purchased f r o m Sigma Chem. Co. , U . S . A . 
Plant ge la t in 
T y p e V io ta-carrageenan, der ived f r o m Gigartina aciciilaire and Gigartina 
pistil lata, was purchased f r o m S igma Chem. Co. , U . S . A . . T h e plant ge la t in was used as a 
s tandard in per ioda te ox i da t i on and to prepare Ge la t in ve rona l bu f fe r ( G V B ) . 
Py r id ine 
Th is o rgan ic so lvent was purchased f r o m E. M e r c k , Ge rmany and was used as 
deve lop ing so lvent in c h r o m a t o g r a p h i c separat ion. 
Schi fFs reagent 
T h e reagent was purchased f r o m B D H , Eng land . T h e reagent w a s used t o sta in 
ingested yeast cel l w a l l par t ic le in phagocy t i c assay. 
C h r o m a t o g r a p h i c mater ia ls 
1. B - c e l l dep le t i ng c o l u m n k i t 
T h e B - c e l l dep le t ing k i t was purchased f r o m Cedar lane L a b . L t d . , Canada. T h e 
c o l u m n was used t o prepare T - c e l l p o p u l a t i o n f r o m splenocytes. 
2. T L C plate 
T h e glass plate is p recoa ted w i t h K iesege l 60 F254 o f d imens ions: 2 0 c m x 20 cm. 
T h e plates w e r e purchased f r o m E. M e r c k , Germany . 
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3. Sephadex G - 1 0 0 and G - 2 0 0 
T h e gel was purchased f r o m Pharmic ia L K B , Sweden and was used to est imate 
the mo lecu la r w e i g h t o f the separated polysacchar ides. 
Dyes 
1. An i l i ne B l u e 
Th i s is purchased f r o m B D H Eng land. Th is dye was used to screen po ten t ia l 
m u s h r o o m w h i c h has P - ( l - > 3 ) - D - g I u c a n in its cel l wa l l . 
2. C o n g o Red So lu t i on 
3.S |_iM C o n g o red (S igma Chem. Co. , U . S . A . ) in d d H ^ O was used to i den t i f y P -
( l - > 3 ) - D - g l u c a n . 
3. N e u t r a l R e d So lu t i on 
0 . 5 % ( w / v ) neut ra l red (S igma Chem. Co. , U . S . A . ) in P B S was used 
as a v i ta l dye f o r the s ta in ing o f v iable cells. 
4. M T T dye ‘ 
M T T dye (3 - [ 4 , 5 - D i m e t h y l t h i a z o l - 2 - y l ] - 2 , 5 - d i p h e n y l t e t r a z o l i u m b r o m i d e ) w a s 
purchased f r o m S igma Chem. Co. , U . S . A . . T h e dye was used in c o l o r i m e t r i c c y t o t o x i c i t y 
assay. 
5. P ro te i n Assay D y e Reagent 
The dye is purchased from Bio-Rad U.S.A. and was used to determine the protein 
con ten t o f the separated po lysacchar ide f rac t ions. 
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6. T r y p h a n B l u e S o l u t i o n 
0 . 1 % ( w / v ) t r y p h a n b lue ( S i g m a Chem. Co., U . S . A . ) in P B S w a s used t o assess 
the v iab i l i t y o f cel ls. 
E l i sa K i t s 
1. M u r i n e G M - C S F E l i sa K i t 
T h e k i t w a s purchased f r o m E n d o g e n , U . S . A . . T h e k i t was used t o de tec t s e r u m 
G M - C S F level o f e x p e r i m e n t i n g m ice and the use o f the k i t s t r i c t l y f o l l o w e d the 
i ns t ruc t i ons o f the k i t . 
2. M u r i n e I n t e r f e r o n - y E l i sa K i t 
T h e k i t w a s purchased f r o m G e n z y m e , U . S . A . . T h e k i t w a s used t o de tec t s e r u m 
In te r fe ron -Y level o f e x p e r i m e n t i n g m ice and the use o f the k i t s t r i c t l y f o l l o w e d the 
i ns t ruc t i ons o f the k i t . 
3. M u r i n e I n t e r I e u k i n - 1 a E l i sa K i t 
T h e k i t w a s pu rchased f r o m G e n z y m e , U . S . A . . T h e k i t w a s used t o de tec t s e r u m 
I L - 1 a level o f e x p e r i m e n t i n g m i ce and the use o f the k i t s t r i c t l y f o l l o w e d the i ns t r uc t i ons 
o f the k i t . 
4. M u r i n e I n t e r l e u k i n - 4 E l i sa K i t 
T h e k i t w a s pu rchased f r o m E n d o g e n , U . S . A . . T h e k i t w a s used t o de tec t s e r u m 
I L - 4 leve l o f e x p e r i m e n t i n g m i ce and the use o f the k i t s t r i c t l y f o l l o w e d the i n s t r u c t i o n s o f 
the k i t . 
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F ico l l -Paque So lu t i on 
T h e ster i le so lu t ion was purchased f r o m Pharmacia L K B , Sweden. Th i s is used fo r 
ill vitro l y m p h o c y t e iso lat ion. 
M i t o g e n s 
M i t o g e n s such as concanava l in A ( C o n A ) and l ipopo lysacchar ide ( L P S ) w e r e 
purchased f r o m the Sigma Chem. Co. , U .S .A . . They w e r e d isso lved in P B S (1 m g / m l ) , 
f i l t e red w i t h 0.45 ).im m i l l i po re membrane and s tored as 300 a l iquots at - 2 0 ^ C un t i l 
use. 
Sc in t i l lan t 
Sc in t i l lan t was prepared by m i x i n g 0 . 0 1 % ( w / v ) d ime thy l - 1 ,4 -b i s (2 - (5 -
pheny loxazo l ) ) benzene ( P O P O P ) and 0 . 4 % ( w / v ) 2 ,5 -d ipheny loxazo le ( P P O ) in to luene 
(F isher Chem. Co . , U . S . A . ) and was st i r red ove rn igh t be fore use. 
Sheep R e d B l o o d Cel ls ( S R B C ) 
Sheep red b l o o d cells ( S R B C ) w e r e purchased f r o m Serotec Co . , U . K . . 
( M e t h y l - m ) T h y m i d i n e O H - T d R ) So lu t i on 
( M e t h y l - ^ H ) T h y m i d i n e (1 m C i / m l ) was purchased f r o m A m e r s h a m , U . K . . 10 | i 
C i / m l w o r k i n g so lu t i on was prepared by d i l u t i ng the s tock so lu t i on w i t h c o m p l e t e R P M I 
m e d i u m . F o r pulse label ing, 50 |al w o r k i n g so lu t i on was added t o each cu l tu re we l l . 
Yeast 
Yeas t {Saccharomyces cerevisiae), was purchased f r o m S igma C h e m . Co . , 
U . S . A . , was used to prepare yeast cell wa l l . T h e yeast cel l w a l l w a s used in phagocy t i c 
and a n t i t u m o r assay. 
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2.1.4 Cell lines 
( 1 ) F ib rob las t - l i ke T u m o r s ( L - 9 2 9 ) : 
Th i s is a t r ans fo rmed f ib rob las t cel l l ine der ived f r o m C 3 H mice. 
( 2 ) M a c r o p h a g e - l i k e t u m o r ( P U 5 - 1 . 8 ) : 
Th i s is a spontaneous mac rophage - l i ke t u m o r der i ved f r o m B A L B / c mice. 
( 3 ) M o u s e Sa rcoma ( S c - 1 8 0 ) : 
Th i s cel l l ine was der i ved f r o m Swiss Webs te r Sa rcoma 180 ascites. A l l these cel l 
l ines ( w i t h the excep t i on o f f ib rob las t cel l l ines) w e r e ma in ta ined in suspens ion cu l tu res i n 
c o m p l e t e R P M I m e d i u m and sub-cu l tu red every 2 to 3 days. T h e f ib rob las t cel l l ines, o n 
the o the r hand, w e r e ma in ta ined in 75 cm2 t issue cu l tu re f lask (Cos ta r , U . S . A . ) i n 30 m l 
c o m p l e t e R P M I m e d i u m . W h e n the cells near ly f o r m e d a con f l uen t mono laye r , they w e r e 
t r yps in i zed w i t h t r yps in ( 0 . 1 % ) - E D T A ( 0 . 0 4 % ) so lu t i on ( G i b c o , U . S . A . ) f o r 2 min . at 37 
OC，washed th ree t imes w i t h c o m p l e t e R P M I m e d i u m and 105 v iab le cel ls w e r e seeded per 
f lask. 
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2.2 M E T H O D S 
2.2.1 SCREENING OF p - ( l - > 3 ) - D - G L U C A N 
M e t h o d s o f Nakan i sh i et al ( 1 9 7 4 ) , w i t h s l ight m o d i f i c a t i o n s , w a s used. A n i l i n e 
b lue dye (1 m g / m l c i H ^ ) , 0 .7 ml , was m i x e d w i t h 0 .7 m l so l id sample suspens ion ( 1 0 0 
m g / 1 . 5 m l d H ^ O ) . T h e m i x t u r e was equ i l i b ra ted f o r 2 hr. w i t h shak ing at r o o m 
tempera tu re . So l i d par t ic les w e r e spun d o w n by c e n t r i f u g a t i o n ( 1 0 , 0 0 0 x g , 10 m i n . ) and 
supernatant was removed . T h e residues w e r e washed t w i c e w i t h me thano l and t w i c e w i t h 
d H ^ O . In the w a s h i n g processes, w a s h i n g so lvent was added to a f ina l v o l u m e o f 1.5 m l 
and equ i l i b ra ted at r o o m tempera tu re f o r 1 hr . , w i t h shak ing. A f t e r wash ing , the c o l o r o f 
the pel let was no ted . A b lue c o l o r means there exist 3 ) - D - g l u c a n in the so l id pel le t . 
2.2.2 E X T R A C T I O N AND FRACTIONATION OF FlammuUna velutipes 
T h e p rocedu res fo r the p repa ra t i on o f the F H and S F A l f r o m FlammuUna 
velutipes ( F . V . ) are s h o w n in F ig . 2 .1. T h e m e t h o d was a d o p t e d f r o m K r a u s et al ( 1 9 9 2 ) 
w i t h s l ight mod i f i ca t i ons . O n e k g o f the f resh f r u i t i n g bod ies o f the m u s h r o o m w e r e 
l yophy l i sed and homogen i sed w i t h a W a r i n g b lender . T h e d r i ed p o w d e r w a s w a s h e d w i t h 
P B S at 4 o c f o r 2 hr. T h e residues w e r e spun d o w n and w a s h e d again w i t h P B S at 4 ^ C 
f o r 1 hr. Res idues f r o m the P B S w a s h i n g w e r e washed sequent ia l l y w i t h 2 x d d H a O，2 x 
1:1 C H C l j - M e O H ， 2 x acetone and 2 x d H ^ O (at 20 o C f o r 30 min . f o r each w a s h ) . T h e 
res idues f r o m these w a s h i n g processes w e r e l y o p h y l i s e d and y i e l ded the ce l l w a l l 
mater ia ls . 
T h e d r i ed cel l w a l l mater ia ls was suspended in d H : 0 (1 g / 1 0 0 m l ) and b o i l e d at 
121 o C f o r 30 min . T h e bo i led suspens ion w a s f i l t e red t h r o u g h a glass f i be r f i l t e r G F / C 
( W h a t m a n , U . S . A . ) and the f i l t e red supernatan t w a s l y o p h y l i s e d and des igna ted F H . T h e 
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Fresh mushroom fruiting bodies ai Flammulina velutipes 
T 




Homogenised into powder with a Waring blender 
T 
Washed with PBS (Ig/ 100ml) at 4 ^C for 2 hr. 
T 
Spun down powder (10,000 xg, 10 min.) 
Z T 
Discarded supernatant Washed with PBS (Ig/ lOOml) at 4 ^C for 1 hr. 
T 
spun down powder (10,000 xg, 10 min.) 
Z T 
Discarded supernatant Washed residues with d d H � � ( 3 g / 100ml) at 20^0 for 30 min. x2 
T 
Spun down residues (10,000 xg, 10 min.) 
z T 
Discarded supernatant Washed residues with 1:1 CHCl3-MeOH (3g/100ml) at 20 ^C for 30 min. x2 
T 
Spun down residues (10,000 xg, 10 min.) 
T 
Discarded supernatant Washed residues with acetone (3g/100ml) at 20 ^C for 30 min. x2 
r 
Spun down residues (10,000 xg, 10 min.) 
Y 
Discarded supernatant Washed residues with ddH^O (3g/100ml) at 20 ^C for 30 min. x2 
r 
Spun down residues (10,000 xg, 10 min.) 
X Y 
Discarded supernatant Lyophylised 
Y 
Cell Wall Materials 
Fig 2.1 A flow chart showing the preparation of the Cell Wall Materials of Flammulina velutipes 
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Ceil Wall Materials 
T 
Suspended in d d H � � ( I g / 100ml) 
r 
Boiled at 121 ^C for 30 nun., (autoclaved) 
T 
Filtered tiirough Whatman GF/C glass fiber filter 
^ 丫 
j iT Residues 
r 
Fil如te Washed residues with ddEjO (Ig/100ml) x2 
T 
Spun down residues (10,000 xg, 10 min.) 
Supernatant Residues 
各 z 
Dialysis 300ml vs 12 1 ddH^O Lyophylised 
at 4 OC for 4 times: 12 hr. each 
(dialysis tubing ofMWCO: 3.5 kD) 
、‘ 
Suspended residues in 10% NaOH + 5% urea solution (Ig/ 100ml) 
、， r 
� ‘ Filtered through Whatman GF/C glass fiber filter 
T 
Lyophylised (FH) Neutralised filtrate with Cone. Acetic Acid 
> f 
Every 300 ml of the filtrate was diaiysed against 12 1 ddHaO 
at 4 Oc for 7 times: 12 hr. each (dialysis tubing ofMWCO: 3.5 kD) 
I 
^ ^ ^ ^ ^ ^ Spun down residues ( 3,000 xg, 10 min. ) 
^ ^ ^ Residues 
Washed residues with ddH^O (Ig /100 ml) 
r 
Spun down residues ( 3,000 xg, 10 min. ) 
X \ 
Supernatant Residues 
” > f 
�f 
Lyophylised (SFAl) Lyophylised (IFAl) 
Fig. 2.1 A flow chart showing the preparation of FH, FAl, SFAl and IFAl 
37 
Materials and Methods 
res idues f r o m the f i l t r a t i on process was washed ex tens ive ly w i t h d d H j O t o r e m o v e any 
r e m a i n i n g F H and then l yophy l i sed . 
T h e bo i l ed and d r ied residues was used to p repare the f rac t ions : F A l , S F A l and 
I F A l . T h e residues was soaked in 10% N a O H + 5 % urea s o l u t i o n ( I g / lOO m l ) at 65 OQ 
f o r 1.5 hr. ( O h n o el al, 1986). A f t e r t rea tmen t , the a lka l ine s o l u t i o n w a s filtered t h r o u g h 
a glass f ibe r f i l t e r G F / C . T h e f i l t e red supernatant was neut ra l i sed w i t h concen t ra ted acet ic 
ac id. T h e neut ra l i sed so lu t i on , 300 ml , was then d ia lysed against 7 x 12 l i t re d d H j O f o r 12 
hr. each by us ing d ia lys is t u b i n g o f M W C O : 3.5 k D ( S p e c t r u m M e d i c a l I ndus t r i a l , I nc . 
U . S . A . ) . T h e d ia lysed so l u t i on was l yophy l i sed to y ie ld F A l f r a c t i o n w h i c h is a m i x t u r e o f 
w a t e r so lub le and w a t e r inso lub le po lysacchar ides . T h e w a t e r inso lub le po l ysaccha r ide 
w a s spun d o w n by a h igh speed cen t r i f uge ( B e c k m a n , M o d e l J2 -21 , U . S . A . ) at 3 , 0 0 0 x g 
f o r 30 min . T h e supernatan t ob ta ined was l yophy l i sed and des ignated S F A l . T h e spun 
d o w n res idues w a s ex tens ive ly washed w i t h d d H ^ O and l yophy l i sed t o y i e l d I F A l . I n th is 
p ro j ec t , b o t h F H and S F A l w e r e selected as the ta rge ts f o r the i nves t i ga t i on o f t he i r 
po ten t i a l a n t i t u m o r ac t i v i t y . 
2 . 2 . 3 C H A R A C T E R I S A T I O N O F Flammulina velutipes 
2.2.3.1 The Determination of Carbohydrate Content o f F . V . Fractions 
T h e m e t h o d o f D u b o i s et al ( 1 9 5 6 ) w a s adop ted . I n the assay, d e x t r a n ( M W 
72，200) w a s used as a s tandard. Pheno l reagent ( 2 5 0 5 % ) w a s m i x e d w i t h 2 5 0 | i l 
samp le (1 m g / i n l d H f i ) . T o the 500 … m i x t u r e , 5 m l concen t ra ted su l fo r i c ac id w a s added 
and w a i t e d f o r 20 min . at r o o m tempera tu re . T h e absorbance o f the r e a c t i o n m i x t u r e at 
4 9 0 n m w a s then measured. T h e a m o u n t o f c a r b o h y d r a t e present in F H , F A l , S F A l and 
I F A l w a s ca l cu la ted f r o m the d e x t r a n s tandard curve . 
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2.2.3.2 The Determinat ion of Protein Content of F.V. Fractions 
The B r a d f o r d m i c r o p r o t e i n assay ( B r a d f o r d , 1976) was used in p r o t e i n con ten t 
de terminat ion . In the de te rmina t ion , B S A was used as p ro te in standard. 0.8 M l sample (1 
m g / m l d H j O ) was a l l owed to m ix w i t h 0.2 ml , f i l tered and non-d i lu ted , B r a d f o r d reagent 
( B i o - R a d , U . S . A . ) . The reac t ion m ix tu re was a l l owed to w a i t f o r 20 min . be fo re 
absorbance at 595 nm was measured. 
2.2.3.3 The Determinat ion of Uronic Acid Content of F.V. Fractions 
T h e carbazo le reac t ion (Chap l i n and Kennedy , 1986) was adpoted. B o r a t e 
su l f l i r i c -ac id reagent ( 1500 |.L1) was added to sc rew-capped tubes and coo led in ice. 
Standard o r test so lu t ions, 250 j.il, w e r e care fu l l y layered on to the sur face o f the bo ra te -
su l fu r ic acid m i x t u r e and a l l o w e d to d i f fuse f o r 10 min. A f t e r d i f fus ion , the tubes w e r e 
gent ly m ixed in ice coo l wa te r . W h e n t h o r o u g h l y m ixed , the tubes w e r e heated in a b o i l i n g 
w a t e r bath f o r 10 min. , then coo led in ice bath. C o o l e d carbazole, 50 |j.l, w a s added t o the 
m i x t u r e and v o i t e x e d . T h e m i x t u r e was bo i led in a wa te r ba th f o r 15 min . T h e bo i l ed 
m i x t u r e was coo led in an ice-bath, and the absorbance was read at 525 nm. 
2.2.3.4 T h e Determinnt ion of C o m p o n e n t Sugar Units of F.V. Fract ions 
T h e m e t h o d o f Szys t k i ew i cz and D e m e t r i o u ( 1 9 7 1 ) w a s adop ted f o r 
c h r o m a t o g r a p h i c separat ion o f m o n o s u g a r un i ts f r o m hyd ro l ysed samples. H y d r o l y s i s w a s 
done by add ing 1.2 ml F H , S F A I , I F A l , P - ( l - > 3 ) - D - g l u c a n {Plenrotus ostreatus) o r 
g lucose (3 m g / m l ) t o 0.6 m l 12 M H C l . T h e m i x t u r e was in jec ted in to a one end sealed 
Pasteur p ipet tes w i t h a syr inge. T h e Pasteur p ipet tes con ta in ing the samples w e r e b o i l e d i n 
a 100 o c w a t e r ba th fo r 5 min . , t o d r i ve away air in the Pasteur p ipet tes. A f t e r bo i l i ng , the 
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Open end o f the Pasteur pipettes was sealed by a tlame. The air t ightened Pasteur pipettes 
were fur ther heated in a 100 oC water bath for 2 hr. One end o f the sealed Pasteur 
pipettes were cut open to w i t h d r a w the hydrolysate. The hydrolysate (2 |.il) f r o m each 
sample was spotted on a T L C plate (Kiesegel 60 M e r c k ) . The spots were air dr ied, 
and the T L C plate was developed in a fume hood w i t h deve lop ing solvent ； pyr id ine: 
ethylacetate: d R j O (26: 66: 8). The sugars on the T L C plate were detected by an alkal ine 
si lver staining method (Treve lyan et al, 1950). The plate was f i rst sprayed w i t h reagent A 
(0 .1 ml o f saturated aqueous si lver ni t rate was added in to 20 m l acetone, and d H z O was 
then added d rop-w ise unt i l the si lver ni t rate redissolve), and then w i t h reagent B (0.5 M 
N a O H in aqueous ethanol). The sprayed plate was air dr ied and the R f value o f any spot 
detected was measured. 
2.2.3.5 Periodate Uptake of F.V. Fractions 
The method o f Wh is t le r (1965) , w i t h sl ight modi f ica t ions , was adopted. l o t a -
Carrageenan, dext ran ( M W 72 ,200) and g lucose were used as standard. F H , S F A l o r 
standard (0.6 ml ) was mixed w i t h 0.6 ml potass ium per iodate so lu t ion (0.045 M ) . T h e 
react ion m ix tu re was kept at r o o m temperature and in dark. A t t ime intervals, 20 [x\ o f the 
react ion m ix tu re was taken out and d i lu ted 250 t imes fo r absorbance measurement. T h e 
wave length used fo r absorbance measurement was 222.5 nm. 
2.2.3.6 Limiiliis Amebocvte Lysate (LAL) Coagulation Assay 
A l l glass wares used in the assays were heated at 180 o c fo r 3 hr. P ipet te t ips and 
dH〗。were autoclaved. The reconst i tu ted Pyrote l l , 0.1 ml, was added to each reac t ion test 
tube. T o the test tube, test sample (1 mg /m l ) was fur ther added, and m i x e d v i g o r o u s l y f o r 
20 -30 seconds. The shaken tubes were placed in a 37 oC ± 1 o c air ba th f o r 60 min . 士 2 
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min. w i t h o u t d is turbance. A t the end o f the incuba t ion per iod , the tube was inver ted w i t h 
one smoo th mo t i on . A pos i t ive test is ind icated by the f o r m a t i o n o f a gel w h i c h d id no t 
col lapse w h e n the tube was inver ted. 
2.2.3.7 The Digestion of F.V. Fractions with Laminarinase 
T h e m e t h o d o f Czop and Aus ten ( 1 9 8 5 ) , w i t h s l ight mod i f i ca t i ons , was adopted. 
Laminar inase, de r i ved f r o m the algae Laminaria sp.’ was used to check the l inkage t ype o f 
the f rac t ions ( F H , S F A l and I F A l ) . A n y g lucose released f r o m the d iges t ion was 
de te rmined by a g lucose ox idase k i t purchased f r o m S igma Chem. , U . S . A . . Laminar inase 
was d isso lved in to c i t ra te bu f fe r (0 .005 M c i t ra te + 0.15 M N a C l , p H . 5 . 2 ) in concen t ra t i on 
equals I u n i t / m l bu f fe r . D i f fe ren t Flammulina f rac t ions and standards w e r e also d isso lved 
in the same bu f fe r (1 mg /m l ) . Equa l v o l u m e o f enzyme and substrate w e r e m i x e d and 
incubated fo r 24 hr. to ensure comp le te d iges t ion ( i f possib le) . F o r every 2 v o l u m e s o f 
enzyme d iges t ion m ix tu re , 4 vo lumes o f PBS were added. P B S was used to adjust the p H 
o f the reac t ion m i x t u r e to 7.0 fo r the ac t ion o f g lucose oxidase. T h e n 0 .1 m l o f p H 
adjusted enzyme digested m i x t u r e was taken to de te rmine g lucose amoun t released by the 
S igma g lucose k i t . T h e percentage o f d igest ib le | 3 - ( l , 3 ) - D - g l u c a n w a s ca lcu la ted 
acco rd ing to the f o l l o w i n g equat ion. 
0/0 of digestion = OD of test sample 
〇D of Laminarm 
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2.2.3.8 Secondary and Tertiary Structure Determination of FH and SFAl 
The m e t h o d o f B laschck et al (1992) , w i t h s l ight mod i f i ca t ions , was adopted. 
O t h e r than IR , N M R and X - r a y analysis, C o n g o Red dye p r o v i d e a cheap, s imple and 
rap id m e t h o d to de te rmine the c o n f o r m a t i o n o f ( 3 - ( 1 ^ 3 ) - D - g l u c a n t h e t r i p le hel ical , the 
s ingle hel ical o r the random co i l s t ructure. The c o n f o r m a t i o n o f the g lucan he l ix is 
ma in ta ined by hyd rogen bonds w h i c h can be d is rup ted by alkal ine. I n fact, the t r i p le hel ical 
s t ruc tu re can be d is rup ted in to single hel ix by a lkal ine p H . A fu r the r increase in a lka l in i ty 
d is rupts the s ingle hel ix in to a r a n d o m coi l . T h e wave leng th , w h e r e m a x i m u m absorp t i on 
occu r red , o f C o n g o Red dye w h e n binds to t r ip le hel ix and r a n d o m co i l s t ruc tu re is s imi lar 
t o that o f u n b o u n d dye. H o w e v e r , there are d i f ferences in the w a v e l e n g t h va lue w h e n 
C o n g o Red dye b inds to a single hel ical s t ruc ture. I n the assay, 0 .375 m l C o n g o R e d 
so lu t i on (3.8 \.iM) was m ixed w i t h 0.75 ml sample (3 m g / m l ) . N a O H , 0 . 3 7 5 m l , o f va r ious 
concen t ra t ions (0 .2 M , 0.4 M , 0.6 M , 0.8 M , 1.0 M , 1.2 M and 2 .0 M ) w e r e added to the 
mixture to study the wavelength shift o f the Congo Red dye in different NaOH 
concent ra t ions . T h e absorp t ion spec t rum o f the C o n g o Red /g lucan comp lexes in d i f fe ren t 
N a O H concen t ra t i on was scanned f r o m 4 5 0 nm to 550 n m and A,max was de te rm ined 
f r o m the abso rp t i on spect rum. 
2.2.3.9 Molecular Weight Estimation of FH and SFAl 
Gel f i l t r a t i o n c h r o m a t o g r a p h y ( A n d r e w s , 1965) w a s used t o es t imate the 
mo lecu la r w e i g h t o f the Flamnwlina f rac t ions ( F H & S F A l ) . Sephadex G - 2 0 0 swe l led in 
0 .15 M N a C l ( the runn ing bu f f e r ) was packed in a c o l u m n o f 1.6 c m x 31 c m d imens ion . 
T h e f l o w rate o f the packed c o l u m n was adjusted to 0.5 m l / m i n . w i t h a per is ta l t i c p u m p . 
T h e eluent o f the c o l u m n was co l lec ted by a f r ac t i on co l l ec to r ( G i l s o n T D C 80 ) w i t h each 
tube co l lec ted 1.1 m l eluent. T h e separat ion capac i ty o f the c o l u m n was character ised b y 
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B l u e Dex t ran (Ave rage mol . w t . > 2000 k D , 10 m g / m l ) and K s O s O ? (mo l . w t . 0 .294 k D , 
100 i T d V I ) . Excep t F H , S F A l and standards (3 m g / m l ) w e r e all d isso lved in 0.15 M NaCI . 
T h e h igh v iscos i ty o f F H make it imposs ib le to be analysed by the c h r o m a t o g r a p h i c 
techn ique w i t h o u t p r io r to processing. I n the processing, F H (3 m g / m l ) was f i rs t d isso lved 
in 0.15 M N a O H . T h e alkal ine t rea tment d is rupt the t r i p le hel ical s t ruc tu re o f F H to single 
hel ical s t ruc ture and thus the mo lecu la r we igh t o f the mo lecu le shou ld r o u g h l y be reduced 
to one - th i rd th o f its or ig inal . B e f o r e app ly ing alkal ine t rea ted F H to the ch roma tog raph i c 
co lumn , every ml sample was neutra l ised by 50 |.il 3 M H C l . T h e N a C l concen t ra t i on o f 
the neutral ised sample was app rox ima ted 0.15 M . T h e de tec t ion o f B l u e D e x t r a n , 
KsCrsO? and the carbohydra te samples' e lu t ion peaks w e r e ach ieved by measur ing O . D . 
650, O . D . 400 and O . D . 490 (pheno l -su l f i i r i c ac id m e t h o d ) respect ive ly . 
2.2.3.10 Vascular Dilation and Hemorrhage (VDH) Activity of F.V. Fractions 
M a l e I C R alb ino mice w e r e d iv ided in to g r o u p s o f ten. T h e m ice w e r e in jec ted 
in t raper i tonea l ly w i t h ei ther 0.2 ml 0.15 M N a C l , F H (2.5 m g / m l ) , F A l (2 .5 m g / m l ) , S F A l 
(2.5 mg /m l ) , I F A l (2.5 m g / m l ) o r dex t ran (2.5 m g / m l ) , f o r four consecu t i ve days ( f r o m 
day 0 to day 3). T h e number o f m ice w i t h V D H response w a s reco rded everyday af ter the 
f i rs t in jec t ion unt i l day 35 was reached. 
2.2.4 ISOLATION A N D P R E P A R A T I O N OF CELLS 
2.2.4.1 Bone Mnrrow Cell 
Female B A L B / c mice w e r e used. M i c e w e r e sacr i f i ced by ce rv i ca l d is loca t ion . 
T h e femurs o f the mice we re r e m o v e d by asept ic techniques. T h e femurs w e r e p u t i n to a 
pe t r i c dish con ta in ing co ld R P M I w i t h 10 % F C S . T h e ends o f the f emurs w e r e cut o p e n 
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w i t h a pair o f scissors. A 2 ml syr inge, connected to a 25 G needle, con ta in ing comp le te 
m e d i u m was used to f lush out the m a r r o w p lug o f the femurs. Cel ls in the p lugs we re 
dispersed by v i g o r o u s shaking. Red b lood cells present in the cel l m i x t u r e w e r e r e m o v e d 
by F i co l l - paque grad ient cen t r i f l i ga t ion . B o n e m a r r o w cells ob ta ined f r o m F i co l l - paque 
grad ient cen t r i f l i ga t i on we re washed t w i c e w i t h R P M I and then resuspended in comp le te 
m e d i u m (106 ce l ls /ml) . 
2.2.4.2 Peritoneal Exudate Cell ( P E Q 
M i c e w e r e k i l led by cerv ica l d is locat ion. T h e ent i re b o d y o f mouse was immersed 
in 70 % ethanol . T h e hair o f the abdomina l sk in was cut and removed . I c e - c o l d P B S , 5 ml , 
was in jected in t raper i tonea l ly . Per i toneal f lu id was co l lec ted by us ing a 5 m l syr inge f i t t ed 
w i t h a 20- gauge needle. T h e per i toneal cav i ty o f mouse was lavaged 2 t imes. T h e cells 
w e r e pel leted by sp inn ing at 3 0 0 x g fo r 5 min. at 4 o C and washed w i t h c o l d P B S t w i c e 
be fo re use. 
2.2.4.3 Splenocvtes 
M i c e w e r e sacr i f iced by cerv ica l d is locat ion . T h e spleens o f the m i ce w e r e 
r emoved asept ical ly , and w e r e cut in to smal l pieces w i t h a pair o f fine scissors. T h e spleen 
f ragments w e r e pressed gent ly t h r o u g h a ster i le 60 mesh stainless steel s ieve w i t h a 
p lunger o f a 5 m l plast ic syr inge. L a r g e cel l c lumps and debr is w e r e r e m o v e d by 
cen t r i f l i ga t i on ( 3 0 0 x g , 10 seconds). T h e cel l pel let was resuspended in p la in R P M I 
m e d i u m and washed three t imes by cen t r i f uga t i on ( 3 0 0 x g , 5 m in . ) . T h e washed cel ls w e r e 
resuspended in comp le te R P M I m e d i u m and kept at 4 o c . T h e v iab i l i t y o f the cel l 
suspension was de te rm ined by the t r yphan b lue dye exc lus ion m e t h o d . 
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2.2.4.4 Depleting Mouse T-cells by Anti-Mouse T-cell Antigen Antibody Plus 
Complement Treatment 
F o r t y |_il an t i -Thy 1.2 an t ibody (20 f o l d d i lu ted, ster i l ised by f i l t e r i ng ) w a s added 
to 2 m l l ymphocy tes cell suspension ( 2 x 1 0 7 ce l ls /ml) at a f ina l an t i body d i l u t i o n o f 1 : 
1,000. T h e m i x t u r e was then incubated at r o o m tempera tu re f o r 30 min. T h e cells w e r e 
spun d o w n and resuspended in 2 ml gu inea p ig comp lemen t (d i l u ted 1 : 5 w i t h R P M I 
m e d i u m ) f o r 45 min. at 37 o C to lyse the T-ce l ls . T h e cel ls w e r e then washed t w i c e w i t h 
R P M I and resuspended in comp le te R P M I m e d i u m ( 5 x 1 0 6 ce l ls /ml) . T h e v iab i l i t y o f the 
rema in ing cells was de termined by t ryphan b lue dye exc lus ion me thod . 
2.2.4.5 Depleting Mouse B-cells by Cedarlnne Column Kit 
Cedar lane C o l u m n K i t was used t o prepare mouse B - c e l l dep l i c ted l ymphocy tes , 
T - l y m p h o c y t e s . T h e p repara t ion s t r i c t l y f o l l o w e d the p r o c e d u r e descr ibed i n the manua l 
o f the Cedar lane mouse T - c e l l recovery c o l u m n k i t . T h e Cedar lane mouse T - c e l l 
R e c o v e r y C o l u m n , e f f i c ien t l l y , r emoved B -ce l l s f r o m mouse l y m p h o c y t e popu la t i on . 
Grea te r than 95 % o f B -ce l l s w e r e r emoved f r o m l y m p h o c y t e p repara t ions under o p t i m a l 
cond i t ions . T h e e lu ted T -ce l l s w e r e f l i l l y f l i nc t iona l . 
2 .2 .5 A S S A Y S F O R T H E C Y T O T O X I C I T Y O F FlammuUna velutipes 
2.2.5.1 Brine Shrimp Assay 
T h e m e t h o d o f Sol is et al ( 1 9 9 2 ) w a s used . E g g s oiArtemia salina, a k i n d o f 
b r ine sh r imp, w e r e a l l o w e d to hatch in 3.3 % sea w a t e r at 2 6 - 2 9 o C f o r 48 hr . 100 ^d 
suspension o f naup l i i con ta in ing 10-25 o rgan isms was added t o each w e l l ( t r i p l i ca te ) o f a 
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9 6 - w e l l plate. 100 [ i l o f test sample o f va r ious concent ra t ions (samples w e r e d isso lved in 
3.3 % sea w a t e r ) was added to the wel ls . T h e plate was then covered and incuba ted at 
26 -29 o c f o r 24 hr. A n y naupl i i in each w e l l that cannot surv ive d u r i n g the i ncuba t i on 
per iod w e r e coun ted under a b inocu la r m ic roscope ( x 15). T o ob ta in the t o ta l coun t , 100 
[ i l o f 1.5 M H C l was added to each we l l . A f t e r 5 min. o f incubat ion , al l su rv i vo rs w e r e 
k i l led by the acid and the to ta l number o f shr imps in each w e l l was counted . T h e % o f 
l i v i ng shr imp was ca lcu la ted acco rd ing to the f o l l o w i n g equat ion. 
… p . total shrimp count - dead shrimp count 
% of survivor = 100% 
total shrimp count 
2.2.5.2 In vitro Cytotoxicity of FH and SFAl on Bone Marrow Cells of Female 
BALB/c Mice 
B o n e m a r r o w cells ob ta ined f r o m female B A L B / c mice under asept ic cond i t i ons 
w e r e resuspended in R P M I supp lemented w i t h 10 % F C S (106 ce l ls /ml) . Ser ia l d i l u t i ons 
o f F H , S F A l and cyc lohex im ide w e r e prepared (50 n g / m l , 100 |. ig/ml and 2 0 0 n g / m l ) . 
Test samples o r cyc l ohex imde ( 1 0 0 was added to the we l l s o f a 9 6 - w e l l p late. T o the 
w e l l w i t h sample o r cyc lohex im ide , 100 bone m a r r o w cel l suspension was added. T h e 
plate was then incubated at 37 o c fo r 72 hr, in an i ncuba to r w i t h 5 % CO2 supp ly . A f t e r 
incubat ion , 0.5 i^iCi t r i t i a ted t hym id ine / 50 m e d i u m was added t o each w e l l and the 
plate was a l l o w e d to incubate f o r another 12 hr. B e f o r e harves t ing the pu lsed cel ls, the 
cells w e r e subjected to one cyc le o f f reez ing and t h a w i n g . T h e rad i oac t i v i t y o f the 
harvested cel ls was de te rm ined by a l i qu id sc in t i l l a t ion coun te r . 
4 6 
Materials and Methods 
2.2.5.3 In vivo Cytotoxicity of FH and SFAl on Female BALB/c Mice 
Female B A L B / c mice were d iv ided in to g roups o f 10. Test samples o r N a C l (0 .2 
ml , 2.5 m g / m l 0.15 M N a C l ) were in jected in t raper i toneal ly . T h e number o f mice, that 
su rv ive the t rea tment , was recorded every day after the in jec t ion unt i l day 35 was 
reached. 
2.2.6 A S S A Y S FOR THE I M M U N O M O D U L A T O R Y ACTIVITIES of 
Fl a nun II lin a vein tip es 
2.2.6.1 fn vitro Mitogenic Activities of FH and SFAl on Murine Lvmphocvtes 
L y m p h o c y t e s obta ined f r o m female B A L B / c mice w e r e used in the assay. 
L y m p h o c y t e s w e r e resuspended in comp le te m e d i u m ( 5 x 1 0 6 cel ls /ml) . T h e cel l 
suspension, 100 was added to each we l l o f a 9 6 - w e l l plate. T h e n 100 F H and S F A l 
o f va r ious concen t ra t ions (50 lag/ml, 100 |. ig/ml and 200 ).ig/ml comp le te m e d i u m ) was 
added to the cells. LPS ( f inal concen t ra t i on ； 10 |ag/ml) and C o n A ( f ina l concen t ra t i on ； 
5 | i g / m l ) w e r e used as pos i t i ve con t ro l . T h e plate was a l l o w e d to incubate at 37 o c , w i t h 
5 % CO2 supp ly , f o r 48 hr. A f t e r the incubat ion , 5 j^Ci t r i t i a ted t hym id ine / 50 | i l 
comp le te m e d i u m was added to the we l l and a l l owed to incubate fo r f u r the r 6 hr. T h e 
pulsed cells w e r e harvested on a glass f iber f i l te r w i t h a cel l harvester , and the 
rad ioac t i v i t y o f the harvested cells was de te rmined w i t h a l i qu id sc in t i l l a t ion coun te r . 
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2.2.6.2 In vitro Mitogenic Activities of FH and SFAI with P M B on M u r i n e 
Lvniphocvtes 
L y m p h o c y t e s ob ta ined f r o m female B A L B / c m ice w e r e resuspended in c o m p l e t e 
m e d i u m ( 1 x 1 0 7 ce l ls /ml) . F i f t y |.il o f the cel l suspension was added t o each w e l l o f a 9 6 -
w e l l plate. T h e n 100 |_il o f comp le te m e d i u m , L P S (10 | , ig/ml) o r test samples o f v a r i o u s 
concen t ra t ions ( 5 0 j . ig/ml, 100 [ i g / m l and 2 0 0 f, ig/ml c o m p l e t e m e d i u m ) w a s added t o the 
cells. F o r we l l s w i t h P o l y m y x i n B ( P M B ) a d d e d ， P M B suppressed all o r m o s t o f the 
m i togen i c ac t i v i t y o f LPS . T h e plate was incubated at 37 o C , w i t h 5 % CO2 supp ly , f o r 
48 hr. A f t e r the incuba t ion , 5 厂 i C i t r i t i a ted t hym id i ne / 50 }.il c o m p l e t e m e d i u m w a s added 
to the we l l and a l l o w e d to incubate f o r f u r t he r 6 hr. T h e pu lsed cel ls w e r e harves ted o n a 
glass f iber f i l te r w i t h a cel l harvester , and the rad ioac t i v i t y o f the harves ted cel ls w a s 
de te rm ined w i t h a l i qu id sc in t i l l a t ion coun te r . 
2.2.6.3 In vitro Mitogenic Activit ies of FH on T-cell depleted M u r i n e L v m n h o c y t e s 
L y m p h o c y t e s ob ta ined f r o m female B A L B / c m ice w e r e resuspended in p la in 
R P M I m e d i u m (2 x l 0 7 ce l ls /ml ) . F o r t y o f ster i le a n t i - T h y 1.2 an t i body w a s added t o 2 
m l cel l suspension ( f ina l an t i body d i l u t i o n ； 1 : 1 ,000) . T h e m i x t u r e w a s i ncuba ted at 
r o o m tempera tu re f o r 30 min . A f t e r i ncuba t ion , the cel ls w e r e spun d o w n and 
resuspended in 2 ml ster i le gu inea p ig c o m p l e m e n t ( d i l u t e d 1: 5 w i t h R P M I m e d i u m ) f o r 
45 min. at 37 o C to lyse any T - l y m p h o c y t e s . A f t e r cel l lysis, the cel ls w e r e w a s h e d t w i c e 
w i t h R P M I m e d i u m . T h e B - l y m p h o c y t e s that su rv i ved the l y t i c p r o c e d u r e w e r e 
resuspended in c o m p l e t e m e d i u m (5 x 106 ce l ls /ml ) . I n th is expe r imen t , 100 \x\ o f t he B -
l y m p h o c y t e enr iched suspension was added t o each w e l l o f a 9 6 - w e l l p la te . T h e n 100 
o f the c o m p l e t e m e d i u m , F H ( 2 0 0 |_ ig/ml)，ConA (2 } i g / m l ) o r L P S ( 1 0 |Ag/ml) w a s 
added to the cells. T h e p la te w a s m i x e d and w a s a l l o w e d t o incuba te at 3 7 o C，w i t h 5 % 
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CO2 supply, fo r 48 hr. A f t e r the incubat ion, 5 \.iCi t r i t i a ted thymid ine / 50 comp le te 
m e d i u m was added to the we l l and a l l owed to incubate f o r fu r ther 6 hr. T h e pu lsed cells 
w e r e harvested on a glass f iber f i l te r w i t h a cell harvester, and the rad ioac t i v i t y o f the 
harvested cells was de termined w i t h a l i qu id sc in t i l la t ion counter . 
2.2.6.4 In vitro Mitogenic Activities of FH on B-cell depleted Murine 
Lymphocytes 
B - c e l l dep le ted l ymphocy tes w e r e prepared by us ing the Cedar lane C o l u m n K i t 
(Cedar lane Lab. L t d . , Canada). T h e T - l y m p h o c y t e s ob ta ined f r o m the c o l u m n w e r e 
washed t w i c e w i t h R P M I , and resuspended in comp le te m e d i u m ( 5 x 1 0 6 cel ls /ml) . I n th is 
case, 100 |.il o f the T -ce l l enr iched suspension was added to each w e l l o f a 9 6 - w e l l plate. 
T h e n 100 … o f the comp le te med ium, F H (200 n g / m l ) , C o n A (2 | . ig/ml) o r L P S (10 \x 
g / m l ) was added to the cells. T h e plate was m ixed and was a l l o w e d t o incubate at 37 oC， 
w i t h 5 % CO2 supply , f o r 48 hr. A f t e r the incubat ion , 5 i^Ci t r i t i a ted thym id ine / 50 j^l 
comp le te m e d i u m was added to the we l l and a l l owed to incubate f o r fu r the r 6 hr. T h e 
pu lsed cells w e r e harvested o n a glass f iber f i l te r w i t h a cel l harvester, and the 
rad ioac t i v i t y o f the harvested cells was de te rmined w i t h a l i qu id sc in t i l la t ion coun te r . 
2.2.6.5 In vitro Co-mitogenic Activity of FH and SFAl on Murine Lymnhocytes 
L y m p h o c y t e s isolated f r o m female B A L B / c m ice w e r e resuspended in comp le te 
m e d i u m ( 1 x 1 0 7 cel ls /ml) . F i f t y | i l o f the cel l suspension was added t o each w e l l o f a 96 -
w e l l plate. T h e n 100 |_il o f comp le te med ium, o r test samples w a s added t o the cells. 
F u r t h e r m o r e , 50 f.il o f ei ther comp le te med ium, L P S (20 | . ig/ml) o r C o n A (4 | , ig/ml) w a s 
added to the 150 |.il cel l m ix tu re . T h e plate was shaken and was a l l o w e d to incubate at 
37 OC, w i t h 5 % CO2 supply , f o r 48 hr. A f t e r the incuba t ion , 5 |_iCi t r i t i a ted t hym id ine / 
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50 |.il comp le te m e d i u m was added to the we l l and a l l owed to incubate f o r fu r ther 6 hr. 
T h e pulsed cells w e r e harvested on a glass f iber f i l ter w i t h a cel l harvester, and the 
rad ioac t i v i t y o f the harvested cells was de termined w i t h a l i qu id sc in t i l la t ion counter . 
2.2.6.6 In vitro Mitogenic Activities of FH and SFAl on M u r i n e B o n e M a r r o w 
cells 
B o n e m a r r o w cells iso lated f r o m female B A L B / c mice, w i t h aseptic techn ique, 
w e r e resuspended in comple te m e d i u m ( 1 0 6 c e l l s / m l ) . T h e cel l suspension, 100 [x\, was 
added to each w e l l o f a 9 6 - w e l l plate. T h e n 100 |.il o f comp le te m e d i u m , mur ine r I L - 3 ( 
4 0 0 | . i g / m l ) o r test samples o f va r ious concent ra t ions ( 50 | i g /m l , 100 |_ig/ml and 2 0 0 
g / m l ) was added to the wel ls . T h e plate was shaken and was a l l o w e d t o incubate at 37 
OC, w i t h 5 % CO2 supply , f o r 48 hr. A f t e r the incubat ion , 5 |.iCi t r i t i a ted thymid ine / 50 p. 
1 comp le te m e d i u m was added to the we l l and a l l owed to incubate f o r f u r the r 12 hr. T h e 
pu lsed cells w e r e subjected to one cyc le o f f reez ing and t haw ing , be fo re be ing harvested 
o n a glass f iber f i l te r w i t h a cel l harvester. T h e rad ioac t i v i t y o f the harvested cells was 
de te rm ined w i t h a l i qu id sc in t i l la t ion counter . 
2.2.6.7 In vivo Mitogenic Activit ies of F H and SFAl on M u r i n e L y m p h o c v t e s 
F o r t y - f i v e female C 5 7 B L / 6 L mice w e r e d i v ided in to g r o u p s o f 15. N a C l (0 .15 
M ) , F H (2.5 m g / m l 0.15 M N a C l ) o r S F A l (2.5 m g / m l 0 .15 M N a C l ) , 0 .2 m l , w a s 
in jec ted i n to the per i toneal cav i t y o f the mice o n day zero. F i v e m ice f r o m each g r o u p 
w e r e k i l l ed o n day zero, three and f ive respect ive ly . L y m p h o c y t e s w e r e ob ta ined f r o m 
the k i l l ed mice. T h e isolated l ymphocy tes w e r e resuspended in c o m p l e t e R P M I m e d i u m 
( 5 x 1 0 6 ce l l s /m l ) .The cell suspension (100 |.il) was added in to each w e l l o f a 9 6 - w e U 
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plate. T h e cells w e r e pulsed w i t h 5 | iC i t r i t ia ted t hym id ine (1 j . iCi /10 \i\ comp le te 
m e d i u m ) f o r 6 hr. immedia te ly . T h e pulsed cells we re harvested on a glass f iber w i t h a 
cel l harvester. T h e rad ioac t i v i t y o f the harvested cells was de te rm ined w i t h a l i qu id 
sc in t i l la t ion coun te r . 
2.2.6.8 Effect of FH and SFAl on the Enhancement of First Antibody Production 
of S R B C [mniiinised Mice 
Fi f teen male I C R alb ino mice we re d i v ided in to g r o u p s o f 5. T o each mouse 0.2 
m l 0.15 M N a C l , F H (2.5 m g / m l 0.15 M N a C l ) o r S F A l (2.5 m g / m l 0 .15 M N a C l ) was 
in jected in to the per i tonea l cav i ty on day -2 , 0 and 2 respect ive ly . T h e n 0.2 m l 20 % 
( v o l / v o l ) sheep red b l o o d cells ( S R B C ) suspension in P B S was in jec ted in to each mice 
in t raper i tonea l l y on day zero. O n day 6, serum was ob ta in f r o m the m ice and w a s 
checked f o r i ts an t i body t i t re by hemagg lu t ina t ion . H e m a g g l u t i n a t i o n w a s done by 
add ing 50 P B S to w e l l 2 to 12 in r o w A , B , C, D ’ E and F o f a V - s h a p e d 9 6 - w e l l p la te 
( rep l ica te f o r each sample serum). F i f t y o f test serum w a s added to w e l l 1 and 2 in 
r o w A and B ( c o n t r o l serum) , C and D (serum f r o m F H t reated mice) , and E and F 
( se rum f r o m S F A l t reated mice) . T w o - f o l d serial d i l u t i ons o f the an t i se rum w a s done 
un t i l a 2048 ( 2 H ) f o l d was reached. T h e n , 50 ).il o f 2 % S R B C was added t o each we l l . 
A negat ive c o n t r o l was done by add ing 50 ).il o f P B S toge ther w i t h 50 | i l o f 2 % S R B C 
to separate we l ls . T h e conten ts o f the we l l s w e r e m ixed gen t l y w i t h a p late shaker. A f t e r 
shak ing, the p late was a l l o w e d t o stand at r o o m cond i t i ons f o r 8 hr. , and then the 
hemagg lu t i na t i on end-po in t recorded. T h e t i t re was repo r ted as the h ighest d i l u t i ons o f 
the serum that has no apparent hemagg lu t ina t ion . 
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2.2.6.9 Effect of FH and SFAl on the in vitro Phagocytic Activity of Murine 
IVI aero phage 
Five female B A L B / c mice were k i l led and thei r per i tonea l cavi t ies w e r e washed 
w i t h PBS to ob ta in PEC. The obta ined P E C was washed t w i c e w i t h P B S and f ina l ly 
resuspended in Hank 's bu f fe r saline w i t h 5 % FCS (108 ce l ls /ml) . T h e suspension, 100 |_d， 
was spreaded o n t o a cover slip, whe re the cover sl ip was p laced inside a 3 5 x 10 m m 
cu l tu re dish (Fa lcon , U .S .A . ) . T h e cells we re incubated at 37 O Q w i t h 5 % CO2 supp ly , 
f o r 4 hr. I n the incubat ion, adherent cel l such as per i tonea l macrophage, adhered t o the 
glass cover slip. A n y non-adherent cells we re washed away w i t h Hank ' s bu f f e r (2.5 m i x 
3 t imes) de l ivered w i t h a Pasteur pipette. A f t e r the remova l o f non-adheren t cel ls, 2 m l 
Hank 's bu f fe r w i t h 5 % FCS was added in to the pet r i dish. T h e n 25 ).il d H s O , test sample 
(1 .2 m g / m l ) o r C o n A (2 m g / m l ) was added to the pet r i d ish and a l l o w e d to incubate f o r 
10 min. A l s o 100 |.il o f yeast cell wa l l suspension ( 2 5 x 107 ce l ls /ml P B S ) was added. 
T h e m i x t u r e was than incubated at 37 o c , w i t h 5 % CO2 supp ly , f o r 1 hr. A f t e r 
incubat ion , non- inges ted yeast cel l w a l l was washed away w i t h H a n k ' s bu f fe r . T h e 
adherent cells w e r e f i xed w i t h methano l fo r 10 min. A f t e r f i xa t i on , the cel l w a l l w a s 
washed w i t h r unn ing wa te r f o r 15 min. T h e washed cells w e r e t rea ted w i t h 10 % 
per iod ic acid f o r 10 min. The ingested yeast cel l wa l l s in adherent cel ls w e r e sta ined by 
immers ing the cells in S c h i f f s reagent f o r 30 min. ( D a c i e and L e w i s , 1991) . A f t e r 
sta in ing, the cells we re r insed 3 t imes w i t h r ins ing so lu t i on (6 m l 10 % s o d i u m 
metab is i i lph i te + 5 ml 1 M H C l was added to 89 ml d H j O ) . T h e r insed cel ls w e r e w a s h e d 
in d is t i l led wa te r fo r 5 min. T h e number o f adherent cells w i t h yeast ce l l wa l l s ingested, 
o f 100 adherent cells were counted . 
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2.2.6.10 Effect of FH and SFAl on the in vivo Phagocytic Activity of Murine 
Macrophage 
T w e n t y - f i v e female B A L B / c mice we re d iv ided in to 5 groups. E a c h g r o u p o f 
mice was in jected in t raper i tonea l ly ei ther w i t h 0.2 ml 0.15 M N a C l , F H (2.5 m g / m l ) , F A l 
(2.5 m g / m l ) , S F A l (2.5 m g / m l ) o r I F A l (2.5 mg /m l ) . Th ree days af ter in jec t ion , m ice 
w e r e k i l led and per i toneal cells w e r e washed out w i t h PBS. T h e washed ou t P E C w e r e 
washed t w i c e w i t h R P M I and then resuspended in Hank 's bu f fe r saline w i t h 5 % F C S 
(107 cel ls /ml) . T h e cells w e r e then assayed fo r the phagocy t i c ac t iv i t y by the same 
p rocedure o f that in in vitro phagocytos is . 
2.2.6.11 In vivo Migration of Macrophage in FH- and SFAl-trented Mice 
Female B A L B / c mice w e r e d iv ided in to g roups o f 5. M i c e in each g r o u p was 
in jec ted ei ther in t raper i tonea l l y w i t h 0.2 m l 0.15 M N a C l , F H (1.25 m g / m l ) , S F A l (1 .25 
m g / m l ) o r 2 ml 3 % Th iog l yco l l a te . Th ree days af ter in jec t ion , the mice w e r e k i l l ed and 
per i tonea l cells w e r e washed ou t f r o m the mice w i t h P B S . P E C w e r e washed t w i c e w i t h 
R P M I and then resuspended in R P M I w i t h 10 % F C S (106 cel ls /ml) . 2 m l o f the cel l 
suspension was added to the we l l s o f 2 4 - w e l l plate. T h e cells w e r e incubated at 3 7 0 C , 
w i t h 5。/o CO2, f o r 4 hr. A f t e r incubat ion , non-adherent cells w e r e washed away w i t h 
P B S . T w o m l 0.5 % neutra l red ( in P B S ) was added t o the cells, and w a s a l l o w e d t o 
incubate fo r f u r the r 1 hr. at 3 7 ° C . Excess neut ra l red was r e m o v e d by w a s h i n g w i t h 
P B S (2 m l X 2 t imes) . T h e washed plate was then dr ied. One % SDS, 6 0 0 ).il, w a s added 
t o the dr ied cells. T h e added S D S d isso lved the cells and neut ra l red. T h e absorbance o f 
S D S w i t h neut ra l red d isso lved was measured at 540 nm, and us ing 1 % S D S as b lank . 
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2.2.6.12 Effect of FH and SFAl on the Enhancement of Murine PEC Cytostatic 
Activity 
Fema le B A L B / c m ice w e r e d i v i d e d i n to g r o u p s o f 5. T h e m i c e w e r e i n jec ted 
i n t r ape r i t onea l l y w i t h e i ther 0 .2 m l 0 . 1 5 N N a C l , F H (2 .5 m g / m l ) o r S F A l (2 .5 m g / m l ) . 
T h r e e days a f te r i n jec t ion , the m ice w e r e k i l l ed and pe r i t onea l cav i t y w a s w a s h e d w i t h 
P B S ( 1 0 m l / m o u s e ) . T h e w a s h - o u t P E C w a s w a s h e d w i t h P B S (15 m l x 2 t imes ) . T h e 
w a s h e d cel ls w e r e resuspended in P B S ( 3 . 2 x 1 0 7 ce l l s /m l ) . Ce l l s suspens ion o f d i l u t i o n s 
2 x , 4 x and 8 x w e r e p repared and 100 o f the cel l suspens ion w a s a d d e d t o 8 x 1 0 5 L -
9 2 9 cel ls in a 9 6 - w e l l plate. T h e L - 9 2 9 cel ls w e r e added t o the w e l l s o f the 9 6 - w e l l p la te 
18 hr. ear l ier . T h e cel l m i x t u r e w e r e then i ncuba ted at 3 7 o c , w i t h 5 % C O 2 supp l y , f o r 
4 hr . A f t e r the i n c u b a t i o n , the cel l m i x t u r e was pu lsed w i t h 5 jaCi t r i t i a t e d t h y m i d i n e / 50 
l-il c o m p l e t e m e d i u m f o r 6 hr. T h e pu lsed cel ls w e r e ha rves ted o n a glass f i be r f i l t e r w i t h 
a ce l l harves ter . T h e r a d i o a c t i v i t y o f the ha rves ted cel ls w a s d e t e r m i n e d w i t h a l i q u i d 
sc in t i l l a t i on c o u n t e r . T h e percen tage o f t u m o r cel l k i l l i n g w a s ca l cu l a t ed a c c o r d i n g t o 
the f o l l o w i n g equa t i on . 
0/ .11. count of control - count of test sample , 
% of killing = ^ 100% 
count of control 
2.2.6.13 Effect of FH nnd SFAl on the Fc Receptor Expression of Peritoneal 
Exudate Cells 
F e m a l e B A L B / c m i c e w e r e d i v i d e d i n t o g r o u p s o f 5. T h e m i c e w e r e i n j ec ted 
i n t r a p e r i t o n e a l l y e i ther w i t h 0 .2 m l 0 . 1 5 N N a C l , F A l (2 .5 m g / m l ) o r S F A l (2 .5 m g / m l ) . 
T h r e e days a f te r i n t r ape r i t onea l i n jec t i on , m i c e w e r e k i l l e d and p e r i t o n e a l ce l ls w e r e 
w a s h e d o u t w i t h P B S . T h e w a s h - o u t pe r i t onea l cel ls w e r e w a s h e d w i t h R P M I ( 1 5 m l x 
2 t imes ) . T h e w a s h e d P E C w a s resuspended in R P M I c o n t a i n i n g 1 0 % F C S ( 2 x 1 0 ^ 
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cel ls). T h e n 0.4 ml PEC suspension was then mixed w i t h 0.4 m l a n t i - S R B C an t ibody 
coa ted S R B C ( 3 x 1 0 ^ cel ls /ml G V B ) . The m ix tu re was incubated at f o r 15 min. 
T h e m i x t u r e was m ixed fo r every 5 min. du r i ng the incubat ion . A f t e r incubat ion , cells 
w e r e spun d o w n ( l , 0 0 0 x g , 10 min . ) at T h e cel l pel let was then resuspended by 
gent le shaking. T h e number o f 100 PEC, w i t h immune rosset t ing, was counted. 
2.2.6.14 Effect of FH and SFAl on Murine Serum Cytokine Level 
M a l e I C R alb ino mice were d i v ided in to g roups o f 20. T h e m ice w e r e in jec ted 
ei ther w i t h 0.2 m l 0.15 M N a C l , F H (2.5 m g / m l ) o r S F A l (2.5 m g / m l ) o n day 0，1’ 2 and 
3. O n day 1, 6, 9 and 12, 5 mice we re selected f r o m each g r o u p and serum was obta ined 
f r o m the mice. T h e serum co l lec ted was tested fo r G M - C S F , I L - 1 a , I L - 4 and I F N - y 
leve l by E L I S A k i ts . 
2.2.6.15 Effect o f F H and SFAl on Murine Serum T N F Level 
Female B A L B / c mice we re d iv ided in to g roups o f 5. Each g r o u p o f m ice may be 
in jec ted in t ravenous ly w i t h 0.2 ml 0 . 1 5 N N a C l , 0.2 m l F H (1.25 m g / m l 0 .15 M N a C l ) , 
0 .2 m l S F A l (1 .25 m g / m l 0.15 M N a C l ) o r 0 .2 ml L P S (25 | . ig/ml 0 .15 M N a C l ) . One 
hr. a f ter in jec t ion , b l o o d was obta ined f r o m the in jected mice. T h e b l o o d w a s a l l o w e d t o 
c lo t in r o o m cond i t ions . A n y b l o o d c lo t f o r m e d was spun d o w n at 3 , 5 0 0 r p m f o r 5 min . 
T h e supernatant / se rum was removed and was subjected to 56 o C t rea tmen t o f 30 min . 
T h e heat t rea ted serum was f i l te red w i t h 0.45 u m pore size ster i le f i l te r un i t . T h e serum 
w a s 10 f o l d d i l u ted w i t h m e d i u m con ta in ing 5 % H I F C S and c y c l o h e x i m i d e ( 1 0 |Ag/ml 
m e d i u m ) . T o assay the level o f T N F in the serum, L - 9 2 9 t u m o r cel l , w h i c h is sensi t ive 
t o T N F , w a s used. L - 9 2 9 t u m o r cel l suspension ( 4 x 1 0 5 ce l ls /ml ) , 100 | i l , w a s added t o 
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each we l l o f a 9 6 - w e l l plate, fo r 18 hr. at 3 7 0 C w i t h 5 % CO： gas supply , be fo re d i lu ted 
serum was added. A f t e r the incubat ion , m e d i u m was removed by suct ion. T h e serum 
was 2 fo ld serial d i lu ted unt i l a d i l u t i on o f 16384 fo ld was reached. T h e d i lu ted 
serum, 100 was added to the we l l (dup l i ca ted fo r each concen t ra t ion ) , and was 
a l l owed to incubate for 24 hr. A t the end o f the incubat ion , serum was r e m o v e d by 
suct ion, and the cells we re washed t w i c e w i t h PBS. V iab le cells w e r e stained w i t h 
Neu t ra l Red. F i f t y neutra l red (0.3 % , w t / v o l ) was added to each w e l l and then 
incubated fo r 1 hr. at 37oC. Excess neutra l red was removed by wash ing the cells t w i c e 
w i t h PBS. T h e washed cells w e r e a l l owed to stay at r o o m cond i t ions . One % SDS, 100 
lal, was added per we l l and was mixed. T h e 1% SDS d isso lved the cells and neut ra l red. 
T h e absorbance o f each we l l was then measured by an E L I S A reader ( B i o - R a d , U S A ) at 
wave leng th 540 nm. The percentage o f k i l l i ng was ca lcu la ted as f o l l o w ; 
OD of control - OD of test sample , % of killiim 二 — 100% 
。 OD of control 
2.2.6.16 Effect of FH and SFAl on the Augmentat ion of S R B C ivsing ability of 
Murine Serum 
Fi f teen male I C R a lb ino mice we re d i v i ded in to g roups o f 5, and 0 .2 m l 0 .15 M 
N a C l , F H (2.5 m g / m i 0.15 M N a C l ) or S F A l (2.5 m g / m l 0.15 M N a C l ) was in jec ted in to 
per i toneal cav i t y o f each mouse on day -2 , 0 and 2 respect ive ly . T h e n 0.2 m l 20 % 
( v o l / v o l ) sheep red b lood cells ( S R B C ) suspension in P B S was in jec ted in to each mouse 
in t raper i tonea l l y on day zero. O n day 6, serum was ob ta in f r o m the m ice and was 
checked f o r its comp lemen t level. T h e serum comp lemen t level was m o n i t o r e d by 
check ing the degree o f S R B C lysis by the serum. T h e serum, 0.2 ml , w a s m i x e d w i t h 0 .2 
m l 2。/o S R B C in PBS. T h e m i x t u r e was shaken gent ly , and was a l l o w e d to stand at r o o m 
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t e m p e r a t u r e f o r at least 8 hr. A n y s u r v i v i n g in tact S R B C was spun d o w n ( 3 0 0 x g , 5 
m in . ) , and 0.3 m l o f the supernatant was r e m o v e d and m i x e d w i t h 0.3 m l P B S . T h e 
absorbance o f the supernatant was measured at w a v e l e n g t h 541 nm. 
2.2.7 A S S A Y S FOR THE A N T I - T U M O R ACTIVITIES OF FlammuUna 
velutipes 
2.2.7.1 In vitro Anti-ti imor Activity of FH and SFAI 
T u m o r cel ls, P U 5 - 1 . 8 and Sc-180 , g r e w in to l o g a r i t h m i c phase w e r e used i n the 
assay. T h e cel ls w e r e washed t w i c e w i t h p la in R P M I u n d e r ster i le cond i t i ons . W a s h e d 
cel ls w e r e resuspended in c o m p l e t e m e d i u m (106 ce l ls /ml ) . T h e ce l l suspens ion, 100 j i l , 
w a s added i n t o each we l l o f a 9 6 - w e l l p late. F rac t i ons t o be tes ted w e r e d i l u t e d t o 
v a r i o u s c o n c e n t r a t i o n (50 n g / m l , 100 |. ig/ml and 200 |_ig/ml) w i t h c o m p l e t e m e d i u m , and 
f i l t e red w i t h a 0 .4 n m pore size ster i le f i l te r un i t . T h e c a r b o h y d r a t e f rac t i ons , 100 | i l，o f 
v a r i o u s c o n c e n t r a t i o n s was added to the w e l l that con ta i n t u m o r cel ls ( t r i p l i ca te ) . T h e 
p la te w a s then a l l o w e d to be incuba ted at 3 7 0 C f o r 48 hr. in a CO2 supp l i ed i ncuba to r . 
A f t e r the i ncuba t i on , 5 |.iCi t r i t i a ted t h y m i d i n e / 5 0 ),il c o m p l e t e m e d i u m w a s added t o 
each w e l l and then fu r the r i ncuba ted f o r 6 hr. T h e pu lsed cel ls w e r e ha rves ted w i t h a ce l l 
harves te r and the r ad i oac t i v i t y o f the harves ted cel l w a s d e t e r m i n e d b y a l i q u i d 
sc in t i l l a t i on coun te r . T h e percen tage o f suppress ion o f the t u m o r g r o w t h w a s ca l cu la ted 
a c c o r d i n g t o the f o l l o w i n g equa t i on : 
% of killing = _ t of control - count of test sample 動。/。 
count of control 
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In o rde r to c o n f i r m the results o f the in vitro a n t i t u m o r ac t i v i t y ( m o n i t o r e d by 
t hym id i ne i n c o r p o r a t i o n ) o f F H and S F A l , M T T assay (Hussa in , 1993) was p e r f o r m e d as 
we l l . T h e assay was done by add ing 50 o f the cel l suspension to each w e l l o f a 96 -
w e l l plate. C a r b o h y d r a t e f rac t ions to be tested w e r e d i l u ted to va r ious concen t ra t i ons 
(50 |_ig/ml，100 n g / m l and 200 n g / m l ) w i t h comp le te m e d i u m , and f i l te red w i t h a 0 .4 | i m 
po re ster i le f i l te r un i t . T h e n 50 |.il o f the sample carbohydra tes o f va r ious c o n c e n t r a t i o n 
was added to the w e l l that con ta in the cel ls ( t r ip l i ca te) . T h e p late was incuba ted at 37 
OC f o r 48 hr. in a CO2 supp l ied incubator . A t the end o f the incuba t ion , 30 |_il M T T 
so lu t i on (5 m g / m l P B S ) was added to each we l l and incubated f o r f u r the r 1 hr. at 3 7 0 C 
in CO2 supp l ied incuba to r . A f t e r this incuba t ion , 100 |.il ac id i f ied i sop ropano l ( w i t h 0 .04 
M H C l ) was added. M i x i n g o f the we l l m i x t u r e was done by repeated p ipe t t i ng . T h e 
absorbance o f the we l l m i x t u r e was read at w a v e l e n g t h 540 n m w i t h a E L I S A reader 
( B i o - R a d , U S A ) . T h e percentage o f suppress ion was ca lcu la ted a c c o r d i n g t o the 
f o l l o w i n g equat ion , 
% of killing 二 QDofcont ro l - OP of test sample 訓。/。 
〇D of control 
2.2.7.2 Effect of FH and SFAl on the Growth of Murine Transplantable Tumor 
in vivo 
P U 5 - 1 . 8 t u m o r cel ls (a syngeneic t u m o r ) and Sc -180 t u m o r cel ls (an a l logene ic 
t u m o r ) w e r e used in the assay. P U 5 - 1 . 8 t u m o r cel ls w e r e g r o w n in female B A L B / c m i c e 
and Sc-180 tumor cells in male ICR albino mice. The t u m o r s were maintained in the 
mice as asci t ic cells. In case o f the syngeneic t u m o r , 7 -day o l d P U 5 - 1 . 8 t u m o r cel ls (0 .5 
m l 2 x 1 0 6 ce l l s /ml P B S ) w e r e in jec ted in to the per i tonea l cav i t y o f fema le B A L B / c m ice 
o n day 0. T h e m ice w e r e also in jec ted w i t h 0 .2 m l 0.15 M N a C l , F H (2 .5 m g / m l ) , F A l 
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(2 .5 m g / m l ) o r S F A l (2.5 m g / m l ) on day -2 , -1 ’ 0 ’ 1 and 2. O n day 7 ’ the regress ion o f 
the P U 5 - 1 . 8 t u m o r was m o n i t o r e d by c o u n t i n g the v iab le cel ls o f the pe r i t onea l wash . 
F o r the a l logene ic t u m o r , 7 - d a y o ld S c - 1 8 0 t u m o r cel ls (0 .05 m l 2 x 1 0 7 ce l l s /m l ) w e r e 
in jec ted i n to ma le I C R a lb ino m ice subcu taneous ly at the r i gh t g r o i n o n day 0. T h e m ice 
w e r e also in jec ted w i t h 0.2 m l 0 .15 M N a C l , F H (2 .5 m g / m l ) , F A l (2 .5 m g / m l ) , S F A l 
(2 .5 m g / m l ) o r I F A l (2.5 m g / m l ) o n day 1’ 3, 5, 7 and 9. O n day 20，mice w i t h no 
no t i ceab le size o f t u m o r w e r e r e m o v e d . T h i r t y days a f te r the t u m o r i n jec t i on , the so l i d 
t u m o r s w e r e exc ised and w e i g h t e d . 
2.2.8 STATISTICAL ANALYSIS 
A l l resul ts w e r e expressed as the a r i t hme t i c m e a n 土 s tandard e r r o r ( S . E . ) . 
Student 's T test was used to de te rm ine the con f i dence l i m i t s i n p o p u l a t i o n compar i sons . 
P < 0 .05 was regarded as s ign i f i can t d i f fe ren t . 
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C H A P T E R T H R E E 
S C R E E N I N G , PURIFICATION, F R A C T I O N A T I O N A N D 
C H A R A C T E R I S A T I O N OF P - ( l - > 3 ) - D - G L U C A N ( S ) F R O M 
Flammulina velutipes 
Introduction 
In m o d e r n w o r l d , the sophis t icated app l ica t ions o f f ung i has b l o o m e d in to many 
d i f fe rent areas. T h e y are the basis o f a number o f f o o d indust r ia l processes i n v o l v i n g 
fe rmen ta t i on such as the m a k i n g o f bread, w ines, beers, the fe rmen ta t i on o f cacao bean, 
the p repara t ion o f cer ta in cheeses and many organ ic acids. I n academic area, f ung i are 
p o w e r f u l t oo ls in b iochemica l , cy to log i ca l and genet ica l studies. I n med ica l area, f u n g i are 
i m p o r t a n t too ls in the p r o d u c t i o n o f many c o m p l e x d rugs such as e rgomet r i ne and 
cor t i sone (Jong and D o n o v i c k , 1989) and some v i t a m i n preparat ions, and are responsib le 
f o r the manu fac tu re o f a number o f an t ib io t ics , no tab ly pen ic i l l in and g r i seo fU lvm (Jong 
and D o n o v i c k , 1989). O the r than these, in the last 4 decades, the app l ica t ions o f f ung i in 
the t rea tment o f cancer was ac t ive ly e luc ida ted by many researchers. T h e earl iest use o f 
f ung i in cancer t rea tment may be represented by the w o r k o f P r o t t i ( 1 9 4 6 ) w h o descr ibed 
the ly t ic ac t ion o f several species o f Saccharomyces o n t ransp lanted ca rc i noma b y a 
process w h i c h he cal led ” c y topho to l ys i s ". I n later years, many d i f fe ren t a n t i t u m o r 
substances w e r e iso la ted f r o m d i f fe ren t species o f fung i . T h e substances are ve r y d iverse in 
the i r nature ( J o n g and D o n o v i c k , 1989). T h e a n t i t u m o r po lysacchar ides ob ta ined f r o m 
fung i represent a un ique g r o u p o f a n t i t u m o r substances as the po lysacchar ides are qu i te 
h o m o g e n e o u s w i t h respect to the i r s t ruc tures. F o r example , mos t o f the po lysacchar ides 
w e r e h o m o p o l y m e r o f g lucose w i t h the g lucose un i ts l i nked toge the r by 3 ) - D -
l inkage. F u r t h e r m o r e , they s h o w s imi lar a n t i t u m o r mechanisms. 
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Results 
3.1 S C R E E N I N G OF B - ( 1 ^ 3 ) - D - G L U C A N 
Three types o f m u s h r o o m ( f r u i t i ng bodies ) ; FlammuUna velutipes, Lyophyllum 
aggregatum ( shimeji) and Volvariella volvacea , as s h o w n in F ig . 3.1 w e r e selected f o r 
the screening o f the presence o f P - ( l — 3 ) - D - g l u c a n s . T h e l yophy l i sed p o w d e r o f the r a w 
f r u i t i n g bodies and the cell wa l l mater ia ls o f the m u s h r o o m s w e r e screened w i t h ani l ine 
b lue sta in ing me thod . A s s h o w n in Tab le 3.1, on ly the p o w d e r o f Flammidina velutipes 
and Volvariella volvacea w e r e pos i t i ve to the present o f P - ( l — 3 ) - D - g l u c a n s . T h e degree 
o f s ta in ing o f the p o w d e r o f Flanmnilitia velutipes and Volvariella volvacea w a s simi lar . 
W h e n the cell w a l l o f FlammuUna velutipes and Volvariella volvacea w e r e stained, on ly 
Flamnmlina velutipes was pos i t ive . W h e n the degree o f s ta in ing o f the p o w d e r and the 
w a l l o f FlammuUna vehidpes was compared , the w a l l mater ia ls was stained m u c h 
s t ronger . 
3.2 E X T R A C T I O N A N D F R A C T I O N A T I O N OF FlammuUna velutipes 
T h e l yophy l i sed m u s h r o o m p o w d e r make up o f a round 9 - 1 0 % o f the f resh 
w e i g h t ( f r u i t i n g b o d i e s ) . A f t e r extens ive wash o f the p o w d e r , the cel l w a l l mater ia ls was 
obta ined. W h e n lyophy l i sed , the w e i g h t o f the w a l l mater ia ls con t r i bu te t o a r o u n d 20 % o f 
the w e i g h t o f the p o w d e r . H o t w a t e r ex t rac t i on o f the w a l l mater ia ls release w a t e r so lub le 
g lucan(s) . T h e released g lucan(s) w h e n dia lysed and l yophy l i sed y ie lded the F H f rac t ion . 
T h e w e i g h t o f the F H f rac t ion composed o f a round 0.5 % that o f p o w d e r . T h e h o t w a t e r 
ex t rac ted cel l w a l l w h e n soaked in to a lka l ine urea so lvent released the F A l f rac t ion . T h e 
neut ra l ised, d ia lysed and l yophy l i sed F A l (con ta ins S F A l and I F A l ) w e i g h e d a round 3 % 
tha t o f the p o w d e r . S F A l was separated f r o m I F A l in F A l by cen t r i f i j ga t i on . T h e 
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一 - _ ^ ’一 
• i ' 一 
I 
Flammulina velutipes 
I I ^^ 
^^H Lyophyllum aggregatum (shimeji) 
I 
Volvariella volvacea 
Fig. 3.1 A diagram showing the fruiting body of the mushrooms; Flammulina 
velutipes, Lyophyllum aggregatum (shimeji) and Volvariella volvacea. 
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Table 3.1 The screening of the presence of P-(l->3)-D-glLican in three edible 
mushrooms: Flammulina velutipes, Lyophylliim aggregatiim ( shimeji) and 
Valvar i el la vol vcicca. 
Sample Degree of staining 
Flammulina velutipes Crude powder ++ 
Cell wall materials ++++++ 
Lyophylliim Crude powder -
aggregatiim 
Cell wall materials -
Voivariella volvacca Crude powder ++ 
Cell wall materials -
Yeast Crude powder ++ 
Cell wall materials ++++ 
a-celliilose / / 
Cell wall materials : 
The solid samples were stained with aniline blue dye ( 1 mg/ ml ) . The stained 
samples were than destained twice with methanol and dHiO. 
- v e represents no observable staining. + ve represents observable staining. 
The greater the nuinber of + ve sign the more intense the staining observed. / 
means the sample had not been determined. 
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l yophy l i sed S F A l and I F A l we igh ted about 0.6 and 2.6 % o f that o f the p o w d e r 
respect ive ly. T h e results are shown in Tab le 3.2. 
3.3 T H E D E T E R M I N A T I O N OF C A R B O H Y D R A T E C O N T E N T OF F.V. 
F R A C T I O N S 
T h e carbohydra te content o f the ex t rac ted f rac t ions w e r e est imated w i t h the 
pheno l - su l fur ic acid method. Dex t ran , 1 m g / m l , in d H : 。 w a s used as the standard. F H ， 
F A l , S F A l and I F A l we re est imated to con ta in carbohydra te 99.8 土 10.2 % , 102.8 土 10.6 
% , 102.7 士 6.1 % and 105.1 ± 0.1 % respect ively. T h e results w e r e l is ted in Tab le 3.3. 
3.4 T H E D E T E R M I N A T I O N OF PROTEIN C O N T E N T OF F.V. F R A C T I O N S 
B r a d f o r d Pro te in microassay ( B r a d f o r d , 1976) was adop ted instead o f F o l i n -
L o w r y m e t h o d ( L o w r y e/ al, 1951) . I n fact , F o l i n - L o w r y reagent caused the 
po lysacchar ide(s ) o f SFAJ to prec ip i ta te. Fu the rmore , the p ro t i en va lue de te rm ined by the 
F o l i n - L o w r y m e t h o d is a f fec ted by the present o f ca rbohydra te b u t no t the B r a d f o r d 
me thod . I n B r a d f o r d ' p ro te in microassay, B S A was used as standard. S ince I F A l is 
inso lub le , its p ro te in content can't be de te rmina ted by th is me thod . W h e n F H and S F A l 
w e r e tested the p ro te in content o f bo th f rac t ions was f o u n d t o be abou t 3 % . These results 
agreed w i t h that o f ca rbohydra te de te rm ina t i on (e.g. near ly 100 % ca rbohyd ra te con ten t 
w a s est imated) . T h e results w e r e s h o w n in Tab le 3.4. 
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Table 3.2 The yield of different polysaccharide fractions isolated from the 
mushroom Flammulina velutipes. 
Sample Mass ( g ) Percentage yield ( % ) 
Fresh 600.00 100.00 
mushroom 
Lyophylised 55.00 9.17 100.00 
powder 
Cell wall 10.30 19.87 
materials 
Lyophylised 0.28 0.51 
FH 
Lyophylised 1.80 3.27 100.00 
FAl 
Lyophylised 0.35 0.64 19.57 
IFAl 
Lyophylised 1.41 2.56 78.29 
SFAl • 
Dry powder of Flammulina velutipes were washed twice with PBS ( 1 g/ 
ml )，ddHiO, methanol-chloroform, acetone, and ddHiO ( 3 g/ m l ) to yield 
cell wall materials. FH was released from the wall materials by hot water 
extraction ( 1 g/ ml, 121 oC, 30 min.). Solid residues, from the hot water 
extraction, was dried. FAl was released from the dry residues by alkaline-
urea mixture ( 1 g/ ml, 65 oC, 90 min. ). The alkaline solution containing 
FAl was neutralised by acetic acid and then dialysed to remove salt. The 
dialysed FAl contained SFAl and IFAl. IFAl was separated from SFAl by 
centrifugation ( 3,000 x g, 10 min.). 
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Table 3.3 The carbohydrate content of different polysaccharide fractions 
isolated from FlammuUna velutipes', FH, FAl, SFAI and IFAl. 
Sample ( 1 mg/ml dHiO ) Percentage of carbohydrate ( % ) 
Dextran (M.W. 72,200 ) 100.0 
FH 99.8 土 10.2 
FAl 102.8 土 10.6 
SFAI 102.7 士 6.1 
105.1 土 0.1 
The carbohydrate content was determined by phenol-sulfuric acid method 
(Dubois, 1956) and absorbance was read at 490 nm using dextran ( M.W. 
72,200 ) as a standard. 
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Table 3.4 The protein content in different polysaccharide fractions isolated 
from Flammulina velutipes. 
Sample ( j i g / m l ) Protein amount ( 昭 ) Percentage of protein 
( % ) 
BSA ( 2 0 ) 20 100.0 
FH(IOOO) 30.3 士 1.0 3.0 土 0.1 
SFAl ( 1000 ) 15.1 土 0.3 1.5 土 0.0 
E F A l ( 1 0 0 0 ) / / 
The protein content was determined by Bradford method (Bradford, 1976) 
and absorbance was read at 595 nm using BSA as a standard. 
/ means the sample cannot be determined by the method as the sample was a 
water insoluble solid. 
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3.5 THE DETERMINATION OF URONTC ACID C O N T E N T OF F.V. 
FRACTIONS 
The me thod adopted was w ide l y used but w i t h d isadvantages. U n d e r the 
exper imenta l cond i t ions , neutral sugars at s imi lar concen t ra t ions s h o w 10 % inter ference. 
I n the est imat ion, D - g l u c u r o n i c acid was used as standard and, D - g l u c o s e (0.5 m g / m l ) and 
D e x t r a n ( M . W . 72 ,200 , 0.5 m g / m l ) we re used as con t ro l . T h e absorbance o f , D - g l u c o s e 
and Dex t ran , w h i c h we re expected to be f ree o f u ron i c acid, w e r e s h o w n in Tab le 3.5. T h e 
absorbance o f S F A l was s imi lar to that o f Dex t ran . H o w e v e r , b o t h F H and I F A l had a 
l o w e r value. 
3.6 T H E D E T E R M I N A T I O N OF S U G A R C O M P O N E N T O F F.V. 
FRACTIONS 
The sugar componen ts o f the f rac t ions w e r e de te rm ined w i t h a T h i n L a y e r 
C h r o m a t o g r a p h i c method . T h e solvent system adop ted w a s e f f i c ien t in separat ing va r ious 
monosugars such as g lucose, mannose, galactose, arabinose, f l i cose and f ruc tose , as 
s h o w n in F ig. 3.2. T h e so lu t ions f r o m acid hydro lys is o f g lucose, S F A L , IFAJ, F H and (3-
( 1 — 3 ) - D - g l u c a n ( f r o m P/nerotus ostreatus) w h e n tested w i t h t h i n layer c h r o m a t o g r a p h i c 
m e t h o d all the samples showed a single spot . F u r t h e r m o r e , the spot o f the sample tested 
has near ly the same R f va lue as s h o w n in F ig . 3.3. 
3.7 P E R I O D A T E U P T A K E OF F.V. F R A C T I O N S 
F r o m prev ious exper imenta l de te rm ina t ion , the f rac t i ons ex t rac ted con ta in m o s t l y 
g lucose as the const i tuents . In o rde r to de te rmine the l i nkage o f the g lucose un i ts i n the 
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I 
• • • • . 
1 2 3 4 5 6 
Fig. 3.2 The separation of various mono sugars by Thin Layer 
Chromatography , Lane 1, fructose; Lane 2, flicose; Lane 3, Arabinose; Lane 
4, galactose; Lane 5, inannose; and Lane 6, glucose. The monosugars ( 3 mg/ 
ml ) were spotted onto the TLC plate and separated by developing solvent ( 
pyridine: ethylacetate: dhhO ； 26: 66: 8 ). The locations of the sugars were 
revealed by alkaline sliver staining method. 
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i 
• I i I 
1 2 3 4 5 
Fig. 3.3 The separation of acid hydrolysate of p-(l->3)-D-glucaii ( 
Pleurotus ostreatus )，FH, IFAl, SFAl and glucose by Thin Layer 
Chromatography , Lane 1, P-(l->3)-D-glucaii (Pleurotus ostreatus ); Lane 
2, FH; Lane 3，IFAl; Lane 4, SFAl; and Lane 5, acid treated glucose. The 
samples ( 3 mg/ m l ) were hydrolysed with 4 N HCl at 100 oC for 2 hr.. The 
hydrolysates were spotted onto the TLC plate and separated by developing 
solvent ( pyridine: ethylacetate: dHiO，26: 66: 8 ). The locations of the 
sugars were revealed by alkaline silver staining method. 
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D e x t r a n ( M . W . 7 2 , 2 0 0 ) and l o ta -ca rageenan w e r e used as a s tandard c o n t r o l . F ig . 3.4，3.5 
and 3 .6 s h o w e d the s t ruc tu re o f g lucose , dex t ran , po lysacchar ide o f exc lus i ve l y (3-(1—>3)-
D - l i n k a g e and io ta -car rageenan. A s s h o w n in F ig . 3 .7，Glucose s tandard as expec ted had 
v e r y h igh pe r i oda te c o n s u m p t i o n . F o r example , g lucose c o n s u m e d abou t 85 % o f 
pe r i oda te in the expe r imen ta l cond i t i ons (assumed 100 % pe r i oda te c o n s u m p t i o n ) . 
D e x t r a n had abou t 67 % c o n s u m p t i o n and l o ta - ca rageenan had no m o r e t h a n 6 % 
c o n s u m p t i o n w i t h respect to g lucose . F o r F H and S F A l , b o t h have a b o u t 2 6 % p e r i o d a t e 
c o n s u m p t i o n w i t h respect t o g lucose. 
3.8 L T M U L U S A M E B O C Y T E L Y S A T E ( L A U C O A G U L A T I O N A S S A Y 
L i m u l u s A m e b o c y t e lysate w h e n encoun te r L P S o r P - ( l - > 3 ) - D - g l u c a n c o a g u l a t e 
t o f o r m gel . T h e f rac t i ons w e r e f o u n d to have no s ign i f i can t a m o u n t o f L P S . W h e n the 
f r ac t i ons w e r e i ncuba ted w i t h L A L all the f rac t i ons caused coagu la t i on . T h e resu l ts w e r e 
s h o w n in T a b l e 3.6. 
3.9 T H E D I G E S T I O N O F F.V. F R A C T I O N S W I T H LAMTNARTNASE 
T h e e n z y m e used in the d iges t ion was Lam ina r i nase w h i c h is d e r i v e d f r o m a 
b r o w n algae, Laminaria sp.. T h e degree o f d i ges t i on was expressed as the pe rcen tage o f 
d i ges t i on w i t h respect to the d iges t i on o f L a m i n a r i n ~ a l inear P - ( l - > 3 ) - D - g l u c a n . T h e 
degree o f d i g e s t i o n o f L a m i n a r i n w a s ass igned 100 % . T h e degree o f d i g e s t i o n o f P - ( l ~ > 
3 ) - D - g l u c a n ( f r o m B a r l e y ) w a s c lose t o tha t o f L a m i n a r i n . T h e d i g e s t i o n o f F H , S F A l and 
I F A l gave 4 9 . 8 %， 8 8 . 4 % and 13.9 % respec t i ve ly . T h e resu l ts are s h o w n i n F i g . 3 .8 . 
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Figure 3.4 Chemical structure of D-glucose and Dextran. 
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Fig. 3.5 Chemical structure ofD-glucose and polysaccharide of |3-(1->3)-
D-linkage. 
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CHjOH 
吟 。 一 
OSO3-
D-galactose 2-suifate unit 
(pH^OH H j C 
z o s c v o s c v 
D-galactose-4-«ulfiate and 3,6-anhyclro-D-
galactose 2-sulfate dimeric repeating units 
Fig. 3.6 Chemical structure of Iota-carrageenan which is made up of D-
galactose-4-sulfate and 3,6-anhydro-D-galactose 2-sulfate with the latter 
residues replaced by about 10% D-galactose 2-siilfate residues. 
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Fig. 3.7 The oxidation of FH and SFAl by potassium periodate. Test sample ( 
3 ing/ ml ) of 0.6 ml was mixed with 0.6 ml potassium periodate solution ( 
0.045 M ). The reaction mixture was kept under dark at room temperature. At 
time intervals, 20 |li1 of the reaction mixture was taken out and diluted 250 
times for absorbance measurement. The absorbance was measured at 222.5 
nm. Vertical bar represents one standard error. 
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Table 3.6 The ability of different isolated polysaccharide fractions, FH, 
FAl, SFAI and IFAl, to initiate the coagulation of Limulus amoebocyte 
lysate. 
Sample ( j ig / ml Coagulation 
d H 2 〇 ） 
Trial 1 Trial 2 Trial 3 
d H i O - - . 
3-(l-»3)-D-glucan + + + 
(1000) 
F H ( 1000) + + + 
FAl ( 1000 ) + + + 
SFAI ( 1000) + + + 
IFAl ( 1000 ) + + + 
Pyrotell Limulus Amebocyte Lysate reagent was mixed with test samples. 
The reaction mixtures were placed at 37 oC 土 1 oC for 60 min. 士 2 min.. A 
positive test was indicated by the fomation of a gel which did not collapse 
when the reaction tube was inverted. 
+ sign represents coagulation occurred and - sign represents no coagulation 
occurred. The P-(l->3)-D-glucan used as positive control was derived from 
Pleurotus ostreatus. 
78 
Fractionation ;ind Characterisation 
110 n 
100 - _ _ 
: I I I 
i 7 。 -
i I . 
m i l 
0 J UJ . I t i 
Fig. 3.8 The digestion of F.V. fractions by Laminaiinase. Samples ( 1 mg/ 
m l ) were digested with Laminarinase ( vol/vol : 1/1 ) in citrate buffer ( 
0.005 M citrate + 0.15 M NaCl, pH 5.2 ) for 24 hr. The pH of the digested 
mixtures were adjusted by PBS to 7.0 before assaying the amount of 
glucose released during the digestion. The amount of glucose was assayed 
by a glucose oxidase kit ( Sigma Chem., U.S.A.). Vertical bar represents 
one standard error. 
b — buffer, e — enzyme, BG — barley p-D-glucan, C 一 a-cellulose, D 
—dextran, I — IFAl, L 一 laminarin, M — mannan, S 一 SFAl and St 一 
starch 
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3.10 S E C O N D A R Y AND TERTIARY S T R U C T U R E D E T E R M I N A T I O N OF 
FH A N D S F ^ 
T h e exper iments p rev ious l y done a imed at the d e t e r m i n a t i o n o f the p r i m a r y 
s t ruc tu re o f the ex t rac ted po lysacchar ide f rac t ions , F H , S F A l and I F A l . T h e present 
m e t h o d a l l o w the de te rm ina t i on o f secondary s t ruc ture . I t was f o u n d that mos t P - ( l - > 3 ) -
D - g l u c a n can a t ta in e i ther a r a n d o m coi l , s ingle hel ical o r t r i p le hel ica l s t ruc tu re . T h e t y p e 
o f s t ruc tu re i n v o l v e d can be de te rm ined f r o m the change in va lue o f w a v e l e n g t h w h e r e 
peak absorbance occu r red ( X m a x i m u m ) o f C o n g o red dye. T h e resul ts are s h o w n in F ig . 
3.9. T h e X m a x i m u m shif t o f F H / C o n g o Red dye c o m p l e x is a charac ter is t i c o f | 3 - ( l - > 3 ) -
D - g l u c a n w i t h a t r i p le hel ical s t ruc ture . W h e n N a O H concen t ra t i on increase f r o m 0 .0 t o 
0.05 there was no t m u c h change in X m a x i m u m ( f r o m 498 .5 to 4 9 7 . 0 ) as the g l ucan 
re ta in ing a t r i p le hel ix s t ruc tu re . Fu r the r increase in N a O H c o n c e n t r a t i o n f r o m 0 .05 t o 
0 .15 , the X m a x i m u m o f C o n g o red increased m a r k e d l y ( e.g., f r o m 4 9 7 . 0 n m t o 5 0 2 . 0 n m 
) . T h e increased N a O H concen t ra t i on d i s rup ted the h y d r o g e n bonds w h i c h he ld the t r i p l e 
hel ical s t ruc tu re , and resul ted in the f o r m a t i o n o f a s ingle he l ix . T h e s ing le he l i x w h e n b i n d 
to C o n g o Red dye caused an increase in X m a x i m u m . W h e n N a O H c o n c e n t r a t i o n 
increased f r o m 0.15 M to h igher concen t ra t i on the X m a x i m u m d r o p d ras t i ca l l y ( f r o m 
504 .0 t o 481 .5 ). T h e h igh N a O H concen t ra t i on d i s rup ted the h y d r o g e n b o n d s tha t he ld 
the s ingle hel ical s t ruc tu re , and resul t in a r a n d o m co i l s t ruc tu re . T h i s r a n d o m c o i l 
s t ruc tu re w h e n b o u n d to C o n g o Red dye resul t in the decreased X max imum-va lue： T h e X 
m a x i m u m shi f t cu r ve o f S F A l is a character is t ic o f (3-( l - > 3 ) - D - g l u c a n w i t h a s ing le 
hel ica l s t ruc tu re . N a O H concen t ra t i on w h e n increased f r o m 0 .00 t o 0 .15 M the X 
m a x i m u m had a l ready in va lue b e y o n d 500 .0 n m ( e.g. change f r o m 522 .5 t o 515 .9 ). 
W h e n fiarther increased the N a O H c o n c e n t r a t i o n the X m a x i m u m d r o p p e d d ras t i ca l l y ( e.g. 
f r o m 515 .9 to 4 8 6 . 7 ). H o w e v e r , o ther po lysacchar ides w h i c h d o n o t have he l ica l 
s t ruc tu res w i l l have X m a x i m u m c u r v e behave s imi la r t o tha t o f d H z O . 
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Fig. 3.9 The dependence of the A^max of Congo Red-glucan complexes on 
the concentration of NaOH. Congo Red solution (3.8 joM) of 0.375 ml was 
mixed with 0.75 ml sample ( 3 mg/ ml ). NaOH, 0.375 ml, of various 
concentrations (0.2 M, 0.4 M，0.6 M, 0.8 M , 1.0 M，1.2 M and 2.0 M ) were 
added to the mixture to study the Xmax shift of the Congo Red-glucan 
complexes in different NaOH concentrations. The absorption spectrum of 
the complexes in different NaOH concentration was measured from 450 nm 
to 550 nm.入隨 was determined from the absorption spectrum. 
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3.11 M O L E C U L A R W E I G H T ESTIMATION OF FH A N D SFAl 
T h e mo lecu la r w e i g h t o f va r ious po lysacchar ide f rac t ions w e r e es t ima ted w i t h ge l 
pe rmea t i on c h r o m a t o g r a p h y . Sephadex G - 2 0 0 was used. T h e resul ts w e r e s h o w n i n F ig . 
3 .10 and 3.11. F ig. 3 .10 shows the e lu t ion p ro f i l e o f B l u e dex t ran and K s C r a O / ’ and F ig . 
3 .11 shows the e lu t i on p ro f i l e o f F H and SFA l . The e lu t i on v o l u m e o f B l u e d e x t r a n 
represent the v o i d v o l u m e o f the c o l u m n and that o f K^CraO? represent the bed v o l u m e o f 
the co lumn . F r o m F ig . 3 .10, the v o i d v o l u m e shou ld be c lose to v o l u m e 23 ml . F i g u r e 3 .11 
s h o w s that b o t h F H and S F A l have e lu t ion peak at e lu t i on v o l u m e o f 2 2 - 2 3 m l , w h i c h w a s 
v e r y c lose to the v o i d v o l u m e . I n the e lu t i on p ro f i l e o f F H , there exist a m a j o r peak and a 
m i n o r peak in b e t w e e n the v o i d and the bed vo lume . T h e m a j o r peak represents abou t 66 
% and the m i n o r peak represent about 34 % o f the F H sample. W h e n F H w a s e lu ted w i t h 
c o l u m n o f ident ica l cond i t i ons , except the Sephadex gel used w a s G - l O O , there appeared 
s ingle peak and the peak was e lu ted at the v o i d v o l u m e as s h o w n in F ig . 3 . 1 2 and 3 .13 . 
3.12 V A S C U L A R DILATION AND H E M O R R H A G E A C T I V I T Y (VDH) O F FH, 
SFAL A N D IFAL 
T h i s response was repo r ted to have h igh co r re l a t i on w i t h a n t i t u m o r ac t i v i t y o f f > - . 
( l - > 3 ) - D - g l u c a n s . P - ( l — 3 ) - D - g l u c a n s w h i c h showed V D H response w e r e e x p e c t e d t o be 
ac t i ve against S c - 1 8 0 so l id t u m o r in vivo. M a l e I C R a lb ino m ice w e r e used i n the assay. 
T h e assay lasted f o r 35 days and the resul ts are s h o w n i n F ig . 3 . 1 4 and 3 .15 . T h e 
response ma in l y loca l ised at the ear o f the mice. A s c lear ly s h o w n i n F i g . 3 .14， the 
i n f l a m m a t o r y response caused extens ive b l o o d vessel d i l a t i o n and h e m o r r h a g e . F r o m 
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Fig. 3.10 Gel permeation ( Sephadex G-200 ) of Blue Dextran and 
K2Cr2〇7. NaCl (0.15 N) was used as the running buffer. The flow rate of 
the column was adjusted to 0.5 ml/ min. with a peristaltic pump. The eluent 
of the column was collected by a fraction collector ( 1.1 ml/ tube ). Blue 
Dextran in the eluent was monitored by measuring asorbance at 660 nm 
and Yi iCi iOi in the eluent was monitored by measuring asorbance at 400 
nm. 
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Fig. 3.11 Gel permeation ( Sephadex G-200 ) of FH and SFAI. NaCl (0.15 
N) was used as the running buffer. The flow rate of the column was adjusted 
to 0.5 ml/ min. with a peristaltic pump. The eluent of the column was 
collected by a fraction collector ( 1.1 ml/ tube ). FH or SFAI in the eluent 
was monitored by phenol-sulfuric acid method and absorbance measured at 
490 nm. 
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Fig. 3.12 Gel permeation ( Sephadex G-lOO ) of Blue Dextran and K2Cr2〇7 
• NaCl ( 0.15 N ) was used as the running buffer. The flow rate of the 
column was adjusted to 0.5 ml/ min. with a peristaltic pump. The eluent of 
the column was collected by a fraction collector ( 1.1 ml/ tube ). Blue 
Dextran in the eluent was monitored by measuring asorbance at 660 nm and 
K2Cr207 in the eluent was monitored by measuring asorbance 400 nm. 
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Fig. 3.13 Gel permeation ( Sephadex G-lOO ) of FH. NaCl (0.15 N) was 
used as the running buffer. The flow rate of the column was adjusted to 0.5 
ml/ min. with a peristaltic pump. The eluent of the column was collected by 
a fraction collector ( 1 . 1 ml/ tube ). FH in the eluent was monitored by 
phenol-sulfuric acid method and absorbance measured at 490 nm. 
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Fig. 3 .15 ’ it was f o u n d that on ly F H and S F A l s h o w n V D H response in the tested per iod , 
bu t not I F A l . Fu r t he rmore , S F A l showed a s t ronger and longer last ing response w h e n 
compa red w i t h F H . 
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Fig. 3.14 Inflammation of male ICR albino mice induced by F.V. fractions; 
Vascular Dilation and Hemorrhage ( V D H ) response. A was ear removed 
from mice injected with SFAl, B was ear removed from mice injected with 
FH, C was ear removed from mice injected with NaCl and D was ear 
removed from mice injected with dextran ( M W 72,200 ). 
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Fig. 3.15 The V D H inducing ability of F.V. fractions. Male ICR albino 
mice were divided into groups of ten. The mice were injected 
intraperitoneally with either NaCl，FH, SFAl, IFAl or dextran, for four 
consecutive days (from day 0 to day 3). The % of mice with V D H response 
was recorded everyday after the first injection until day 35. 
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Discuss ion 
In the screening, all mush rooms chosen were stained pos i t i ve by ani l ine b lue, 
w h i c h stain 3 ) - D - g l u c a n speci f ical ly (Nakan ish i et al, 1974, 1976). H o w e v e r , i t was 
f o u n d that the cell wa l l o f Flammulina velii/ipes, was stained the most intense and was 
selected as a r ich source o f P - ( l - > 3 ) - D - g l u c a n in this pro ject . The P - ( l - > 3 ) - D - g l u c a n , a 
s t ruc tura l componen t o f the cel l wa l l , was cova lent ly at tached to o ther inso lub le w a l l 
mat r i x . D u e to this s t ructura l ar rangement , the hot wa te r ex t rac t ion process w a s no t 
e f fec t ive in releasing the (3-( l - > 3 ) - D - g l u c a n . Indeed, the percentage y ie ld o f F H on l y 
represent 0.5 % o f the dry m u s h r o o m and most o f the p - ( l — 3 ) - D - g l u c a n present in the 
cel l wa l l escaped the hot wa te r ex t rac t ion procedure. W h e n us ing a lka l ine-urea m i x t u r e 
instead o f wa te r as the ex t rac t ion solvent all the remain ing g lucan in the cel l w a l l w e r e 
released. T h e y ie ld o f the g lucan ( F A l ) by this ex t rac t ion me thod was 7 t imes that o f the 
ho t w a t e r ex t rac t i on method . A b o u t 80 % o f the F A l f rac t ion was w a t e r so lub le ( the 
S F A l ) and the rema in ing 20 % was wa te r - inso lub le ( the I F A l ) . 
I n o rde r to p rove the ident i ty o f the f ract ions, the f rac t ions w e r e sub jec ted t o 
chemica l and physical analysis. Since I F A l was wa te r insoluble, analysis i n v o l v e d 
spec t ropho tome t r i c measurement was not suitable f o r I F A l . I f the ex t rac ted 
po lysacchar ides w e r e ( 3 - ( l - > 3 ) - D - g l u c a n , they w o u l d be very l i ke ly t o be a h o m o p o l y m e r 
o f g lucose. A s expected, the carbohydra te content o f all the f rac t ions w a s c losed t o 100 
% . T h e results f r o m pro te in conten t and u ron i c acid conten t qu i te agree w i t h tha t o f 
ca rbohydra te content de te rmina t ion . In fact , the p ro te in and u ron i c ac id con ten t o f the 
f rac t ions was i n s i g n i f i c a n t — n o m o r e than 5 % o f the to ta l mass o f the sample. T h e sugar 
c o m p o n e n t o f the f rac t ions was de te rmined in o rder to p rove whe the r the f rac t i ons w e r e 
g lucose h o m o p o l y m e r . In the de te rmina t ion , g lucose, galactose, mannose, xy lose , f l i cose 
and f ruc tose w e r e chosen as standards in the de te rm ina t i on as these sugars w e r e 
c o m m o n l y f o u n d in f l inga l cel l w a l l ( C r o o k et al, 1961). A s expected, the resul ts o f the 
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m e t h o d s h o w e d that there was on l y g lucose present in the hyd ro l ysa te o f the f rac t ions . 
W h e n the f rac t ions we re sub jected to pe r ioda te o x i d a t i o n the resul ts s h o w e d tha t the 
f rac t ions con ta ins l i nkage o the r than p - ( 1 - ^ 3 ) - D - l i n k a g e . Per ioda te c leaves c a r b o n - c a r b o n 
s ingle b o n d o f t w o adjacent ca rbons w h i c h bear f ree h y d r o x y l g r o u p s ( G o l d s t e i n et al, 
1976; Kaba t and Mayer ' s , 1971). T h e f rac t ions , F H and S F A l , s h o w e d abou t 23 % o f 
pe r ioda te up take . I f the f rac t i ons w e r e h o m o p o l y m e r o f g lucose w i t h P - ( l ~ > 3 ) - D - l i n k a g e 
on ly , the pe r ioda te up take o f the f rac t i ons shou ld be c lose to zero . W h e n the pe rcen tage 
o f pe r ioda te u p t a k e o f dex t ran was c o m p a r e d w i t h that o f the f rac t i ons the ra t i o o f the 
percentage u p t a k e was 2 .00 : 0 .82 . Since dex t ran is g lucose p o l y m e r l i n k e d t o g e t h e r b y a -
( 1 ^ 6 ) - D - l i n k a g e as s h o w n in F ig . 3 .16, there shou ld be 2 c leavages b y p e r i o d a t e pe r 
every g lucose m o n o m e r in dex t ran . F r o m the ra t io , it was c lear tha t the re w a s less t h a n 
one c leavage per g lucose m o n o m e r in the f rac t ions . I t w a s l i ke l y that the p e r i o d a t e u p t a k e 
o f the f rac t ions was due to the a t tachment o f g lucose b r a n c h i n g to the (3 - (1—>3) -D-g lucose 
ma in chain in the f o r m o f (3-( 1 - > 6 ) - D - l i n k a g e . T h e specu la t ion base o n the fac t tha t m a n y 
P - ( l — 3 ) - D - g l u c a n s iso lated f r o m d i f fe ren t f ung i do possess some p - ( l — 6 ) - D - l i n k a g e s . 
T h e b ranch -cha in may con ta in one to several D - g l u c o s y l un i t s l i n k e d at the 0 - 6 a t o m such 
as |3 -D-g lucans f r o m Phylophthora species ( K r a u s et al, 1992; W a n g et al, 1974 ) , 
C o r i o l a n f r o m Corioliis versicolor ( M i y a z a k i el al 1974; I t o et al, 1979) , A P f r a c t i o n f r o m 
Grifola frondosa ( O h n o et al, 1984) , Sc le rog lucan f r o m Sclerothim glncaniciim ( S i n g h et 
al, 1974) , (3 -D-g lucan f r o m Cochlioholus miyabeamis ( N a n b a et al, 1987 ) , l en t i nan 
( L N T ) f r o m Lefitimis eclocks (Ch iha ra et al, 1 9 7 0 )， s c h i z o p h y l l a n ( S P G ) f r o m 
SchizophyHum commune ( M i s a k i el al, 1981) etc. . I f the pe r i oda te u p t a k e w a s rea l l y due 
t o 6 ) - D - l i n k e d D - g l u c o s e m o i e t y , it w a s es t ima ted that the re w a s 4 0 % o f the 
g l ucose un i ts in the f rac t i ons c o n t r i b u t e d t o the | 3 - ( l - > 6 ) - D - l i n k a g e . T h e v a l u e w a s 
possib le. I n case o f sch i zophy l l an , len t inan and |3 -D-g lucan f r o m Phylophthora species, i t 
was 25。 /o , 29 % and 60 % respec t i ve ly . T h e s t r uc tu re o f s c h i z o p h y l l a n and l en t i nan w a s 
s h o w n in F ig . 3 .17 . 
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Figure 3.16 Chemical structure of D-glucose and Dextran. Dotted line 
represents cleavage site of periodate. 
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Figure 3.17 Chemical structure of Schizophyllan (SPG) and Lentinan (LNT). 
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A l l the po lysacchar ide f rac t ions ex t rac ted have the capac i t y t o coagu la te the 
L i m u l u s amebocy te lysate ( L A L ) b iochemica l reagent. Th i s fu r the r s u p p o r t the idea that 
the f rac t ions w e r e P - ( 1 ^ 3 ) - D - g l u c a n s as the coagu la t i on o f the reagent w a s sensi t ive t o p 
- ( l - ^ 3 ) - D - g l u c a n and LPS ( M o r i t a et al, 1981; Sai to et al, 1991) . T h e resu l ts f r o m the in 
vilw m i t ogen i c and in vivo T N F i nduc t i on assays suggested that there ex is ted no o r 
ins ign i f i cant a m o u n t o f L P S in the f rac t ions. I n fact , the L P S c o n t a m i n a t i o n w a s es t ima ted 
t o be t o o l o w in the f rac t ions t o ac t iva te the L A L b iochemica l reagent t o coagu la te . W h e n 
the f rac t ions w e r e subjected to Laminar inase e n z y m e，w h i c h d igest P - ( l - > 3 ) - D - g l u c a n , 
d igest ion . G l u c o s e was released f r o m all the f rac t ions. H o w e v e r , on l y S F A l f r a c t i o n w a s 
near ly comp le te l y d igested. F H s h o w e d 50 % d iges t ion and I F A l s h o w e d abou t 15 % 
d igest ion . T h e i ncomp le te d iges t ion o f F H may be due t o the present o f o the r 
po lysacchar ides in F H f rac t i on o r the secondary s t ruc tu re o f F H . I n la ter d iscuss ion, i t 
w o u l d po in t ou t that F H and S F A l bear d i f fe ren t secondary s t ruc tu re and S F A l bears the 
same secondary s t ruc tu re as the natura l substrate ( L a m i n a r i n ) o f the e n z y m e Lamina r i nase . 
T h e l o w d iges t i on o f the I F A l f r ac t i on may be due t o the phys ica l appearance ( the I F A l 
f r a c t i o n was w a t e r inso lub le) o f I F A l . 
A l l the w o r k done p rev ious l y t r ied t o p r o v e the p r i m a r y s t r u c t u r e o f the f r ac t i ons 
on ly . T o reveal the secondary s t ruc tu re o f the f rac t ions , I R , N M R s p e c t r u m o r X - r a y 
analysis data o f the f rac t ions shou ld be ob ta ined. Instead o f I R , N M R and X - r a y analysis, 
a cheaper, faster and s impler m e t h o d was adop ted to inves t iga te the seconda ry s t r uc tu re 
the C o n g o R e d m e t h o d ( K r a u s et al, 1992). F r o m the resul ts , t he c u r v e o f F H w a s a 
charac ter is t i c o f P - ( l - ^ 3 ) - D - g l u c a n w i t h a t r i p le he l ica l s t ruc tu re , and t he c u r v e o f S F A l 
w a s a charac ter is t i c o f P - ( l - > 3 ) - D - g l u c a n w i t h a s ingle he l ica l s t ruc tu re . 
T h e f rac t i ons , i f so lub le in wa te r , w e r e h igh l y v i scous s o l u t i o n w h e n d i sso l ved i n 
d is t i l led wa te r . T h i s obse rva t i on suggested that the f rac t ions w e r e m a c r o m o l e c u l e s o f v e r y 
la rge mo lecu la r we igh t . T h e mo lecu la r w e i g h t o f the f rac t i ons w e r e es t ima ted b y ge l 
p e r m e a t i o n c h r o m a t o g r a p h y . SFAJ was es t imated t o have m o l e c u l a r w e i g h t g rea te r t h a n 
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or equal to 200 k D . For F H f rac t ions, it was t reated w i t h a lkal ine be fore app ly ing to 
ch roma tog raph i c separat ion, to reduce the v iscos i ty o f the sample. A s c lear ly s h o w n in the 
results o f the C o n g o Red method , the a lkal ine c o n d i t i o n used in the t rea tment b r o k e the 
t r ip le hel ix o f F H to f o r m single hel ix. Hence, the est imated va lue shou ld be three t imes 
that o f the de termined value fo r F H f rac t ion in mo lecu la r we igh t . T h e mo lecu la r w e i g h t 
o f F H f rac t ion was est imated to be greater than or equal to 600 k D ( 3 x 200 k D ) f o r the 
ma jo r e lu t ion peak. The m ino r e lu t ion peak d id not appear w h e n F H was separated by G -
100 but by G - 2 0 0 . Th is suggested that the m i n o r peak o f F H shou ld have mo lecu la r 
w e i g h t o f greater than or equal t o 300 k D ( 3 x 100 k D ) . 
I t was repor ted that f l i nga l a n t i t u m o r po lysacchar ides w i t h p - ( l - > 3 ) - D - l i n k a g e 
can t r i gger a un ique type o f i n f l a m m a t o r y response; vascu lar d i l a t i on and hemor rhage 
act iv i t ies ( V D H ) ( A o k i , 1983). The re exist a h igh co r re la t i on be tween the i n f l a m m a t i o n 
and the a n t i - t u m o r ac t iv i t y o f the polysacchar ides. Th i s reac t ion was thus used as the basis 
f o r the select ion o f the ex t rac ted f rac t ions f o r fu r the r studies. A m o u n t the f rac t ions , on l y 
F H , F A l and S F A l have the capac i ty to t r i gger V D H responses and F H and S F A l w e r e 
i 
selected f o r f u r the r invest igat ion. 
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Toxicity 
C H A P T E R FOUR 
T H E T O X I C I T Y O F Flammulina velutipes 
I n t r o d u c t i o n 
M o s t chemica l agents emp loyed in cancer therapy are h igh l y t ox i c . T h e y 
preferent ia l ly af fect d i v i d i ng cells in t u m o r s and thei r hosts, and the side ef fects are o f t e n 
most apparent in those tissues or organs whe re there is a rap id cel l t u rnove r . These inc lude 
the bone m a r r o w , gast ro in test ina l ep i the l ium and hair fo l l ic les. A s a po ten t ia l a n t i t u m o r 
agents, the i r t o x i c i t y should be evaluated. . 
Results 
4.1 L A C K OF C Y T O T O X I C I T Y OF Flammulina velutipes TO B R I N E S H R I M P 
F H , S F A l and I F A l w e r e f i rst assayed f o r the i r c y t o t o x i c i t y t o w a r d s b r ine 
shr imp la rva {Artemia salina). T h e results o f the exper imen t w e r e s h o w n in Tab le 4 .1 . 
C y c l o h e x i m i d e , a p ro te ih synthesis inh ib i to r , was used as a pos i t i ve con t ro l . T h e 
exper imenta l va lue o f the LC50 ( | . ig /ml) o f c y c l o h e x i m i d e is abou t 1.6 f o l d la rger w i t h 
respect to the repor ted value. F r o m the results, F H , S F A l and I F A l al l s h o w n LC50 (m. 
g / m l ) greater than 1000. 
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Table 4.1 Cytotoxicity of FH and SFAl on Brine Shrimp 
Sample LC50 i^g/ ml LC 5 0 )ig/ ml 
(Observed Value ) (Reported Value ) 
Cycloheximide 47.3 土 6.9 • 29.4 土 0.3 
FH > 1000 / 
FAl > 1000 / 
SFAl > 1000 / 
W M > 1 0 0 0 / 
Suspension of nauplii, 100 jil, containing 10-25 organisms was mixed with 
100 [ lI of test sample of various concentrations. The mixture was incubated 
at 26-29 OC for 24 hr. At the end of the incubation period, the number of 
nauplii that cannot survive the incubation was counted. 




4.2 LACK OF CYTOTOXICITY OF Flaniimilina velutipes TO M U R I N E B O N E 
M A R R O W CELLS 
The c y t o t o x i c i t y o f F H and SFA l were fu r ther tested on mouse bone m a r r o w cells. 
Th ree concen t ra t ions o f F H and S F A l were tested (25 |. ig/ml, 50 |. ig/ml and 100 |ag/ml). 
C y c l o h e x i m i d e was used as the con t ro l . As s h o w n in F ig. 4 .1, un l i ke cyc lohex im ide , w h i c h 
caused m o r e than 70 % decrease in D N A i nco rpo ra t i on by the bone m a r r o w cells, F H and 
S F A l caused no decrease in D N A inco rpo ra t i on o f the bone m a r r o w cells. 
4.3 L A C K OF CYTOTOXTCITY OF Flammulina velutipes TO M O U S E 
Female B A L B / c mice w e r e used in the assay. T h e results w e r e s h o w n in Tab le 4 .2 . 
T h e results s h o w e d that the in jec t ion o f bo th F H and S F A l in to mice in t ravenous ly had no 
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Fig. 4.1 The toxic effect of FH and SFAI on bone marrow cells of female 
BALB/c mice. Various concentrations ( 50 )ig/ ml, 100 jig/ ml and 200 jig/ 
m l ) of 100 )il FH, SFAI, or cycloheximide were cultured with 100 )il bone 
marrow cells ( 106 cells /m l ) . The cell mixtures were incubated at 37 oC 
with 5 % CO2 supply for 72 hr. The kil l ing of the bone marrow cells was 
monitored by thymidine uptake. Vertical bar represents one standard error. 
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Table 4.2 Cytotoxicity of FH and SFAl on female BALB/c mice. 
Sample L D 5 0 jig/ mouse 
NaCl (0.15 N ) > 1000 -
FH > 1000 
S ^ > 1 0 0 0 
Female BALB/c mice were divided into groups of 10. Test sample (2.5 mg/ 
ml) or 0.15 N NaCl, 0.2 ml, was injected intravenously. The number of mice 
，that survive the treatment, was recorded every day after the injection until 
day 35 was reached. 
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Table 4.2 Cytotoxicity o f F H and SFAl on female BALB/c mice. 
Sample L D 5 0 |ig/ mouse 
NaCl ( 0.15 N ) > 1000 
FH > 1000 
S m > 1000 
Female BALB/c mice were divided into groups of 10. Test sample (2.5 mg/ 
ml) or 0.15 N NaCl, 0.2 ml, was injected intravenously. The number of mice 
，that survive the treatment, was recorded every day after the injection until 




The tox i c i t y o f F H and S F A l were f i rst tested w i t h br ine shr imp. T h e test p rov ide 
a cheap, rapid, s imple and rel iable method ( M e y e r et al�1982) fo r p re l im inary study. I t 
was demonst ra ted that the isolated macromolecu les were not t ox i c at the concen t ra t ion 
tested (LC50 > 1 0 0 0 jiig/ ml) . As ment ioned before, the most suscept ib le cells to the a t tack 
o f chemotherapeut ic drugs are rap id ly d i v i d i ng cells. M o u s e bone m a r r o w cells we re 
chosen as the representat ive rap id ly d i v id ing mammal ian cells t o test f o r the t ox i c ef fect o f 
F H and SFA l . B o t h F H and S F A l showed no signi f icant t o x i c ef fect on the bone m a r r o w 
cells hi vitro. H o w e v e r , these t w o models fa i led to detect the t ox i c e f fect o f chemicals 
w h i c h were not t ox i c in their nat ive f o r m but tox ic af ter metabo l ised w i t h l iver . E v e n F H 
and S F A l we re s h o w n to be non - tox i c to br ine shr imp and bone m a r r o w cells, the mode ls 
fa i led to detect the tox ic effect o f compounds w h i c h show no t o x i c i t y in the i r nat ive f o r m 
but show tox i c i t y af ter metabo l isa t ion in l iver cells. Fo r example, br ine shr imp assay fa i led 
to detect the t o x i c i t y o f cyc lophosphamide w h i c h is k n o w n to requ i re metabo l i c ac t i va t ion 
in the l iver f o r ac t i v i t y in man (Sol is et al, 1992). W h e t h e r chemicals are t o x i c af ter 
metabol ised w i t h l iver can be par t ly ref lected by the t o x i c i t y o f the chemicals t o the w h o l e 
animals. F H and S F A l w h e n in jected in t ravenous ly in to mice showed no s ign i f icant t ox i c 
ef fect (LD50 > 1 0 0 0 j i g / mouse). 
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C H A P T E R F I V E 
t h e i m m u n o m o d u l a t o r y a c t i v i t i e s o f FlammiiHna velutipes 
I n t r o d u c t i o n 
T h e ac t i v i t y o f the i m m u n e system, w h i c h play the cen t ro l ro le in the ant i -cancer 
mechanisms, can be modu la ted by many chemica l agents. T h e m o d u l a t i o n can be e i ther 
suppress ion or po ten t i a t i on depend ing on the types o f chemicals i nvo lved . D r u g s such as 
stero ids and cyc lophosphamide result in suppress ion o f the i m m u n e system, and drugs 
such as Levam iso le ’ Ca lme t t e -Gue r i n bac i l lus ( B C G ) and P - D - g l u c a n s resul t i n 
po ten t i a t i on o f the immune system. I n m o d e r n medic ine, the t rea tment o f cancer ma in ly 
re ly o n the use o f external agents; rad ia t ion , surg ica l ope ra t i on and c y t o t o x i c d rugs t o 
r e m o v e o r k i l l m o s t o f the cancer cells o f a cancer pat ient . T h e comp le te e rad ica t ion o f the 
cancer cells st i l l re ly on the endogenous ant i -cancer mechan ism o f the p a t i e n t s t h e 
i m m u n e system. I n cancer pat ients, the i m m u n e system o f the pat ients is usua l ly d o w n 
regulated. The re fo re , it is log ica l to use i m m u n o p o t e n t i a t o r t o res tore o r boos t up the 
i m m u n e system o f a cancer pat ient in cancer t rea tment . B - , T -ce l l s and macrophages are 
the ma jo r cells that play a ro le in ant i -cancer mechanisms. T h e a u g m e n t a t i o n o f the ac t i v i t y 
o f these cells shou ld help fijrnishing cancer cure. .. 
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Results 
5.1 EFFECT OF Flanwmlina velutipes ON M U R I N E L Y M P H O C Y T E S 
5.1.1 Mitogenic Effect of FH and SFAI on Mouse Lvmnhocytes In Vitro 
L y m p h o c y t e s ob ta ined f r o m female B A L B / c mice w e r e used in the assayed. F H 
and S F A I w e r e cu l t u red w i t h the l ymphocy tes at va r ious concen t ra t ions ( 25 pig/ml, 50 \ i 
g / m l and 100 (.ig/ml ). T h e results w e r e s h o w n in F ig . 5.1. I n the f i gu re , F H s h o w a 
g radua l increase in m i togen i c ac t i v i t y f r o m 25 |ag/ml to 100 |. ig/ml. A t 100 f i g /m l , at least 
100 % increase in t hym id ine i nco rpo ra t i on was observed ( e.g. S.I . o f 2 t o 4 had been 
observed ). H o w e v e r , S F A I s h o w n no s igni f icant increase in t hym id i ne i n c o r p o r a t i o n at the 
concent ra t ions tested ( e.g. S.I. remains at 1 ). A s expected, L P S and C o n A caused 
extensive blast ic t r ans fo rma t i on o f the l ymphocy tes ; e.g. the S.I . o f L P S (20 | i g / m l ) and 
C o n A (5 | . ig/ml) was 227 and 524 respect ive ly (data no t s h o w n in the f i gu re ) . 
5.1.2 Mitogenic Effect of FH plus P M B on Mouse Lvmnhocytes In Vitro 
I t is i m p o r t a n t to check w h e t h e r the m i togen ic e f fec t o f F H exer ted o n the m u r i n e 
l ymphocy tes was due to L P S con tamina t ion . P M B , w h i c h can abo l i sh the m i t o g e n i c 
ac t i v i t y o f L P S , toge ther w i t h F H was added to l ymphocy tes cu l tu re . F r o m the resul ts i n 
F ig . 5.2, the add ing o f P M B reduced, bu t no t abol ished, the m i t o g e n i c ac t i v i t y o f F H . F o r 
example , the t h y m i d i n e i n c o r p o r a t i o n o f l ymphocy tes cu l t u red w i t h F H w a s j u s t s l igh t l y 
reduced by P M B . In case o f L P S ( f ina l concen t ra t ion , 10 |.ig/ m l ) , the add ing o f P M B 
( f ina l concen t ra t i on , 5 |.ig/ m l ) reduced the t hym id i ne i n c o r p o r a t i o n , caused by L P S , by at 
least 50 % (da ta no t s h o w n in the f igure ) . 
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Fig, 5.1 The initogenic effect of FH and SFAl on murine lymphocytes in 
vitro. Various concentrations of FH and SFAl were cultured with 5x105 
mouse lymphocytes. The sample/cell mixture was incubated for 48 lir. After 
incubation, the cells were pulsed with 0.5 ).iCi 3H-TdR and radioactivity 
incorporated was determmed. Stimulation index (S.I.) is a ratio: radioactive 
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Fig. 5.2 The mitogenic effect o f F H plus PMB on murine lymphocytes in 
vitro. Various concentrations of FH together with 5 jiig PMB were cultured 
with 5x105 mouse lymphocytes. The sample/cell mixture was incubated for 
24 hr. After the incubation, the cells were pulsed with 5 jaCi 3H-TdR and 
radioactivity was determined. Stimulation index (S.I.) is a ratio: radioactive 




5.1.3 Mitogenic ElTcct of FH on T- lymnhocvtes In Vitro 
L y m p h o c y t e s obta ined f r o m female B L A B / c mice w e r e used in the assay. T -
l y m p h o c y t e subpopu la t i on was prepared by Ceder lane C o l u m n k i t ( an a f f i n i t y c o l u m n ). 
T h e results w e r e s h o w n in F ig. 5.3. W h e n the cell p repara t ion was cu l t u red w i t h F H ( 100 
l_ ig /ml ) , C o n A ( 1 | . i g / m l ) o r L P S ( 10 ) , i g /m l ) the s t imu la t ion index w a s 1.6’ 2 .8 and 70.5 
respect ive ly . 
5.1.4 Mitogenic Effect of FH on B- lymnhocvtes In Vitro 
L y m p h o c y t e s ob ta ined f r o m female B A L B / c m ice w e r e ' u s e d in the assay. B -
l y m p h o c y t e subpopu la t i on was prepared by add ing an t i -T l y m p h o c y t e an t i body and 
comp lemen t to the l y m p h o c y t e preparat ion. T h e an t ibody toge ther w i t h the c o m p l e m e n t 
lysed the T - l y m p h o c y t e s and remained beh ind the B - l y m p h o c y t e popu la t i on . T h e B -
l ymphocy tes w e r e cu l t u red w i t h ei ther F H ( 100 |. ig/ml )，ConA ( 1 | A g / m l ) o r L P S ( 10 \x 
g / m l ). T h e resul ts w e r e s h o w n in F ig. 5.4. T h e B - l y m p h o c y t e s c u l t u r e d w i t h C o n A 
s h o w e d no s ign i f icant increase in t hym id ine i nco rpo ra t i on . H o w e v e r , B - l y m p h o c y t e s 
cu l tu red w i t h F H s h o w e d an increase in t hym id ine i n c o r p o r a t i o n ; S. I . equa led 7.2. A s 
expected, the B - l y m p h o c y t e s cu l tu red w i t h L P S showed a great increase in t h y m i d i n e 
i n c o r p o r a t i o n ; S. I . equaled 61.3. 
5.1.5 Co-mi togen ic Effect of FH and SFAl on M u r i n e L y m p h o c y t e s In Vitro 
E v e n S F A l cannot induce l y m p h o c y t e p ro l i f e ra t i on in vitro, i t 's c o - m i t o g e n i c 
ac t i v i t y w a s also tested. L y m p h o c y t e s obta ined f r o m female B L A B / c m i ce w e r e used in 
the assay. T h e resul ts w e r e s h o w n in Fig. 5.5. L y m p h o c y t e p repa ra t i on w h e n c u l t u r e d 
w i t h F H - L P S m i x t u r e and F H - C o n A m i x t u r e had S.I . s imi la r t o tha t o f l y m p h o c y t e s 
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Fig. 5.3 The mitogenic effect of FH on murine T-lymphocytes in vitro. FH 
was cultured with 5x105 murine B-lymphocytes at 100 \xg/ ml. The 
sample/cell mixture was incubated for 48 hr. After incubation, the cells were 
pulsed with 0.5 ^Ci 3H-TdR and radioactivity incorporated was determined. 
Stimulation index (S.I.) is a ratio: radioactive count of sample/ radioactive 
count of control. Vertical bar represents one standard error. 
109 
Iminunoniodulntion 
70 - r 




！ I • 
o ^ Z 
‘ m m J 
FH 100 LPS 10 ConA1 
Fig. 5.4 The initogenic effect of FH on murine B-lymphocytes in vitro. FH 
was cultured with 5x105 murine T-lymphocytes at 100 [xg/ ml. The 
sample/cell mixture was incubated for 24 hr. After the incubation, the cells 
were pulsed with 5 jaCi ''H-TdR and radioactivity was determined. 
Stimulation index (S.I.) is a ratio: radioactive count of sample/ radioactive 
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Fig. 5.5 The co-initogenic effect o f F H and SFAl on murine lymphocytes. FH 
and SFAl were cultured with 5x105 mouse lymphocytes at 100 |ig/ m l The 
sample/cell mixture was incubated for 48 hr. After incubation, the cells were 
pulsed with 0.5 ).iCi 3H-TdR and radioactivity incorporated was determined. 
Stimulation index (S.I.) is a ratio: radioactive count of sample/ radioactive 
count of control. Vertical bar represents one standard error. 
M e d C o m p l e t e medium (RPMI with 10 % FCS supplemented). 
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cu l tu red w i t h L P S and C o n A alone. L i k e F H , S F A l cannot enhance the blast ic 
t r ans fo rma t ion ab i l i ty o f LPS and C o n A at the concen t ra t ion tested. 
5.1.6 Mitogenic ElTect of FH and SFAl on iVlurine Bone Marrow Cells In Vitro 
B o n e M a r r o w cells ob ta ined f r o m female B A L B / c mice w e r e used in the assay. 
A s s h o w n in Fig. 5.6, F H and S F A l tested at var ious concent ra t ions (25 |. ig/ml, 50 |_ig/ml 
and 100 |ag/ml) cannot induce the p ro l i f e ra t ion o f bone m a r r o w cells. A s expected, the 
pos i t i ve con t ro l , mur ine r I L - 3 (200 f i g /m l ) induced extensive p ro l i f e ra t i on o f m u r i n e bone 
m a r r o w cells ； S.I . equaled 31.4 (data not s h o w n in the f igure) . 
5.1.7 Mitogenic Effect of FH and SFAl on Murine Lymphocytes In Vivo 
Female C 5 7 B L / 6 J mice we re used in the assay. T h e mice w e r e in jec ted e i ther 
w i t h N a C l , F H or S F A l on day 0. L y m p h o c y t e s we re obta ined f r o m the m ice o n day 0, 3 
and 5. T h e p ro l i f e ra t i on o f the isolated l ymphocy tes w e r e m o n i t o r e d by t h y m i d i n e 
i nco rpo ra t i on . A s c lear ly s h o w n in Fig. 5.7’ on ly l ymphocy tes p repared f r o m mice , 5 days 
af ter F H and S F A l in jec t ion, had s igni f icant increase in D N A synthesis; F H increased the 
D N A synthesis by 143 % and S F A l increased the D N A synthesis by 195 % . L y m p h o c y t e s 
prepared f r o m mice, 0 and 3 days af ter F H and S F A l in jec t ion , had no s ign i f i cant increase 
in D N A synthesis w i t h respect to con t ro l . 
5.1.8 Effect of FH and SFAl on the Enhancement of First Ant ibody Production 
of S R B C Immunised Mice 
M a l e I C R alb ino mice w e r e in jected w i t h S R B C in t raper i tonea l l y o n day 0. T h e 
m ice w e r e also in jected ei ther w i t h N a C l , F H or SFAJ o n day -2 , 0 and 2. S e r u m 
ob ta ined f r o m the mice on day 6 was tested f o r a n t i - S R B C an t ibody t i t re . A s s h o w n in 
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Fig. 5.6 The mitogenic of FH and SFAl on murine bone marrow cells in 
vitro. Various concentrations of FH and SFAl were cultured with 105 mouse 
bone marrow cells. The sample/cell mixture was incubated for 72 hr. After 
incubation, the cells were pulsed with 5 [xCi 3HTdR and radioactivity 
incorporated was determined. Stimulation index (S.I.) is a ratio: radioactive 
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Fig. 5.7 The mitogenic effect of FH and SFAI on murine lymphocytes in 
v/va Female C57BL/6J mice were either injected intraperitoneally with 
NaCl, FH or SFAI. Lymphocytes were prepared from the mice on day 0, 3 
and 5. 5x103 of the isolated lymphocytes were pulsed with 5 illCi 3H-TdR for 
6 hr. and radioactivity incorporated was determined. Stimulation index (S.I.) 
is a ratio: radioactive count of sample/ radioactive count of control Vertical 
bar represents one standard error. 
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Tab le 5.1, the range o f the serum an t ibody t i t re o f mice t rea ted w i t h F H o r S F A l w e r e 
r ough l y the same w h e n compa red w i t h con t ro l . 
5 .2 E F F E C T O F Flammulina velutipes O N M U R I N E M A C R O P H A G E 
5.2.1 Effect of FH and SFAl on In Vitro Phagocytic activity of Murine Macrophage 
Per i tonea l macrophages p repared f r o m female B A L B / c m ice w e r e used in the 
assay. F H and F A l at va r ious concen t ra t ions (3.5 |ag/ml ’ 7 .0 | . ig/ml, 14 | , ig/ml and 28 | i 
g / m l ) w e r e added t o the per i tonea l macrophage. T h e resul ts are s h o w n in F ig . 5 .8 and F i g . 
5.9, F H at the concen t ra t i on tested cannot enhance m a c r o p h a g e p h a g o c y t i c ac t i v i t y . 
H o w e v e r , F A l at the concen t ra t i on tested increased the phagocy t i c ac t i v i t y o f m a c r o p h a g e 
s ign i f i can t ly and the ac t i v i t y peaked at 14 n g / ml . I n o rde r t o f i nd o u t w h e t h e r the 
ac t i va t i on o f mac rophage by F A l was due to S F A l o r I F A l . S F A l o r I F A l w e r e added t o 
per i tonea l mac rophage (14 | . ig/ml). A s s h o w n in F ig . 5 . 1 0，S F A l d i d n o t enhance the 
phagocy t i c ac t i v i t y o f per i tonea l mac rophage but I F A l d id . 
5.2.2 Effect of FH, SFAl and IFAl on In Vivo Phagocytic Activity of Mur ine 
Macrophage 
Fema le B A L B / c m ice w e r e used in the assay. T h r e e days a f te r i n t r ape r i t onea l 
i n jec t i on w i t h e i ther N a C l , F H , S F A l o r I F A l , per i tonea l mac rophages f r o m the m i c e w e r e 
p repared and tested f o r phagocy t i c ac t i v i t y . A s s h o w n in F ig . 5 .11 , F H enhanced the 
phagocy t i c ac t i v i t y s l igh t ly but F A l and S F A l enhanced the p h a g o c y t i c a c t i v i t y m a r k e d l y . 
115 
Iminunoniodulntion 
Table 5.1 Effect of FH and SFAl on the augmentation of primary antibody 
response of mice to SRBC. 
Treatment Antibody titre 
(dilution fo ld) 
NaCl 26 - 29 
FH 27-28 
S ^ 2 7 - 2 9 
Male ICR albino mice were injected with SRBC intraperitoneally on day 0. 
The mice were also injected either with NaCl, FH or SFAl on day -2, 0 and 
2. Serum obtained from the mice on day 6 was tested for anti-SRBC 
antibody titre. The range of the senim antibody titre of mice treated with FH 
or SFAl were roughly the same when compared with control. The range was 
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Fig. 5.8 The effect of FH on in vitro phagocytic activity of murine 
macrophages. Mouse peritoneal macrophages were treated with FH of 
various concentrations. After treatment, 25x106 yeast cell wall particles ( 
YW ) were added to the macrophages. YW ingested by macrophages was 
stained and the % of 100 macrophages with > 1 YW ingested was counted. 
Vertical bar represents one standard error. 
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Fig. 5.9 The effect of FAl on in vitro phagocytic activity of murine 
macrophages. Mouse peritoneal macrophages were treated with FAl of 
various concentrations. After treatment, 25x106 yeast cell wall particles ( 
Y W ) were added to the macrophages. Y W ingested by macrophages was 
stained and the % of 100 macrophages with > 1 Y W ingested was counted. 
Vertical bar represents one standard error. 
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Fig. 5.10 The effect of FH, SFAl and IFAl on in vitro phagocytic activity of 
murine macrophages. Mouse peritoneal macrophages were treated with FH, 
SFAl or IFAl at 15 jig/ ml. After treatment, 25x106 yeast cell wall particles 
( Y W ) were added to the macrophages. YW ingested by macrophages was 
stained and the % of 100 macrophages with > 1 YW ingested was counted. 
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Fig. 5.11 The effect of FH, SFAl and IFAl on in vivo phagocytic activity of 
murine macrophages. Female BALB/c mice were injected either with NaCl, 
FH, FAl, SFAl or IFAl. Three days after treatment, peritoneal macrophages 
were prepared from the mice and 25x106 yeast cell wall particles ( YW ) 
were added to the macrophages. YW ingested by macrophages was stained 
and the % of 100 macrophages with > 1 YW ingested was counted. Vertical 
bar represents one standard error. 
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5 2.3 Effect of FM and SFAI on In Vivo Migration of Murine Macrophages 
Female B A L B / c mice w e r e used in the assay. T h r e e days a f te r i n t r ape r i t onea l 
i n j ec t i on w i t h e i ther N a C l , F H o r S F A I , pe r i tonea l exuda te cel ls f r o m the m i ce w e r e 
p repared . T h e m a c r o p h a g e p o p u l a t i o n in the P E C p r e p a r a t i o n w a s d e t e r m i n e d b y neu t ra l 
red dye. A s s h o w n in F ig. 5 .12 , the i n j ec t i on o f F H increased the n u m b e r o f m a c r o p h a g e 
b y 90 o/o and the i n j ec t i on o f S F A I increased the n u m b e r o f m a c r o p h a g e b y 160 % . I n case 
o f t h i o g l y c o l l a t e (a pos i t i ve c o n t r o l ) , the increase w a s abou t 2 0 0 % . 
5.2.4 Cytostatic Activity of IVIacrophages in FH- and SFAI- treated mice 
Fema le B L A B / c m ice w e r e in jec ted w i t h e i ther N a C l , F H o r S F A I o n day 0. 
T h r e e days a f te r i n jec t i on , P E C w e r e harves ted f r o m the m ice . T h e ha rves ted P E C w e r e 
c o - c u l t u r e d w i t h L - 9 2 9 t u m o r cel ls at cel l ra t i o ; 5 :1 , 10:1，20:1 and 4 0 : 1 respec t i ve l y . T h e 
resul ts are s h o w n in F ig . 5 .13. A s c lear ly s h o w n in the f i gu re , the pe rcen tage o f t u m o r ce l l 
k i l l i n g by P E C ob ta i ned f r o m F H - and S F A l - t r e a t e d m i ce had no s ign i f i can t increase w i t h 
respect t o c o n t r o l at cel l ra t io 5 :1 and 10:1. H o w e v e r , w h e n ce l l n u m b e r r a t i o increased t o 
2 0 : 1 and 4 0 : 1 the percen tage o f t u m o r ce l l suppress ion b y P E C o b t a i n e d f r o m F H - and 
S F A l - t r e a t e d m i c e had s ign i f i can t increase w i t h respect t o c o n t r o l . 
5 2.5 Effect of FH and SFAI on Fc Receptor Expression of Peritoneal Exudate Cells 
F e m a l e B A L B / c m ice w e r e in jec ted i n t r ape r i t onea l l y w i t h e i ther N a C l , F H o r 
S F A I o n day 0. T h r e e days a f te r i n jec t i on , the P E C w e r e ha rves ted and assayed f o r the 
exp ress ion o f Fc recep to r . T h e resul ts are s h o w n in F i g . 5 .14 . I n case o f P E C o b t a i n e d 
f r o m F H t rea ted mice , there was a g radua l increase in Fc r e c e p t o r exp ress ion as the 
1 2 1 
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Fig. 5.12 The effect of FH and SFAl on in vivo migration of murine 
macrophages. Mice were either injected intraperitoneally with NaCl, FH or 
SFAl at 500 fig/ mouse. Three days after treatment, PEC were obtained 
from the mice. Two ml (106 cells/ ml) PEC suspension was added per well 
of a 24-well plate. The cells were incubated at 37oC for 4 hr. After 
incubation, non-adherent cells were washed away with PBS. The number of 
adherent cells was determined with neutral red dye and absorbance 
measured at 540 nm. The relative macrophage number was obtained from 
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Fig. 5.13 The effect of FH and SFAl on cytostatic action of murine 
macrophages. Mice were injected intraperitoneally with either NaCl, FH or 
SFAl. Three days after injection, PEC were obtained from the mice. The 
prepared PEC was co-cultured with 8x105 L-929 cells in a 96-well plate at 
40:1, 20:1,10:1 and 5:1 cell ratio. After 4 hr. of incubation, the cell mixture 
was pulsed with 5 |iCi 3H-TdR for 6 hr. and the radioactivity incorporated 
was deteimined. Vertical bar represents one standard error. 
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Fig. 5.14 The effect of FH and SFAl on Fc receptor expression of mouse 
PEC. Mice were injected intraperitoneally with either NaCl, FH or SFAl. 
Three days after injection, PEC were obtained from the mice. 2x106 PEC 
was mixed with 1.2x108 anti-SRBC antibody coated SRBC. After 
incubation at 37 oC for 15 min., cells were spun down and pellet obtained 
was then resuspended by gentle shaking. The number of 100 PEC with 
immune rossetting was counted. Vertical bar represents one standard error. 
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injection dosage increase from 125 ng/mouse to 500 }.ig/mouse. At 500 |.ig/mouse, the 
increase was significant with respect to control. In case of SFAl, there was no significant 
increase in Fc receptor expression at the dosage tested. 
5.3 EFFECT OF Flammuliim velutipes ON MURINE SERUM C Y T O K I N E 
AND C O M P L E M E N T LEVEL 
5.3.1 Effect of FH and SFAl on Murine Serum Cytokine Level 
Male ICR albino mice were injected intraperitoneally with either NaCl, FH or 
SFAl on day 0, 1, 2 and 3. Serum was obtained from the mice on day 1, day 6，day 9 and 
day 12. The serum GM-CSF, IL-1 a, IL-4 and INF-y level was assayed with ELISA kits. 
The results are shown in Fig. 5.15, 5.16, 5.17 and 5.18 respectively. As shown in Fig. 
5.15, 5.16 and 5.17, the injection of FH and SFAl induced no significant increase of serum 
GM-CSF, IL-l a and IL-4. However, the injection of FH or SFAl did induce a significant 
increase in serum INF-y level as shown in Fig. 5.18. SFAl when compared with FH can 
induce much more INF-y release. The release peaked on day 6 and returned to basal level 
on day 12. To assay the effect of FH and SFAl on the induction of TNF release, female 
BALB/c mice were intravenously injected with either NaCl, FH, SFAl or LPS. One hour 
after injection, serum was obtained from the mice . The serum was diluted to different 
concentrations, 10 fold to 10 x 10 fold. The diluted serum was cultured with L-929 
tumor cells. The degree of L-929 cell killing was monitored by neutral red dye. The results 
are shown in Fig. 5.19. As shown in the figure, the TNF titre of FH- and LPS- treated, but 
not SFAJ -treated mice, were significantly higher than that of the control. The TNS titre of 
FH-treated mice when compared with that of LPS was similar. 
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Fig. 5.15 Male ICR albino mice were injected intraperitoneally either with 
NaCl, FH or SFAl on day 0，1，2 and 3. On day 1，6，9 and 12, 5 mice were 
selected from each group and serum was obtained from the mice. The serum 
collected was tested for GM-CSF level by murine GM-CSF ELISA kit. 
Vertical bar represents one standard error. 
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Fig. 5.16 Male ICR albino mice were injected intraperitoneally either with 
NaCl, FH or SFAl on day 0, 1, 2 and 3. On day 1, 6, 9 and 12, 5 mice were 
selected from each group and serum was obtained from the mice. The serum 
collected was tested for IL-1 a level by murine IL-1 a ELISA kit. Vertical 
bar represents one standard error. 
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Fig. 5.17 Male ICR albino mice were injected intraperitoneally either with 
NaCl, FH or SFAI on day 0’ 1，2 and 3. On day 1，6’ 9 and 12, 5 mice were 
selected from each group and serum was obtained from the mice. The serum 
collected was tested for IL-4 level by murine IL-4 ELISA kit. Vertical bar 
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Fig. 5.18 Male ICR albino mice were injected intraperitoneally either with 
NaCl, FH or SFAl on day 0，1, 2 and 3. On day 1’ 6，9 and 12，5 mice were 
selected from each group and serum was obtained from the mice. The serum 
collected was tested for INP-y level by murine INP-y ELISA kit. Vertical 
bar represents one standard error. 
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Fig. 5.19 The effect of FH and SFAl on murine serum TNP level. Mice 
were injected intravenously with either NaCl, FH, SFAl or LPS. 1 hr after 
treatment, blood was obtained from the mice. Serum prepared from the 
blood was diluted, with medium containing cycloheximide, to various 
concentrations. The diluted serum, 100 \ i l was incubated with 4x104 L-929 
cells to test the TNF level. The amount of L-929 cells that survived the 




5.3.2 Effect of FH and SFAl on the Augmentation of Murine Serum S R B C Lvsing 
Factor Level 
Male ICR albino mice were injected with SRBC intraperitoneally on day 0. The 
mice were also injected either with NaCl, FH or SFAl on day -2, 0 and 2. Serum obtained 
from the mice on day 6 was tested for SRBC lysing factor level. The SRBC lysing factor 
level was monitored by the degree of SRBC lysis. As clearly shown in Fig. 5.20’ serum 
obtained from ICR albino mice treated with SFAl caused significantly more SRBC lysis 
with respect to control. However, serum obtained from ICR albino mice treated with FH 
just increased the SRBC lysis slightly when compared with control. 
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Fig. 5.20 The effect of FH and SFAl on the augmentation of mouse serum 
SRBC lysing factor (complement) level. Mice, immunised with SRBC on day 
0，were either injected with NaCl, FH or SFAl intraperitoneally on day -2, 0 
and 2. Serum was obtained from the mice on day 6 and the SRBC lysing 
factor level of the serum was monitored by the ability of the serum to lyse 
sensitised SRBC. The degree of SRBC lysis was measured by measuring 




The results of this chapter summarised the effect of FH and SFAI on some 
important immune cells—B-, T-cells and macrophages. In the in vitro system, it is clear 
that only FH possess the ability to cause blastic transformation of murine splenic 
lymphocytes. Even the mitogenic activity of FH is small but still significant. The mitogenic 
activity of FH was not affected much by the present of PMB. Since PMB can bind to lipid 
A of LPS and abolishes the mitogenic activity of LPS (Jacobs, 1977), the blastic 
transformation ability of FH in the in vitro system should not be due to LPS 
contamination. When further tested, it was found that FH is a weak B-cell rather than a T-
cell mitogen in vHro. Even though FH possesses some blastic transformation ability by 
itself alone, FH like SFAI cannot potentiate the mitogenic activity of some powerful 
mitogenic agent such as LPS and ConA in vitro. Furthermore, FH and SFAI also failed to 
increase the division of mouse bone marrow cells in vitro. In in vivo system, a different 
situation was observed, both FH and SFAI were found to possess the ability to increase 
the blastic transformation of mouse splenic lymphocytes. In SRBC immunised mice, the 
first antibody production was not affected by FH and SFAI. This implied that FH and SFAI 
lack the capacity to stimulate B-cell in the in vivo system. 
Macrophages which play both regulator and effector function in in vivo system 
were not affected by FH but by SFAI in the in vitro system. However, in the in vivo 
system, the macrophages were activated by both FH and SFAI as there was a significant 
enhancement of in vivo phagocytic activity. Other than the enhancement of phagocytic 
activity, FH and SFAI also caused an increase in the migration of macrophages to the 
injection site in vivo. PEC containing macrophages, lymphocytes and other cell types 
when obtained from FH- and SFAI- treated mice did show an increased cytostatic activity 
against L-929 tumor cell in vitro. The increased cytostatic activity of the PEC inevitably 
enhance tumor killing process. Furthermore, PEC also exert a slight increase in Fc 
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receptor expression. The increased Fc receptor expression may enhance tumor killing 
through the antibody dependent cell cytotoxicity (ADCC) pathway. A greater number of 
Fc receptor on macrophage cell surface facilitated the binding of macrophages to tumor 
cells coated with antibody and thus enhanced subsequent tumor cell lysis. 
There exist many types of cytokines of different biological functions. Cytokines 
act as chemical messengers for the communication of immune cells and other cell types. In 
fact, the effector phases of both natural and specific immunity are mediated by cytokines. 
In natural immunity, the effector cytokines (monokines) are mainly produced by 
mononuclear phagocytes. In specific immunity, most of the cytokines (lymphokines) are 
produced by T-lymphocytes. The lymphokines are mainly responsible for the regulation of 
the activation, growth and differentiation of lymphocyte population. Some of the 
lymphokines may also regulate and activate inflammatory cells, such as mononuclear 
phagocytes, neutrophils and eosinophils. The augmentation of the immune cells by FH and 
SFAl should involve an increase in the secretion of certain kinds of cytokines. Five types 
of cytokines; IL-1 a , IL-4, GM-CSF, TNF and IFN-y，were selected for the investigation. 
It was found that only the serum TNF and IFN-y level was affected by the administration 
o f F H and SFAl. 
Only FH has the capacity to trigger a higher serum TNF level. TNF was secreted 
from activated macrophages, T-cells, NK cells and mast cells. TNF kill tumor cells but not 
normal cells. The direct binding of TNF to tumor cells trigger lethal cellular events. TNF 
flirther enhance tumor killing by affecting the vasculature of tumor (cutting off nutrient 
supply to the tumor). 
Both FH and SFAl have the capacity to increase serum IFN-y level. The biological 
actions of IFN-y support the idea that FH and SFAl when administered into mice activated 
T-cells and macrophages, and contributed to anti-tumor activity. IFN-y was mainly 
secreted from activated T-cell but NK cells also have some serections. The secreted IFN-y 
activated the mononuclear phagocyte, endothelial cell, NK cell, and increase the class I 
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and II MHC molecules of all cell types (Abbas, 1991). Mononuclear phagocyte and NK 
cell activated by IFN-y acquire capacity to kill tumor cells effectively. The augmentation 
of the expression of class I MHC molecule may make the tumor more susceptible to 
attack achieved by immune effector mechanisms. 
Other than serum cytokine level, the serum SRBC lysing factor level was also 
affected by FH and SFAl. SFAl did increase the serum SRBC lysing factor level of treated 
mice significantly. However, FH only increase the mouse serum SRBC lysing factor level 
just slightly. The increased SRBC lysing factor may be complement, which may play a role 
in the regression of tumor in vivo. Tumor cells that express particular antigens on the cell 
surface such as TSAs may sensitise the tumor bearing host to produce specific antibody 
direct against the tumor antigens. Tumor cells that were coated with the antibody were 
susceptible to lysis by complement through the classical complement pathway. 
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T H E A N T I T U M O R ACTIVITIES OF Flammulina velutipes 
Introduction 
Antitumor polysaccharides have been obtained from diverse sources, such as 
yeasts, fungi, lichens, bacteria and plants. The most active polysaccharides are 3)-
D-glucan isolated from flingi and lichens (Chihara et al, 1970; Shibata et al, 1968). The 
structure and anti-tumor activity of the glucans vary from source to source. Lentinan 
(LNT)’ a famous P-(l—3)-D-glucan extracted from Lentimis edodes, is very effective 
against mouse Sc-180 (Chihara et al, 1970), whereas the related pachyman is inactive but 
gains activity after partial Smith degradation which remove the side branches. In contrast 
to pachyman, schizophyllan (SPG) from Schizophylhim comnwne (Yamamoto et al, 1981) 
and zymosan from yeast cell wall (Brander et al, 1958) are highly branched p - ( l ->3 ) -D-
glucan, which show anti-tumor activity. Despite of the variations in the structure of the 
active |3-(l->3)-D-glucans, mechanism involved in the antitumor action of the 
polysaccharides against various implantable tumor cells is generally considered to be host 
mediated and not directly cytocidal (Bradner et al, 1958; Chihara et al, 1970). 
Results 
6.1 IN VITRO A N T I - T U M O R ACTIVITY OF FH A N D SFAl 
PU5-1.8 and Sc-180 tumor cells were cultured with FH or SFAl at various 
concentration (25 }.ig/ml, 50 |.ig/ml and 100 ^ig/ml). The direct toxic effect o f F H and SFAl 
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on the tumor cells were monitored by both thymidine incorporation and MTT dye. The 
results are shown in Fig. 6.1，6.2，6.3 and 6.4 respectively. The results of thymidine 
incorporation agreed with that of MTT dye. For both FH and SFAl, they showed little 
cytotoxic effect on the tumor cell lines. As the concentration of the polysaccharides 
increased, the percentage of tumor killing increased. Maximum killing usually attained at 
concentration beyond 50 ng/ml. 
6.2 Effect of FH and SFAl on the Growth of Murine Transplantable Tumors 
PU5-1.8 tumor cells ( a syngeneic tumor ) were grown in female BALB/c mice 
and Sc-180 tumor cells (an allogeneic tumor) were grown in male ICR albino mice. In 
case of PU5-1.8 tumor cells, the syngeneic tumor were injected into the peritoneal cavity 
of the female BALB/c mice on day 0. The regression of PU5-1 .8 tumor was monitored by 
counting the number of viable tumor cells of the peritoneal wash on day 7. The mice were 
either injected with NaCl, FH, FAl, SFAl or Yeast cell wall (YW) on day -2，-1，0，1，and 
2. The results were shown in Fig. 6.5. As shown in the figure, the injection of FH，but not 
FAl or SFAl，at 500 |.ig/mouse reduced the tumor growth significantly. For Sc-180 tumor, 
the allogeneic tumor cells were injected into male ICR albino mice subcutaneously. The 
mice were also injected either with NaCl, FH, FAl, SFAl, IFAJ or a-cel lulose on day 1，3， 
5, 7 and 9. Thirty-five days after the tumor injection, the regression of the tumor was 
monitored by weighting the solid tumor. The results are shown in Table 6 .1. The injection 
of FH, FAl and SFAl caused regression of the tumor significantly but not the injection of 
IFAJ or a-cellulose. The regression potency of FH, FAl and SFAl was similar (93, 98 and 
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Fig. 6.1 The in vitro cytotoxic effect of FH and SFAl on PU5-1.8 tumor 
cells. Various concentrations of FH and SFAl were cultured with 105 tumor 
cells for 48 hr. After the incubation, the cells were pulsed with 5 jnCi 3H-
TdR for 6 hr. and radioactivity incorporated was determined. Vertical bar 
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Fig. 6.2 The in vitro cytotoxic effect of FH and SFAl on PUS-1.8 tumor 
cells. Various concentrations of FH and SFAl were cultured with 105 tumor 
cells for 48 hr. After the incubation, 30 )il (5 mg/ml) MTT solution was 
added and incubated for further 1 hr. at 37 oC. Any blue formazan formed 
was solubilised by acidified isopropanol. Absorbance was measured at 540 
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Fig. 6.3 The in vitro cytotoxic effect of FH and SFAl on Sc-180 tumor 
cells. Various concentrations of FH and SFAl were cultured with 105 tumor 
cells for 48 hr. After the incubation, the cells were pulsed with 5 )iCi 3H-
TdR for 6 hr. and radioactivity incorporated was determined. Vertical bar 
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Fig. 6.4 The in vitro cytotoxic effect of FH and SFAl on Sc-180 tumor 
cells. Various concentrations of FH and SFAl were cultured with 105 tumor 
cells for 48 hr. After the incubation, 30 |i l (5 mg/ml) M T T solution was 
added and incubated for further 1 hr. at 37 oC. Any blue foraiazan formed 
was solubilised by acidified isopropanol Absorbance was measured at 540 
nm. Vertical bar represents one standard error. 
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Table 6.1 In vivo antitumor activity of different polysaccharide fractions 
isolated from FlammuUna velutipes. 
Sample Dose Inhibition Complete Significance 
( m g / k g ) ( % ) regression ( P < ) 
NaCl / / 0/6 / 
FH 15 93.1 土 10.1 3/6 0.05 
FAl 15 97.8 土 2.9 3/6 0.05 
SFAl 15 94.1 ±9.1 4/7 0.05 
IFAl 15 5.0 土 34.2 0/6 N.S. 
g-cellulose 15 -24.7 ±40.5 0/5 N.S. 
Sarcoma 180 tumors were implanted subcutaneously in male ICR albino 
mice on day 0. The mice were also injected either with NaCl, FH, FAl, 
SFAl, IFAl or a-cellulose. Mice with no noticeable size of tumor, 20 days 
after tumor inoculation, were removed. Thirty days after tumor injection, 
tumor was excised and weighted. 
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Fig. 6.5 The effect of FH and SFAl on the growth of PU5-1.8 tumor in 
vivo. Seven day old PU5-1.8 tumor cells, 106 were injected into the 
peritoneal cavity of female BALB/c mice on day 0. The mice were also 
treated with either NaCl, FH, FAl or SFAl on day -2, -1,0, 1 and 2. On day 
7, the number of viable PUS-1.8 tumor cells was counted by the tryphan 
blue dye exclusion method. The * mark means that the experimental value 
was significantly different from that of control at p < 0.05. Vertical bar 




In our previous work, FH and SFAl were shown to be non-toxic to normal cells. 
The lack of direct cytocidal activity of FH and SFAl on tumor cells was demonstrated by 
culturing PU5-1.8 and Sc-180 tumor cells with FH and SFAl in vitro. In contrast to the in 
vitro studies, the administration of FH and SFAl into tumor bearing mice caused 
regression of the tumor. The regression of the tumor should not be due to a direct 
cytocidal effect of FH and SFAl, as the in vitro studies suggested, but very likely be due to 
the enhancement of host mediated killing mechanisms~the immune system. 




G E N E R A L DISCUSSION AND FUTURE PERSPECTIVES 
Flammulina velutipes is an edible mushroom which is a popular foodstuff in 
Oriental countries. This type of flingus has no known medicinal purposes in traditional 
Chinese medicine. However, like other edible mushrooms, the p-( l->3)-D-glucans 
extracted from the mushrooms were active against murine syngeneic and allogeneic 
tumors in mice. 
The FH and SFAl fractions extracted from Flammulina velutipes were found to 
contain mainly polysaccharides which have mainly P-(l->3)-D-linkage and other minor 
linkage(s) in the polymer. The minor linkage as revealed by the periodate oxidation is very 
likely to be P-(l-^6)-D-linkage. If there are really 40 % of glucose in the fractions 
involved in the P-(l->6)-D-linkage, it is very likely that the primary structure of FH and 
SFAl is similar to structure shows in Fig. 7.1—a structure of ( l ->3)-D-glucan containing 
3 p-( l—3)-D-glucose residues in a linear chain and 2 p-( l ->3)-D-glucose residues 
forming a single branch, or similar to the structure of the water-soluble D-glucan extracted 
from AuricuJaria aiiricu/a-Judae (Misaki et al, 1981; Ukai et al, 1983) as shown in Fig. 
7.2—a structure of ( l -^3)-D-glucan consisting 3 p-( l ->3)-D-glucose residues in a linear 
chain and 2 P-( 1 ->6)-D-glucopyranoside branches. The minor linkage or the actual 
linkage can be elucidated by methylation analysis which has not been done in this project. 
As mentioned before, the Congo Red method just provided a preliminary study of the 
higher structure of the P-(l->3)-D-glucan(s) in FH and SFAl. P-( l—3)-D-glucan(s) in FH 
was found to have a triple helical structure but SFAl was found to have a single helical 
structure. In order to have a clearer picture of the structures, data from IR, N M R and 
even X-ray crystallographic analysis should be obtained. 
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Fig. 7.1 Chemical structure of aD-glucan containing 3 p-(l—3)-D-glucose 
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The purity of the fractions especially the FH fraction was challenged by the gel 
permeation chromatographic separation using G-200. Indeed, the separation profile of FH 
showed a major and a minor peak. The two fractions, the major and the minor peak, of FH 
were not separated for bioassay or further analysis. The chromatographic separation 
require FH fraction to be treated with alkaline to reduce the viscosity of FH but at the 
same time disrupted the higher structure of FH. From chemical analysis, the 
polysaccharides of FH were very likely to have no charge and thus ion exchange 
chromatography was not suitable for separation purpose. It seems that fractional 
precipitation or ultracentrifugation may be ideal for the further purification of FH and 
SFAl. 
In general, FH and SFAl were both not very active in in vitro system. However, 
in the in vivo system, FH and SFAl were found to be able to activate macrophage and 
lymphocyte. The type of lymphocytes to be activated was very likely to be T-lymphocyte 
as suggested by the VDH response (Aoki, 1984). In fact, FH and SFAl were demonstrated 
not able to enhance the B-lymphocyte function iu vivo. Whether other immune cells such 
as NK，CTL etc. were activated by FH and SFAl require further investigation. FH and 
SFAl were found to be able to activate some effectors of the immune system of mice. It is 
still a question whether FH and SFAl have the capacity to activate the human immune 
system. 
The activation of the immune effectors may lead to the secretion of TNF. FH 
was found to be able to trigger the release of a factortaht killed the tumor cells, which may 
be tumor necrosis factor (TNF), one hour after intraveneous injection. If the released 
killing factor was really TNF, FH can thus trigger TNF release by a single injection. This is 
quite uncommon. The release of TNF may involve three stages; the normal stage, the 
primed stage and the triggered stage. At normal stage, no transcription or translation o f 
TNF occurred. At the primed stage, TNF gene is actively transcripted and the transcripted 
TNF inRNA is then translated to give precursor TNF. The translated precursor TNF 
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anchored on cell surface membrane and ready to be released. At triggered stage, stimulant 
elicits the processing of precursor TNF and releases of mature TNF. Most substances 
which can elicit TNF release by furnishing the triggered stage but not the primed stage. If 
the released factor is TNF, the action of FH may already exist at the primed stage. 
Therefore, no priming action (e.g. administration of zymosan<Va primer) is required. 
Alternatively, the polysaccharide(s) of FH may serve as a primer as well. Zymosan, which 
is roughly composed of equal amount of P-(l->3)-D-glucan and mannan. The close 
resemblance of polysaccharide(s) of FH to P-(l->3)-D-glucan of zymosan may allow FH 
to flirnish the priming and the triggering event. 
FH and SFAl were found to be non-toxic to normal and tumor cells in vitro. 
However, FH and SFAl were highly tumoricidal in vivo. All the evidence so far suggested 
that FH and SFAl caused the regression of tumor in vivo by the enhancement of host 
mediated killing mechanisms rather than a direct cytocidal effect. The actual mechanism of 
the augmentation of the antitumor immunity was not known but it may be due to the 
antigenicity of the polysaccharides. Exogenous substances activate host immune system 
when entered the host body. Unlike proteins, the antigenicity of polysaccharides is rather 
low. In fact, polysaccharide polymer with highly regular structure and small molecular 
weight such as dextran of molecular weight below 50,000 do not induce antibody 
response in humans (Kabat, 1993). However, polysaccharide with highly regular structure 
but high molecular weight such as dextran of molecular weight over 90,000 have been 
shown to be antigenic in humans (Kabat, 1993). The extremely high molecular weight of 
the polysaccharides in the FH and SFAl fractions support the postulation that the injection 
of FH and SFAl into tumor bearing mice activated the immune system of the host. The 
activation may involve the processing of the possible antigenic polysaccharides. The 
activated immune cells not only remove the invading antigenic polysaccharides but also 
help flirnishing tumor cells killing. Alternatively , FH and SFAl may augment the 
antitumor immunity through non-specific activation of the host immune system. The 
1 5 1 
General Discussion 
administration of the FH and SFAl into tumor bearing host stimulates the host immune 
response non-specifically but activated immune cells contribute to tumor cells killing in 
tumor bearing host. In this case, FH and SFAl may not act as antigenic polysaccharides. 
For example, FH and SFAl were not processed before they can activate the immune 
system. In fact, no evidence suggested that there exist (3-( 1 ->3)-D-glucanase, which can 
digest p-(l->3)-D-glucan, in mammalian cells. Therefore, there may not exist any 
processing mechanisms to process the administered FH and SFAJ. Furthermore, Czop and 
Austen (1985) reported a p-D-glucan inhibitable receptor on human monocytes. The 
investigation of Czop found that the binding P-D-glucan to the P-D-glucan receptor elicits 
monocytes to metabolise endogenous arachidonic acid to substantial amount of 
luekotriene B 4 and thus cellular events. The experiment of Czop was done in in vitro 
conditions and no processing of glucan exist before the p-D-glucan applied to the 
monocytes. 
No matter which pathways is involved in the augmentation of the antitumor 
immunity. The administration of FH and SFAl into tumor bearing mice may activate 
macrophages and T-lymphocytes. The activated macrophages may furnish tumor cell 
killing through direct interaction with tumor cells or the secretion of TNF and 
complement. The direct binding of TNF to tumor cells trigger lethal cellular events. TNF 
further enhance tumor cells killing by cutting the blood supply of tumor mass. 
Complement secreted by macrophage may assist tumor cells killing through complement 
cell lysis pathway. The activation of T-cells may lead to the secretion of interferon-
gamma (INF-y) . The secreted INF-y may help furnishing tumor cells killing through 
several means. Firstly, INF-y can augment the action of TNF and thus tumor cells killing. 
Secondly, INF-y can promote the differentiation of B- and T- lymphocytes directly. The 
differentiated B- and T-lymphocytes may regulate antitumor effectors or be effector 
themselves. Finally, INF-y can augment the expression of Class I and II MHC molecule. 
The increase class II MHC molecule may enhance the recognition of tumor antigens by the 
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immune system and thus enhance tumor cells killing. An increase in the expression of class 
I MHC molecule also help furnishing tumor cells killing. The increased expression of class 
I MHC molecule may make tumor cells more susceptible to attack achieved by immune 
effector such as cytolytic T-lymphocytes. 
To be a useful antitumor agent for clinical purpose, FH and SFAl should be shown 
to be active anti-tumor agent in human. Furthermore, the usefulness also depends on 
whether the fractions were active against various type of cancer. All these require further 
investigations. Other than the use of FH and SFAl as a potential anti-tumor agent, the 
immunopotentiating activities of FH and SFAl suggest that FH and SFAl may have 
potential use in the therapy of some viral, bacterial, flingal and even highly pathogenic 
parasitic diseases such as leishmaniasis, filariasis, toxoplasmosis etc.. 
The hydroxyl groups of the glucose monomers of the glucan can easily be 
substituted with groups such as sulfate, acetate, amino, carboxyl methyl etc.. It is 
interesting to chemically modify FH and SFAl by adding substituent group to the 
polysaccharides. Furthermore, the effect of debranching and digesting the polysaccharides 
on the immunomodulatory and antitumor activity will remain an interesting topic for 
future investigations. 
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